Variability in Creatinine and Estimated Glomerular Filtration Rate in diabetic nephropathy by Nair, S
	  
	  





	  	  	  
	  
 
Variability	  in	  Creatinine	  and	  Estimated	  Glomerular	  Filtration	  Rate	  in	  
diabetic	  nephropathy	  	  
 
Thesis submitted in accordance with the requirements of the University of Liverpool 
for the degree of Doctor of Philosophy by 
 
 






University of Liverpool, Department of Obesity and Endocrinology, Clinical Sciences 






2	  |	  P a g e 	  
	  
                   
 Acknowledgements	  
This	  project	  would	  not	  have	  been	  possible	  without	  the	  support	  and	  contributions	  of	  various	  
people,	  some	  of	  whom	  I	  would	  like	  to	  acknowledge	  here.	  
I	  would	   like	   to	   express	  my	   gratitude	   to	   Professor	   John	  P	  H	  Wilding	   and	  Professor	   Kevin	   J	  
Hardy	   for	   their	   supervision	   for	   my	   studies	   and	   providing	   mentorship	   for	   my	   career	  
development.	  
I	  would	   like	  to	  thank	  Professor	  Paulo	  Lisboa	  at	  JMU	  for	  his	  help	  and	  advice	  with	  statistical	  
analysis	   of	  my	   data.	   I	  would	   also	   like	   to	   thank	  Dr	   Richard	   Chudleigh	   and	   Professor	   David	  
Owens	  at	  Cardiff	  University	  for	  sharing	  their	  data,	  which	  was	  used	  in	  chapter	  5	  of	  this	  thesis.	  
I	  am	  grateful	  to	  Professor	  Vinjamuri	  at	  RLUH	  nuclear	  medicine	  department	  for	  his	  support	  
with	  glomerular	  filtration	  measurements.	  
As	   always,	   I	   am	   fortunate	   to	   have	   the	   enthusiastic	   support	   of	   my	   wife	   Vidya,	   and	   my	  
children	  Adi	  and	  Ria,	  which	  was	  crucial	  for	  completion	  of	  this	  project.	  
Finally	  my	  sincere	  thanks	  to	  all	  the	  participants	  of	  the	  studies	  including	  people	  with	  diabetes	  













Diabetic	   nephropathy	   is	   a	   leading	   cause	   of	   end	   stage	   renal	   disease	   (ESRD)	   in	   the	   world.	  
Accurate	   screening	   and	   staging	   of	   chronic	   kidney	   disease	   (CKD)	   is	   essential	   for	   timely	  
intervention	  as	  recommended	  by	  national	  and	  international	  guidelines	  (KDOQI,	  2007,	  RCP,	  
2006)	  and	  to	  guide	  dose	  adjustment	  of	  several	  medicines.	  Glomerular	  filtration	  rate	  (GFR)	  is	  
recognised	  as	  the	  best	  measure	  of	  kidney	  function	  in	  health	  and	  disease,	  but	  measuring	  it	  by	  
gold	   standard	   techniques	   such	  as	   inulin	   clearance,	   and	   radio-­‐isotopic	  methods	   is	   clinically	  
impractical.	   Therefore	   estimation	   of	   GFR	   using	   serum	   creatinine	   and	   other	   variables	   like	  
age,	   gender	   race	   and	   body	   size	   is	   recommended	   (Levey,	   2003,	   Levey,	   2006).	   The	   most	  
widely	  used	  formula	  to	  estimate	  GFR	  is	  the	  4-­‐variable	  MDRD	  equation.	  
Aims	  &	  Methods	  
My	  thesis	  contains	  studies	  of	  variation	  in	  serum	  creatinine,	  estimated	  glomerular	  filtration	  
rate	   and	   urinary	   albumin	   creatinine	   ratio.	   There	   are	   two	  main	   experimental	   studies	   and	  
three	  further	  studies	  based	  on	  data	  analyses	  and	  validation.	  	  
1. Effect	   of	   obesity	   on	   eGFR	   in	   type	   2	   diabetes:	   The	   aim	   was	   to	   estimate	   the	   bias	  
between	   isotopic	  glomerular	   filtration	  rate	   (GFR)	  and	  eGFR	   in	  patients	  with	  Type	  2	  
diabetes	  with	  chronic	  kidney	  disease	  and	  relate	  it	  to	  their	  body	  mass	  indices	  (BMI).	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GFR	  was	  measured	  using	   51Cr	  EDTA	  method	  and	  was	  estimated	  by	  4v-­‐MDRD	  eGFR	  
using	  IDMS	  calibrated	  creatinine	  in	  111	  participants.	  
2. The	  performance	  of	  CKD-­‐EPI	  formula	  compared	  to	  the	  MDRD	  equation	  in	  estimating	  
GFR	   in	   participants	  with	   type	   2	   diabetes	   associated	   CKD:	   The	   aim	  was	   to	   use	   our	  
dataset	  to	  compare	  the	  effect	  of	  obesity	  on	  eGFR	  calculated	  by	  the	  CKD-­‐EPI	  formula	  
(Levey	  and	  Stevens)	  and	  by	  the	  4-­‐variable	  MDRD	  equation.	  	  
3. Derivation	   of	   obesity	   correction	   equation	   for	   4-­‐variable	   MDRD:	   To	   derive	   a	  
‘correction	   factor’	   for	   the	   4-­‐variable	   MDRD	   equation	   to	   adjust	   for	   the	   equation’s	  
underestimation	  of	  true	  (isotopic)	  GFR	  in	  obese	  subjects	  with	  Type2	  diabetes.	  Linear	  
and	   non-­‐linear	   regression	   analysis	   were	   performed	   to	   derive	   equations	   which	  
reduced	  the	  bias	  between	  estimated	  and	  measured	  GFR	  
4. Effect	  of	  cooked	  meat	  protein	  on	  eGFR	  estimation	  in	  type	  2	  Diabetes	  related	  chronic	  
kidney	  disease:	  To	  estimate	  the	  biological	  variation	   in	  creatinine	   levels	  caused	  by	  a	  
standardised	  cooked	  meat	  meal	  in	  subjects	  with	  diabetes	  mellitus	  and	  various	  stages	  
of	  chronic	  kidney	  disease,	  compared	  to	  healthy	  volunteers.	  64	  participants	  in	  chronic	  
kidney	  disease	  stages	  1-­‐4	  and	  16	  healthy	  volunteers	  were	  fed	  cooked	  meat	  and	  non-­‐
meat	   protein	  meals	   to	   study	   the	   effect	   of	   cooked	  meat	   protein	   on	   creatinine	   and	  
eGFR.	  
5. Effect	  of	   cooked	  meat	  protein	  on	  urinary	   albumin	   creatinine	   ratio	   in	  patients	  with	  
type2	  Diabetes	  related	  chronic	  kidney	  disease:	  To	  determine	  the	  effect	  of	  a	  cooked	  
meat	   meal	   on	   UACR	   in	   diabetic	   patients	   with	   diabetes	   related	   chronic	   kidney	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disease.	  80	  participants	  had	  their	  urinary	  albumin	  creatinine	  ratio	  calculated	  before	  
and	  4	  hours	  after	  a	  cooked	  meat	  meal.	  
	  
Results	  &	  Conclusions	  
1. The	  4-­‐v	  MDRD	  formula	  underestimates	  GFR	   in	  overweight	  and	  obese	  patients	  with	  
Type	  2	  diabetes.	  The	  bias	  between	  estimated	  and	  measured	  GFR	  in	  the	  obese	  type	  2	  
diabetic	  subjects	  persists	  across	  the	  range	  of	  CKD	  stages.	  This	  may	  have	  Implications	  
for	  management	  of	  obese	  patients	  with	  Type	  2	  diabetes,	  where	   treatment	  options	  
for	   the	   management	   of	   hyperglycaemia,	   hypertension	   and	   other	   concomitant	  
conditions	  are	  often	  determined	  by	  the	  eGFR.	  
2. The	   bias	   between	   estimated	   and	  measured	   GFR	   significantly	   worsens	   when	   eGFR	  
was	   calculated	   using	   the	   CKD-­‐Epi	   compared	   to	   the	   4	   variable	   MDRD	   formulas	   in	  
patients	  with	  type2	  diabetes	  and	  chronic	  kidney	  disease.	  	  There	  remains	  a	  need	  for	  
better-­‐validated	  equations	  to	  estimate	  GFR	  in	  the	  obese	  patients	  with	  diabetes.	  
3. The	   linear	   and	   non-­‐linear	   equations	   derived	   from	   our	   study	   reduce	   the	   bias	  
significantly	  in	  the	  external	  dataset;	  this	  improvement	  being	  more	  pronounced	  in	  the	  
obese	   subjects	   and	   is	   best	   achieved	   by	   the	   ratio	   model	   equation	   which	   scores	  
consistently	   well	   across	   all	   three	   ranges	   of	   GFR	   studied,	   including	   a	   very	   good	  
positive	  predictive	  value	  in	  CKD	  stage	  3	  in	  the	  obese.	  This	  simple	  corrective	  factor	  if	  
externally	  validated	  can	  be	  used	  when	  making	  management	  decisions	   in	  the	  obese	  
with	  type2	  diabetes	  based	  on	  eGFR.	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4. Consumption	   of	   a	   standardised	   cooked	   meat	   meal	   significantly	   increased	   serum	  
creatinine	  and	  resulted	  in	  significant	  fall	  in	  eGFR	  in	  all	  stages	  of	  CKD	  studied;	  6	  of	  16	  
CKD	  3a	  patients	  were	  misclassified	  as	  CKD	  3b.	  	  This	  effect	  of	  cooked	  meat	  on	  serum	  
creatinine	  disappears	  after	  12	  hours	  of	   fasting	   in	  all	   study	  participants.	  Creatine	   in	  
meat	   is	   converted	   to	   creatinine	   on	   cooking.	   This	   is	   absorbed	   causing	   significant	  
increase	  in	  serum	  creatinine	  levels	  and	  a	  consequent	  drop	  in	  eGFR.	  This	  could	  impact	  
management	  as	  threshold	  for	  commencing	  and	  withdrawing	  certain	  medications	  and	  
decisions	   regarding	   investigations	   is	   defined	   by	   eGFR.	   An	   eGFR	   calculated	   using	  
fasting	   serum	   creatinine	   would	   be	   a	   better	   reflection	   of	   kidney	   function	   in	   these	  
patients.	  
5. Urine	   albumin	   to	   creatinine	   ratio	   falls	   after	   a	   cooked	  meat	   meal	   in	   patients	   with	  
diabetes	  associated	  chronic	  kidney	  disease.	  This	  fall	  in	  ACR	  increases	  with	  worsening	  
stages	  of	  chronic	  kidney	  disease.	  Cooked	  meat	  consumption	  is	  a	  major	  factor	  leading	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   Angiotensin	  converting	  enzyme	  
ARB	   Angiotensin	  receptor	  blocker	  
ACR	   Albumin	  creatinine	  ratio	  
BMI	   Body	  mass	  index	  
BSA	   Body	  surface	  area	  
CAD	   Coronary	  artery	  disease	  
CC	   Creatinine	  clearance	  
CE	   Capillary	  electrophoresis	  
CG	   Cockcroft-­‐Gault	  
51Cr	   Radioactive	  chromium	  
CKD	   Chronic	  kidney	  disease	  
CV	   Coefficient	  of	  variation	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   Cardiovascular	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DTPA	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  triamine	  penta	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   Ethylenediaminetetraacetic	  acid	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EM	   Electron	  microscope	  
ESRD	   End	  stage	  renal	  disease	  
eGFR	   Estimated	  glomerular	  filtration	  rate	  
GFR	   Glomerular	  filtration	  rate	  
HbA1c	   Glycated	  haemoglobin	  
IBW	   Ideal	  body	  weight	  
IDMS	   Isotope	  dilution	  mass	  spectrometry	  
MA	   Microalbuminuria	  
MDRD	   Modification	  of	  diet	  in	  renal	  disease	  
MS	   Mass	  spectrometry	  
PAS	   Periodic	  acid	  Schiff	  
RAAS	   Renin	  angiotensin	  aldosterone	  system	  
RR	   Relative	  risk	  
RRT	   Renal	  replacement	  therapy	  
SD	   Standard	  deviation	  
T2DM	   Type	  2	  diabetes	  mellitus	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Glomerular	  filtration	  rate	  
	  
1.2	  Glomerular	  structure	  and	  physiology	  
	  
The	  two	  human	  kidneys	  contain	  nearly	  2	  million	  glomeruli,	  each	  having	  an	  average	  volume	  
of	  0.0042	  cubic	  mm.	  The	  glomerulus	  consists	  of	  a	   tuft	  of	  capillaries	   that	   is	   supplied	  by	  an	  
afferent	   arteriole.	   The	   afferent	   arteriole	   breaks	   into	   as	  many	   as	   50	   capillary	   loops,	  which	  
coalesce	   into	  an	  efferent	  arteriole.	  This	  glomerular	   tuft	   is	  enveloped	   in	  a	  spherical	  double	  
walled	   capsule	   called	   the	   Bowman’s	   capsule	   derived	   from	   the	   renal	   tubule(Smith,	   1951).	  
The	   glomerular	   filtration	   barrier	   is	   formed	   by	   the	   fenestrated	   endothelium,	   glomerular	  
basement	  membrane	  and	  podocytes	  and	  their	  slit	  processes.	  
In	   each	   glomerulus	   about	   0.001	   cubic	   mm.	   of	   filtrate	   is	   formed	   per	   second.	   The	   total	  
filtration	   area	   in	   the	   two	   kidneys	   has	   been	   calculated	   from	   autopsy	   specimen	   in	   a	   child	  
(Book,	  1936)and	  adult	  kidneys	   (Vimtrup,	  1928)	  and	  estimate	   it	   to	  be	  0.76	  m2	  and	  1.76	  m2	  
respectively	  or	  nearly	  the	  body	  surface	  area	  of	  man	  (1.73m2).	  
The	  average	  rate	  of	  filtration	  in	  man	  corrected	  to	  standard	  body	  surface	  area	  (1.73m2)	  is	  127	  
ml/minute:	   85%	   of	   this	   is	   reabsorbed	   in	   the	   proximal	   tubule	   (obligatory	   reabsorption)	  
leaving	   only	   about	   20	  ml/minute	   to	   be	   excreted	   during	  maximum	  water	   diuresis.	   During	  
periods	  of	  dehydration	  however,	  most	  of	  this	  water	  is	  reabsorbed	  (facultative	  reabsorption)	  
reducing	  the	  urine	  flow	  to	  1	  ml/minute	  (Smith,	  1951).	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Figure	  1:	  Glomerular	  physiology	  
	  
Glomerular	   filtration	   rate	   is	   the	   sum	   of	   filtration	   of	   all	   nephrons.	   The	   determinants	   of	   a	  
single	  nephron	  GFR	  are	  included	  in	  the	  following	  equation:	  
GFR	  =	  KF	  (Ultrafiltration	  coefficient)	  X	  ΔP	  (Net	  filtration	  pressure)	  
KF	   represents	   the	   product	   of	   glomerular	   surface	   area	   available	   for	   filtration	   and	   its	  
permeability.	  ΔP	  is	  defines	  as	  the	  difference	  between	  trans-­‐glomerular	  hydrostatic	  pressure	  
and	   oncotic	   pressure	   gradients.	   The	   level	   of	   renal	   blood	   flow	   and	   afferent	   and	   efferent	  
arteriolar	  resistances	  in	  turn	  affects	  the	  hydrostatic	  pressure	  gradients.	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The	  ultrafiltration	  coefficient	  can	  drop	  owing	  to	  a	  reduction	  in	  glomerular	  surface	  area	  as	  in	  
glomerular	  injury	  due	  to	  various	  causes	  and	  also	  as	  a	  result	  of	  reduced	  permeability	  due	  to	  
damage	   to	   glomerular	   capillary	   wall	   as	   in	   diabetic	   nephropathy.	   Perfusion	   of	   previously	  
under	  perfused	  capillaries	  or	  glomerular	  hypertrophy	  may	  compensate	  for	  these	  changes	  to	  
maintain	   KF.	   Once	   ultrafiltration	   coefficient	   starts	   to	   reduce,	   increase	   in	   trans-­‐glomerular	  
hydrostatic	  pressure	  gradient	  sets	  in	  as	  a	  compensatory	  mechanism	  to	  maintain	  glomerular	  
filtration	  rate.	  Hence	  the	  measurement	  of	  GFR	  may	  not	  initially	  reveal	  structural	  damage	  to	  
the	  nephrons	  (Levey,	  1990).	  
	  
1.2	  Renal	  auto-­‐regulation:	  
Glomerular	   filtration	   remains	   relatively	   constant	  over	  a	   range	  of	  physiological	   renal	  blood	  
flow	   and	   urine	   output.	   This	   is	   possible	   due	   to	   renal	   auto-­‐regulation,	   which	   is	   a	   process	  
independent	   of	   the	   central	   nervous	   system.	   Auto-­‐regulation	   is	   primarily	   affected	   by	   the	  
preferential	  constriction	  of	  afferent	  and	  efferent	  arterioles	  to	  maintain	  a	  relatively	  constant	  
glomerular	   filtration	   pressure.	   The	   renal	   blood	   flow	   remains	   relatively	   constant	   in	  
individuals	  and	  this	  is	  primarily	  mediated	  by	  the	  efferent	  arteriolar	  tone.	  Adrenaline	  infusion	  
causes	   decreased	   blood	   flow	   but	   an	   increase	   in	   filtration	   fraction	   due	   to	   maximal	  
constriction	   of	   the	   efferent	   arterioles	   causing	   increase	   in	   filtration	   pressure.	   Infusion	   of	   a	  
pyrogen	  such	  as	  Typhoid	  vaccine	   increases	  renal	  blood	  flow	  but	   leads	  to	  a	   fall	   in	   filtration	  
pressure	   due	   to	  maximal	   dilatation	   of	   the	   efferent	   arterioles.	   The	   filtration	   pressure	   and	  
filtration	   fraction	   remains	   constant	   due	   to	   the	   predominance	   of	   efferent	   over	   afferent	  
arteriolar	  tone	  (Chasis	  et	  al.,	  1938).	  	  	  
	  
	  




Figure	  1.2:	  Simultaneous	  inulin	  and	  urea	  clearances	  in	  man	  at	  constant	  and	  decreasing	  urine	  flows	  
Reproduced	  with	  permission	  (Chasis	  and	  Smith,	  1938).	  The	  rate	  of	  clearance	  of	  urea	  and	  inulin	  
remains	  relatively	  constant	  despite	  a	  range	  of	  urine	  flow.	  
	  
The	  current	  view	  is	  that	  renal	  autoregulation	  is	  based	  mainly	  on	  two	  adaptive	  mechanisms	  
acting	  on	  the	  pre-­‐glomerular	  resistance	  vessels	  (arcuate,	  interlobular	  and	  afferent):	  
1. Myogenic	   response:	   it	   is	   a	   function	   of	   smooth	   muscle	   to	   contract	   in	   response	   to	  
stretching	  force.	  The	  exact	  mechanism	  remains	  unclear,	  but	  it	  is	  known	  to	  involve	  a	  
stretch	   dependent	   depolarisation	   of	   cell	   membranes	   and	   influx	   of	   calcium	   ions	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Myogenic	  response	  has	  not	  been	  observed	  in	  efferent	  arterioles	  probably	  because	  of	  
lack	  of	  voltage	  gated	  calcium	  channels.	  
	  
2. Tubulo-­‐glomerular	  feedback	  (TGF):	  TGF	  leads	  to	  constriction	  of	  afferent	  arterioles	  in	  
response	   to	   increase	   in	   sodium	   chloride	   at	   the	   maculo-­‐densa	   in	   the	   early	   distal	  
tubules.	   Increased	  arterial	  pressure	   increases	  tubular	   flow	  by	   increasing	  GFR	  which	  
leads	  to	  rise	  in	  tubular	  sodium	  chloride	  concentration(Just,	  2007).	  	  
	  
NSAIDs	   and	   COX	   2	   inhibit	   afferent	   arteriolar	   vasodilatation	   by	   inhibiting	   prostaglandin	   E2	  
production.	   ACE-­‐inhibitors	   /	   Angiotensin	   receptor	   blockers	   inhibit	   efferent	   arteriolar	  
vasoconstriction	  by	   inhibiting	  the	  effect	  of	  Angiotensin	  II.	  These	  medications	  severely	   limit	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Inulin	  clearance	  
1.3	  Renal	  Clearance	  
Renal	   clearance	   is	   a	   longstanding	   concept	   that	   came	   into	   being	   before	   the	   concept	   of	  
glomerular	  filtration	  rate.	  It	  is	  defined	  as	  the	  rate	  at	  which	  the	  kidney	  excretes	  a	  substance	  
in	   relation	   to	   its	   plasma	   concentration.	   Renal	   clearance	   is	   expressed	   by	   the	   equation	  
UxVx/Px	  where	  Ux	  is	  the	  urinary	  concentration	  of	  x,	  V	  is	  the	  rate	  of	  urine	  formation,	  and	  Px	  
is	  the	  plasma	  concentration.	  It	  is	  the	  volume	  of	  plasma	  completely	  cleared	  of	  that	  substance	  
in	  a	  minute(Smith,	  1951).	  Renal	  clearance	  however	  does	  not	  inform	  us	  of	  the	  mechanism	  of	  
clearance	  of	  a	  substance;	  whether	  by	  filtration	  and	  tubular	  reabsorption,	  filtration	  alone,	  or	  
filtration	  plus	  tubular	  secretion.	  
Homer	  Smith	  and	  co-­‐workers	  undertook	   to	   find	  a	  substance	   that	  can	  be	  used	   to	  measure	  
glomerular	   filtration.	   The	   observation	   of	   aglomerular	   kidneys	   in	  marine	   fishes	   particularly	  
goosefish	  and	  toadfish	  was	  very	  useful	  for	  some	  of	  the	  subsequent	  glomerular	  physiological	  
studies.	   The	   substances	   which	   were	   previously	   shown	   to	   be	   excreted	   by	   aglomerular	  
kidneys,	  like	  magnesium,	  sulphate,	  chloride,	  creatinine,	  uric	  acid,	  phenol	  red,	  etc.	  could	  be	  
excluded	  straight	  away.	  The	  fact	  that	  aglomerular	  kidney	   is	  unable	  to	  excrete	  glucose	  was	  
an	   interesting	  observation	  and	  made	  glucose	  a	  potential	   candidate,	  but	  experiments	  with	  
phlorizin	   had	   already	   established	   that	   glucose	   is	   reabsorbed	   from	   the	   tubules.	   They	  
therefore	   focussed	   attention	   on	   metabolically	   inert	   carbohydrates	   that	   may	   not	   be	  
reabsorbed	  by	  the	  renal	  tubules	  (Smith,	  1951).	  
Inulin	  is	  a	  starch	  like	  polymer	  consisting	  of	  fructose	  with	  a	  molecular	  weight	  of	  about	  5000	  
Daltons,	  but	  having	  an	  elongated	  structure	  its	  diffusion	  coefficient	  is	  similar	  to	  a	  substance	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with	  a	  molecular	  weight	  of	  15000.	  The	  limit	  of	  glomerular	  permeability	  has	  been	  shown	  to	  
be	  around	  60000	  (Smith,	  1951).	  Inulin	  is	  completely	  filterable	  from	  plasma.	  It	  is	  not	  excreted	  
by	   aglomerular	   fish	   kidney.	   After	   intravenous	   administration	   in	   7	   volunteers	  with	   normal	  
kidney	  function	   inulin	  was	  rapidly	  and	  completely	  excreted	  in	  the	  urine	  and	  was	  shown	  to	  
have	   a	   linear	   relationship	   between	   its	   rate	   of	   excretion	   and	   plasma	   concentration.	   This	  
could	  only	  be	   achieved	  by	   a	   substance,	  which	   is	   not	   reabsorbed	  or	   excreted	  by	   the	   renal	  
tubules,	   as	   both	   these	   processes	   have	   a	   tubular	   maximum.	   	   Inulin	   clearance	   was	   thus	  
considered	  a	  good	  measure	  of	  glomerular	   filtration	   rate.	  The	  actual	  method	  of	  measuring	  
inulin	  clearance	  has	  remained	  a	  subject	  of	  discussion	  and	  controversy.	  	  
	  
1.4	  Urine	  collection	  method	  
The	   classical	   method	   of	   inulin	   clearance	   involved	   infusing	   inulin	   and	   measuring	   inulin	   in	  
timed	  urine	  and	  plasma	  samples.	  These	  values	  are	   then	  used	   to	  calculate	   inulin	  clearance	  
using	   the	   clearance	   equation	  mentioned	   above.	   The	   following	  method	   is	   as	   described	   by	  
Shannon	  and	  Smith	  in	  their	  classical	  experiment	  published	  in	  1935.	  	  
Inulin	   is	   dissolved	   in	   sterile	   sodium	   chloride	   by	   heating	   to	   a	   temperature	   of	   85	   degree	  
Celsius	   and	   then	   cooled.	   100	   grams	   of	   inulin	   yield	   a	   blood	   concentration	   of	   300-­‐400	  mg	  
percent	   and	   fall	   to	   100	  mg	   percent	   in	   1.5	   to	   3	   hours.	   Inulin	   infusion	   is	   completed	   in	   30	  
minutes.	  A	  urinary	  catheter	  is	  inserted	  at	  80	  minutes	  and	  a	  preliminary	  washout	  of	  bladder	  
performed.	   The	   first	   period	   of	   urine	   collection	   is	   started	   at	   90	   minutes;	   each	   collection	  
period	  varies	  between	  10	  to	  20	  minutes	  in	  duration	  and	  3	  to	  12	  in	  number.	  Blood	  samples	  
were	  drawn	  as	  close	  to	  the	  middle	  of	  the	  periods	  of	  urine	  collection	  as	  possible,	  one	  sample	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for	  each	  urine	  collection.	  Glucose	  was	  removed	  by	  treating	  with	  yeast,	  as	  it	  is	  necessary	  to	  
make	  the	  sample	  starch	  free	  before	  measuring	  inulin.	  Inulin	  was	  hydrolysed	  in	  sugar	  tubes	  
by	  adding	  0.5cc	  of	   sulphuric	  acid,	  heating	   in	  a	  water	  bath	   for	  15	  minutes	  and	  cooling	  and	  
neutralising	   with	   potassium	   hydroxide.	   Inulin	   concentration	   was	   expressed	   as	   the	   total	  
reducing	  power	   expressed	   as	   the	   amount	   of	   glucose	   after	   hydrolysis.	  Once	   the	  urine	   and	  
plasma	   concentrations	   of	   inulin	   are	   measured,	   inulin	   clearance	   is	   calculated	   by	   the	  
clearance	  equation	  UV/P	  (Shannon	  and	  Smith,	  1935).	  
	  	  
1.5	  Constant	  infusion	  technique:	  
Several	  investigators	  introduced	  a	  constant	  infusion	  technique	  to	  obviate	  the	  need	  for	  timed	  
urine	  collections	  to	  measure	  urinary	  clearance	  (Earle	  and	  Berliner,	  1946,	  Berger	  et	  al.,	  1948).	  
Earle	  et	  al.	  demonstrated	  that	  if	  a	  substance	  is	  completely	  excreted	  through	  the	  kidneys	  and	  
if	   the	  plasma	   level	  were	  constant,	   then	   the	   rate	  of	   renal	  excretion	  would	  be	  equal	   to	   the	  
rate	  of	  infusion.	  Therefore	  in	  the	  clearance	  equation	  UV/P,	  UV	  can	  be	  replaced	  by	  the	  rate	  
of	   infusion.	   Earle	   et	   al	   compared	   renal	   clearance	  measured	   by	   serial	   urine	   collection	   and	  
constant	   infusion	   technique.	   The	  methodology	   used	   was	   described	   as	   follows.	   A	   priming	  
dose	   of	   inulin	  was	   given	   intravenously	   to	   achieve	   a	   plasma	   level	   of	   5	   to	   20	  mg	   per	   cent.	  
2grams	   of	   inulin	   priming	   injection	   resulted	   in	   plasma	   levels	   of	   10	   to	   15	   per	   cent.	  
Maintenance	  infusion	  was	  delivered	  by	  a	  pump	  at	  a	  rate	  calculated	  according	  to	  estimated	  
renal	   function	   of	   the	   subject.	   If	   the	   estimated	   filtration	   rate	   was	   100mls/min	   and	   if	   the	  
plasma	   concentration	   desired	   and	   achieved	   by	   the	   priming	  was	   5mg	   per	   cent,	   then	   each	  
minute	  100	  x	  0.005	  or	  5	  mg	  would	  be	  excreted	   in	  urine.	  The	  maintenance	   infusion	  should	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therefore	   be	   5mg	  per	  minute.	  Generally,	   infusion	   equilibrium	   is	   achieved	   at	   the	   end	  of	   1	  
hour.	  
They	  performed	  45	  experiments	   in	  26	  participants	  and	  found	  the	  results	  comparable.	  Also	  
the	  variation	   in	   clearance	  was	  much	   less	  with	   the	   infusion	  method	  compare	   to	   the	   timed	  
urine	  collection	  method	  
	  
1.6	  Single	  injection	  technique:	  
The	   intravenous	   infusion	   and	   timed	   urine	   measurement	   being	   labour	   intensive,	   several	  
studies	  were	  conducted	  to	  investigate	  the	  possibility	  of	  single	  injection	  techniques.	  	  
The	  filtration	  rate	  or	  plasma	  flow	  of	  a	  substance	  can	  be	  calculated	  from	  the	  rate	  of	  change	  
of	   plasma	   concentration	   of	   a	   substance.	   This	   however	   assumes	   that	   the	   volume	   of	  
distribution	   (V)	   of	   the	   substance	   is	   constant,	   mixing	   throughout	   of	   the	   substance	   is	  
instantaneous	   and	   so	   its	   concentration	   is	   uniform,	   and	   the	   substance	   is	   cleared	   from	   the	  
plasma	  at	  a	  constant	  rate	  (C).	  The	  concentration	  P2	  at	  any	  time	  t	  (in	  minutes)	  after	  P1	  will	  be:	  
Log	  P2=log	  P1-­‐Ct/V	  
The	  rate	  of	  clearance	  is	  expressed	  as:	  
C=V	  (log	  P1-­‐	  log	  P2/t)	  
The	  assumptions	  made	  were	  shown	  to	  be	  not	  valid	  by	  several	  investigators.	  Schachter	  et	  al.	  
showed	  that	  the	  mean	  concentration	  of	  inulin	  in	  the	  extracellular	  fluid	  is	  identical	  to	  that	  in	  
plasma	   at	   only	   one	   moment.	   They	   pointed	   out	   that	   after	   a	   single	   injection	   of	   inulin,	  
	  
	  
30	  |	  P a g e 	  
	  
equilibrium	  between	  plasma	  and	  extravascular	  component	  of	  the	  volume	  of	  distribution	  is	  
never	   reached(Schachter	   et	   al.,	   1950).	   Hence	   for	   inulin	   clearance	   the	   single	   injection	  
technique	   was	   not	   frequently	   employed.	   There	   have	   been	   some	   subsequent	   studies	  
demonstrating	  good	  agreement	  between	  single	  shot	  inulin	  injections	  and	  constant	  infusion	  
techniques	  over	  wide	  range	  of	  GFR.	  The	  coefficient	  of	  variation	  for	  the	  plasma	  clearance	  by	  
constant	   infusion	  and	   single	   shot	   injection	  was	   shown	   to	  be	  much	   lower	   than	   the	  urinary	  
clearance	  methods	  in	  a	  study(Florijn	  et	  al.,	  1994).	  
	  
1.7	  Limitations	  of	  inulin	  as	  a	  marker	  of	  renal	  clearance:	  
Inulin	   is	   most	   extensively	   investigated	   from	   a	   physiological	   point	   of	   view	   and	   hence	  
considered	  the	  gold	  standard,	  but	   it	  has	  several	   limitations.	   Its	  high	  molecular	  weight	  and	  
viscosity	   doesn’t	   allow	   it	   to	   reach	   volume	   of	   distribution.	   This	   may	   be	   the	   reason	   why	  
constant	  infusion	  with	  timed	  urinary	  collection	  is	  the	  only	  methodology	  with	  good	  accuracy.	  
Inulin	   is	   also	   expensive	   and	   not	   easily	   available	   on	   the	   market.	   There	   is	   also	   significant	  
variability	   in	  the	  different	  methodologies	   involved	  in	   its	  measurement	  in	  urine	  and	  plasma	  
(Delanaye	   et	   al.,	   2012).	   Most	   inulin	   measurement	   methods	   are	   based	   on	   fructose	  
estimation,	   as	   it	   is	   a	   fructose	   polymer.	   Methods	   other	   than	   the	   enzymatic	   ones	   can	   be	  
subject	  to	  assay	   interference	  by	  glucose	   leading	  to	  overestimation	  of	   inulin	  concentration,	  
which	  makes	   it	   not	   an	   ideal	  marker	   for	   patients	  with	   diabetes.	   Lentjes	   et	   al.	   described	   a	  
method	  to	  measure	  glucose	  simultaneously	  to	  make	  correction	  for	  it	  which	  could	  be	  helpful	  
in	  diabetes(Lentjes	  G	  W	  M,	  1994).	  Autonomic	  neuropathy	   in	  patients	  with	  diabetes	   could	  
contribute	  to	  incomplete	  urinary	  bladder	  clearance	  which	  makes	  timed	  urine	  collection	  very	  
challenging	  (Sambataro	  et	  al.,	  1996).	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1.8	  Single	  injection	  technique	  with	  Radiolabelled	  markers:	  
	  
Nosslin	   in	   1965	   demonstrated	   plasma	   clearance	   using	   the	   single	   injection	   technique.	   If	   a	  
substance	   mixes	   instantaneously	   with	   plasma,	   its	   initial	   concentration	   is	   the	   dose	  
administered	   divided	   by	   plasma	   volume	   (V).	   This	   is	   taken	   as	   1	   and	   subsequent	   values	  
represent	  the	  proportion	  of	  initial	  dose	  remaining	  at	  the	  time	  of	  sampling.	  The	  clearance	  is	  
calculated	   by	   the	   equation:	   C=	   V/A,	   where	   A	   is	   the	   total	   area	   under	   the	   plasma	  
disappearance	  curve.	  Since	  renal	  clearance	  occurs	  from	  the	  arterial	  blood,	  ideally	  arterial	  or	  
capillary	   samples	   should	   be	   used	   to	   construct	   the	   plasma	   disappearance	   curve.	   As	   time	  
elapses	  after	  injection	  at	  some	  point	  the	  arterial	  and	  venous	  concentrations	  become	  equal	  
and	  then	  the	  venous	  concentration	  starts	  to	  rise.	  The	  other	  caveat	  explained	  by	  Nosslin	  was	  
that	   some	   substances	  might	   require	   a	   long	   time	   to	   reach	   its	   true	   final	   slope.	   If	   sampling	  
ceases	   before	   reaching	   the	   final	   slope	   and	   the	   curve	   is	   extrapolated	   to	   infinity,	   the	   area	  
under	   the	   curve	   becomes	   too	   small	   and	   the	   clearance	   too	   large.	   The	   shorter	   the	   plasma	  
disappearance	  curve	  is	  followed	  the	  greater	  the	  error.	  It	  is	  better	  to	  sample	  at	  long	  intervals	  
for	  a	  long	  time	  than	  short	  intervals	  for	  a	  short	  period	  of	  time(Nosslin,	  1969).	  The	  single	  shot	  
technique	   is	   based	   on	   bi-­‐exponential	   function	   of	   time.	   The	   initial	   part	   of	   the	   plasma	  
disappearance	   curve	   is	   rapid	   and	   it	   is	   due	   to	   the	   redistribution	   of	   tracer	   into	   the	  
extracellular	  space.	  The	  second	  portion,	  called	  the	  second	  exponential	  represents	  the	  much	  
slower	  elimination	  of	  the	  tracer	  by	  glomerular	  filtration	  once	  the	  extracellular	  compartment	  
is	  saturated	  (Peters,	  1991).	  The	  figure	  below	  represents	  a	  2-­‐compartment	  model	  assuming	  
fixed	   flow	   rates	   between	   the	   intra	   and	   extra	   vascular	   volumes.	   A	   third	   compartment	   is	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considered	  when	  a	  patient	  has	  significant	  third	  space	  fluid	  such	  as	  oedema,	  pleural	  effusion	  
and	  ascites	  (Murray	  et	  al.,	  2013).	  
	  
Figure	  1.3:	  2	  and	  3-­‐compartment	  models	  with	  respective	  rate	  constants.	  K10	  is	  taken	  to	  be	  
GFR	   clearance.	   Compartment	   1	   is	   intravascular	   volume	   and	   compartment	   2	   is	   the	  
extravascular	  volume.	  Compartment	  3	  is	  considered	  to	  be	  present	  in	  patients	  with	  known	  





Two- and 3-compartment models with respective rate constants, kij. Anthony W. Murray et al. J. Nucl. Med. 
Technol. 2013;41:67-75 
(c) Copyright 2014 SNMMI; all rights reserved 
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1.9	  Slope-­‐intercept	  technique:	  
Although	  simpler	  than	   inulin	   infusion,	   the	  bi-­‐exponential	   techniques	  are	  still	  cumbersome,	  
as	   they	   require	  multiple	   blood	   sampling	   over	   several	   hours.	   Chantler	   et	   al	   demonstrated	  
that	  the	  plasma	  clearance	  technique	  correlated	  well	  with	  urinary	  clearance	  methods	  using	  
51Cr-­‐EDTA	  and	  restricting	  blood	  sampling	  to	  the	  second	  of	  the	  two	  exponential	  components	  
of	   clearance.	   This	   is	   called	   the	   slope	   intercept	   method	   (Chantler,	   1969)	   which	   is	  
demonstrated	  in	  the	  figure	  below.	  The	  logarithm	  of	  plasma	  activity	  is	  plotted	  as	  a	  function	  
of	  time.	  The	  zero	  time	  plasma	  activity	  (P0)	   is	  determined	  by	  extrapolation	  of	   linear	  part	  of	  
the	   curve	   to	   the	   y-­‐axis.	   The	   half	   period	   (T1/2,	  minutes)	   of	   the	   linear	   part	   of	   the	   plasma	  
disappearance	   was	   determined	   from	   the	   graph	   and	   the	   slope	   calculated	   as:	   C-­‐slope=	  












Figure	  1.4:	  Plasma	  disappearance	  curve	  showing	  the	  bi-­‐exponential	  curve	  with	  time	  on	  the	  
x-­‐axis	  and	  plasma	  concentration	  on	  the	  y-­‐axis.	  The	  logarithm	  of	  plasma	  activity	  is	  plotted	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1.10	  Correction	  factors	  for	  the	  first	  exponential:	  
The	  slope	  intercept	  method	  is	  based	  on	  only	  the	  second	  exponential	  and	  as	  it	  neglects	  the	  
first	  exponential,	  leads	  to	  overestimation	  of	  clearance.	  
Chantler	   correction:	   Chantler	   et	   al.	   in	   1972	   estimated	  GFR	  using	   51Cr-­‐EDTA	  with	   both	   the	  
slope	   intercept	   and	   urinary	   clearance	   methods.	   The	   slope	   clearance	   was	   shown	   to	  
consistently	   overestimate	   GFR	   measured	   by	   urinary	   clearance.	   They	   conclude	   that	   a	  
correction	   factor	   of	   0.87	   (i.e.	   clearance	   by	   slope	   intercept	   method	   X	   0.87)	   provides	   a	  
reasonable	  estimate	  of	  the	  GFR	  (Chantler	  and	  Barratt,	  1972).	  
Brochner-­‐Mortensen	   correction:	   Brochner-­‐Mortensen	   compared	   51Cr-­‐EDTA	   plasma	  
clearance	   (Cl)	  with	   51Cr-­‐EDTA	   clearance	   from	   a	   one-­‐pool	   system	   (Cl1)	   in	   74	   adult	   patients	  
with	  renal	  dysfunction.	  Plasma	  clearance	  was	  calculated	  as	  a	  ratio	  of	  injected	  dose	  of	  tracer	  
and	  the	  total	  area	  under	  the	  plasma	  disappearance	  curve.	  This	  was	  always	  exceeded	  by	  51Cr-­‐
EDTA	  clearance	  by	  one	  pool	  system	  and	  the	  correlation	  between	  them	  can	  be	  expressed	  as:	  
Cl=0.990778	  Cl1	  –	  0.001218	  (Cl1	  )	  2	  	  	  
This	   correction	   is	   widely	   used	   to	   improve	   the	   accuracy	   of	   the	   slope-­‐intercept	   GFR	  
measurements	  (Brochner-­‐Mortensen,	  1972).	  
A	   study	   by	   De	   Sadeleer	   et	   al.	   compared	   the	   Chantler’s	   linear	   correction	   formula	   and	  
Brochner-­‐Mortensen	   quadratic	   equation	   using	   data	   from	   47	   adults	   with	   normal	   renal	  
function	  with	   the	  bi-­‐exponential	   fit	  method.	   In	   the	  normal	   clearance	   range	  of	  120	   to	  140	  
mls/min.	   both	   corrections	   led	   to	   slightly	   lower	   results	   than	   the	   bi-­‐exponential	   method.	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However,	   in	   all	   values	   less	   than	   140mls/minute	   the	   difference	   between	   the	   2	   correction	  
formulae	  was	  clinically	  insignificant	  (De	  Sadeleer	  et	  al.,	  2006).	  
	  
	  
Radioisotope	  labelled	  renal	  clearance	  markers	  
Radiolabelling	   allows	   detection	   of	   minute	   quantities	   of	   the	   filtration	   marker	   in	   urine	   or	  
plasma.	  Radiation	  exposure	   is	  minimal	  with	  all	   commonly	  used	   isotopes	  and	   the	  choice	   is	  
primarily	  based	  on	  ease	  of	  obtaining,	  administering	  and	  counting	  the	  radioisotopes	  (Levey,	  
1990).	   One	   of	   the	  main	   disadvantages	   of	   radiolabelled	   techniques	   is	   the	   requirement	   for	  
storage	  and	  disposal	  of	  radioactive	  substances	  and	  the	  need	  to	  perform	  these	  investigations	  
in	  nuclear	  medicine	   laboratories.	  The	  most	  commonly	  used	  radiolabelled	   isotopic	  markers	  
worldwide	   are	   51Cr-­‐EDTA,	   99	   Tc-­‐DTPA,	   and	   125I	   Iothalamate,	   which	   are	   discussed	   below.	  
Iothalamate	   and	   iohexol	   are	   non-­‐ionic	   contrast	  markers	   and	   can	   be	  measured	   using	   high	  
performance	  liquid	  chromatography	  (HPLC).	  	  
	  
1.11	  	  51Cr-­‐EDTA	  (Ethylene	  diamine	  tetra	  acetic	  acid):	  
51Cr-­‐EDTA	  is	  a	  radionuclide	  marker	  with	  low	  molecular	  weight	  of	  about	  292	  Dalton	  and	  does	  
not	   bind	   to	   plasma	   proteins,	   so	   it	   is	   freely	   filtered	   through	   the	   glomerulus.	   The	  
measurement	  of	  51Cr-­‐EDTA	  by	  nuclear	  count	  is	  easy	  because	  of	  its	  long	  half-­‐life	  of	  27	  days.	  
The	  radiation	  dose	  received	  by	  the	  patient	   is	   relatively	  small	  and	  also	  the	  dose	  of	  EDTA	   is	  
100	  times	  less	  than	  the	  dose	  considered	  to	  be	  safe	  (Chantler,	  1969).	  Its	  clearance	  has	  been	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shown	  to	  be	  closest	  to	  that	  of	  inulin	  and	  is	  considered	  the	  radionuclide	  agent	  of	  choice	  for	  
GFR	  measurement,	  particularly	   in	  Europe	  (Blaufox	  et	  al.,	  1996).	  Garnett	  et	  al.	   in	  1967	  first	  
described	   measurement	   of	   GFR	   using	   51Chromium	   conjugated	   to	   EDTA.	   They	   compared	  
inulin	   clearance	   with	   51Cr	   EDTA	   using	   both	   infusion	   and	   urine	   collection	   techniques.	   51Cr	  
EDTA	   showed	   very	   good	   correlation	   (r=0.995)	   to	   inulin	   clearance.	   Since	   equilibrium	   with	  
extravascular	   compartment	   takes	   less	   than	  2	  hours	   and	   there	   is	   no	   significant	   extra-­‐renal	  
excretion,	  the	  slope-­‐intercept	  method	  based	  on	  2-­‐4	  hours	  plasma	  activity	  can	  be	  used	  as	  a	  
simple	   procedure.	   The	   authors	   emphasise	   that	   this	   method	   is	   not	   accurate	   in	   the	  
oedematous	  patients	  (Garnett	  et	  al.,	  1967).	  
The	  main	   limitations	  of	   51Cr	  EDTA	  as	  a	  marker	   for	   renal	   clearance	  are	   that	   it	   needs	   to	  be	  
performed	  in	  a	  nuclear	  medicine	  department	  and	  also	  that	  it	  is	  not	  FDA	  approved	  hence	  not	  
studied	  in	  USA	  
	  
1.12	  	  	  	  99	  Technetium-­‐DTPA	  (Diethylenetriaminepenta-­‐acetic	  acid):	  	  
99	  Tc-­‐DTPA	  is	  another	  widely	  used	  radionuclide	  marker	  for	  GFR	  measurement,	  particularly	  in	  
the	  United	  States.	  It	  has	  a	  low	  molecular	  weight	  of	  393	  Dalton.	  Klopper	  1972	  studied	  the	  use	  
of	  99	  Tc-­‐DTPA-­‐clearance	  in	  dogs	  and	  humans	  and	  found	  the	  clearance	  to	  be	  lower	  than	  inulin	  
clearance	  primarily	  due	  to	  protein	  binding	  of	  99	  Technetium-­‐DTPA.	  Protein	  binding	  was	  much	  
lower	  when	  a	  single	  injection	  technique	  was	  used	  compared	  to	  continuous	  infusion	  (Klopper	  
et	   al.,	   1972).	   This	   study,	   which	   is	   one	   of	   the	   few	   physiological	   studies	   with	   this	   marker,	  
showed	  no	  tubular	  secretion	  or	  reabsorption	  for	  99	  Technetium-­‐DTPA.	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The	  main	   limitation	  of	  99	  Technetium-­‐DTPA	  is	   its	  protein	  binding.	   It	  also	  has	  a	  shorter	  half-­‐
life	   compared	   to	   51Cr	  EDTA,	  which	  means	  GFR	  measurements	  have	   to	  be	  done	  soon	  after	  
sampling	   and	   can	   cause	   some	   practical	   difficulties.	   Simultaneous	   measurement	   of	   99	  
Technetium-­‐DTPA,	   51Cr	  EDTA	  and	   inulin	   in	  patients	  with	  decreased	   renal	   function	   showed	  
that	  plasma	  clearance	  of	  inulin	  exceeded	  that	  of	  99	  Tc-­‐DTPA,	  however	  clearance	  of	  the	  two	  
radio	  isotopic	  markers	  were	  comparable(Rehling	  et	  al.,	  1984).	  
	  
1.13	  Iothalamate:	  
125	   I	   Iothalamate	   is	   one	   of	   the	  most	   used	   radiolabelled	  markers	   in	   USA	   and	   notably,	   the	  
modification	   of	   diet	   in	   renal	   disease	   (MDRD)	   study	   used	   this	   marker.	   There	   is	   however	  
evidence	  to	  suggest	  that	  Iothalamate	  is	  secreted	  by	  renal	  tubules	  and	  it	  also	  has	  some	  extra	  
renal	  clearance.	  These	  are	  its	  major	  limitations	  as	  a	  marker	  and	  lead	  to	  slight	  overestimation	  
of	  GFR.	  Iothalamate	  can	  also	  be	  measured	  without	  radiolabelling,	  but	  the	  limiting	  issues	  are	  
the	   need	   for	   larger	   doses	  with	   the	   risk	   of	   nephrotoxicity	   and	   allergies,	   and	   the	   need	   for	  
expensive	  assays	  such	  as	  high	  performance	  liquid	  chromatography	  (HPLC)	  methods.	  	  
Elwood	   and	   Sigman	   in	   1967	   compared	   GFR	   in	   21	   patients	   with	   various	   levels	   of	   renal	  
function	   using	   inulin	   and	   125	   Iodine	   Iothalamate	   by	   constant	   infusion	   technique.	   They	  
determined	  the	  activity	  of	  125I	  in	  a	  scintillation	  (gamma)	  counter	  and	  demonstrated	  the	  ratio	  
of	  inulin	  to	  Iothalamate	  clearance	  to	  range	  from	  0.93	  to	  1.09	  with	  a	  mean	  of	  1.00	  (Elwood	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1.14	  Iohexol:	  	  
Iohexol	  is	  a	  non-­‐ionic	  contrast	  agent	  that	  has	  been	  relatively	  popular	  in	  Scandinavia	  for	  GFR	  
measurement	  in	  adults	  and	  children	  (Krutzen	  et	  al.,	  1990).	  Like	  Iothalamate	  iohexol	  can	  be	  
measure	  using	  HPLC	  or	  by	  X-­‐ray	  fluorescence.	  
Renal	   clearance	   of	   inulin	   and	   plasma	   clearance	   of	   iohexol	   (HPLC	   assay)	   using	   the	   two-­‐
compartment	  model	  showed	  highly	  significant	  correlation	  across	  a	  range	  of	  renal	   function	  
(Gaspari	  et	  al.,	  1995).	   Iohexol	  clearance	  also	  compared	  very	  well	  with	   radioactive	   labelled	  
markers	  like	  51Cr-­‐EDTA	  (Olsson	  et	  al.,	  1983)	  
Schwarz	  et	  al.	  investigated	  how	  plasma	  disappearance	  curves	  could	  be	  used	  in	  children	  and	  
adolescents	  with	  mild	   to	  moderate	   chronic	   kidney	  disease	   by	   iohexol	  method	   assayed	  by	  
HPLC.	   They	   compared	   GFR	   using	   a	   9	   data	   point	   (10	   minutes	   to	   360	   minutes	   following	  
injection)	   plasma	   disappearance	   curve	   method	   with	   4	   data	   points	   curve,	   which	   showed	  
excellent	  correlation	  (r=0.999).	  One	  compartment	  GFR	  with	  two	  data	  points	  at	  120	  and	  300	  
minutes	   after	   injection	   using	   Brochner-­‐Mortensen	   quadratic	   equation	   also	   showed	   good	  
correlation	  (r=0.986)	  (Schwartz	  et	  al.,	  2006).	  The	  iohexol	  method	  has	  been	  used	  extensively	  
in	  adults,	  children	  and	  adolescents	  in	  several	  cohort	  and	  experimental	  studies.	  Iohexol	  as	  a	  
contrast	  agent	  compared	  to	  other	  markers	   is	   less	  expensive.	  The	  main	   limitation	  seems	  to	  
be	   that	   there	   are	   only	   few	   studies	   comparing	   iohexol	   with	   inulin	   and	   also	   very	   few	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Creatinine	  as	  a	  marker	  for	  GFR	  
	  
1.15	  Creatinine	  biosynthesis	  and	  physiology	  
Creatine	  and	  Creatine	  phosphate	  from	  which	  creatinine	  is	  formed	  exists	  in	  muscle	  tissue	  and	  
serve	   as	   a	   rapid	   source	   of	   high-­‐energy	   phosphate	   to	   produce	   ATP.	   Thus	   the	   rate	   of	  
endogenous	  production	  of	  creatinine	  depends	  on	  the	  muscle	  mass;	  it	  averages	  20mg/Kg/24	  
hours	  for	  normal	  subjects.	  Once	  formed,	  creatinine	  distributes	  rapidly	  throughout	  the	  body.	  
It	   is	  normally	  produced	  at	  a	   constant	   rate	  and	  eliminated	  at	  a	   rate	  proportional	   to	   serum	  
creatinine;	  thereby	  achieving	  a	  relatively	  steady	  state	  in	  the	  blood(Lott	  and	  Hayton,	  1978).	  	  
Up	   to	   94%	   of	   the	   Creatine	   in	   the	   body	   is	   found	   in	   muscular	   tissues.	   Muscle	   does	   not	  
synthesise	  creatine	  and	  thus	  has	  to	  take	  in	  large	  quantities	  of	  it	  through	  creatine	  transporter	  
on	  the	  plasma	  membrane.	  Creatine	  in	  the	  body	  is	  either	  of	  dietary	  origin	  or	  synthesised	  de	  
novo.	  The	  first	  step	  of	  Creatine	  biosynthesis	  probably	  occurs	  mainly	  in	  the	  kidney,	  whereas	  
the	   liver	   is	   likely	   to	   be	   the	   principal	   organ	   accomplishing	   the	   subsequent	  methylation	   of	  
guanidinoacetic	   acid	   (GAA)	   to	   Creatine.	   The	   contribution	   of	   other	   tissues	   in	   creatine	  
generation	  remains	  unclear.	  Creatine	  is	  phosphorylated	  enzymatically	  by	  creatine	  kinase	  to	  
Phospho-­‐Creatinine,	   which	   is	   the	   source	   for	   immediate	   generation	   of	   ATP.	   The	  muscular	  
Creatine	   and	   Phospho-­‐Creatine	   are	   nonenzymatically	   converted	   at	   an	   almost	   steady	   rate	  
(∼2%	  of	  total	  Cr	  per	  day)	  to	  creatinine,	  which	  diffuses	  out	  of	  the	  cells	  and	  is	  excreted	  by	  the	  








Figure	   1.5:	   (permission	   sought,	   but	   none	   required	   for	   reproduction	   in	   thesis):	   shows	  
synthesis	   of	   creatine	   in	   the	   body;	   formation	   of	   guanidinoacetic	   acid	   in	   the	   kidneys	   and	  
subsequent	   conversion	   into	   creatine	   in	   the	   liver.	   Biosynthesised	   and	   dietary	   creatine	   is	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Rehberg	  as	  part	  of	  his	   investigation	  of	   the	   two	  prevailing	   theories	  of	   kidney	   function;	   the	  
secretion	  theory	  and	  the	  filtration-­‐reabsorption	  theory	  described	  the	  use	  of	  creatinine	  as	  an	  
“exogenous	   filtration	   marker”	   as	   early	   as	   1926	   (Rehberg,	   1926).	   In	   his	   experiment	   on	  
himself,	  Rehberg	  ingested	  5g	  of	  creatinine	  dissolved	  in	  200mls	  of	  water;	  blood	  samples	  were	  
drawn	  hourly	  by	  finger	  prick	  and	  urine	  collected	  as	  per	  diuresis.	   	  Creatinine	   in	  plasma	  and	  
urine	  was	  assayed	  using	  the	  picric	  acid	  method	  described	  as	  follows;	  1	  ml	  of	  the	  sample	  is	  
mixed	  with	  5ml-­‐saturated	   solution	  of	  picric	  acid	  and	  at	   the	   same	   time	  1	  ml	  of	  a	   standard	  
solution	   of	   creatinine	   is	   treated	   in	   the	   same	   way	   in	   another	   tube.	   To	   both	   tubes	   a	   10%	  
solution	  of	  picric	  acid	  is	  added	  and	  then	  they	  are	  compared	  using	  a	  colorimetric	  technique.	  
A	   plasma	   creatinine	   against	   hours	   after	   ingestion	   of	   creatinine	   curve	  was	   drawn	   and	   the	  
plasma	  creatinine	  corresponding	  to	  the	  timing	  of	  urine	  samples	  were	  used	  to	  calculate	  the	  
filtration	  rate.	  He	  concluded	  that	  the	  amount	  of	  creatinine	  in	  the	  urine	  after	  ingestion	  is	  so	  
large	  that	  filtration	  of	  up	  to	  200	  mls	  per	  minute	  needs	  to	  happen	  to	  explain	  it	  and	  that	  the	  
filtration	  reabsorption	  theory	  was	  more	  tenable	  than	  the	  secretion	  theory.	  
	  
1.16	  Tubular	  secretion	  of	  creatinine	  
Creatinine	  is	  not	  present	  in	  the	  urine	  of	  aglomerular	  fishes,	  but	  when	  injected	  they	  excrete	  
creatinine	  in	  their	  urine.	  It	  has	  also	  been	  shown	  that	  the	  rate	  of	  excretion	  does	  not	  increase	  
in	   proportion	   to	   the	   rate	   at	   which	   creatinine	   is	   injected.	   For	   a	   substance	   that	   is	   freely	  
filtered	   through	   the	   glomerulus,	   this	   should	   not	   be	   the	   case.	   Several	   subsequent	   studies	  
showed	   that	   tubular	   secretion,	   which	   has	   a	   tubular	   maximum,	   is	   responsible	   for	   this	  
curvilinear	   relationship.	   As	   the	   plasma	   concentration	   of	   creatinine	   rises	   above	   10mg	   per	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cent,	  there	  is	  reduction	  in	  creatinine	  clearance.	  To	  investigate	  if	  this	  was	  due	  to	  reduction	  in	  
filtration	  Shannon	  in	  1935	  compared	  creatinine	  clearance	  with	   inulin	  clearance,	  which	  had	  
been	   shown	   to	   be	   equivalent	   to	   glomerular	   filtration.	   They	   showed	   that	   at	   low	  
concentration	   of	   creatinine,	   the	   creatinine	   clearance	   was	   30	   to	   45%	   higher	   than	   inulin	  
clearance.	  As	  the	  plasma	  concentration	  of	  creatinine	  rises,	  the	  creatinine	  clearance	  falls	   in	  
comparison	   to	   that	   of	   inulin	   to	   about	   12%.	   This	   phenomenon	   could	  only	   be	   explained	  by	  
tubular	  secretion	  of	  creatinine.	  As	  the	  next	  step,	  they	  administered	  high	  dose	  of	  intravenous	  
phlorizin	  (100mg/Kg)	  and	  repeated	  the	  experiment.	  This	  brought	  creatinine	  clearance	  very	  
close	  to	  that	  of	  inulin,	  which	  the	  author	  concluded	  was	  due	  to	  specific	  inhibition	  of	  tubular	  
secretion	  of	  creatinine	  by	  phlorizin(Shannon,	  1935).	  
Shemesh	  et	  al.	   compared	  creatinine	  clearance	  with	  that	  of	   inulin	  and	  99Tc	  DTPA	   in	  a	   large	  
population	   of	   patients	   with	   diverse	   glomerular	   disease.	   The	   fractional	   clearance	   of	  
creatinine	   relative	   to	   inulin	   was	   much	   higher	   (1.64	   ±	   0.05).	   But,	   on	   blocking	   the	   tubular	  
activity	  by	  infusion	  of	  Cimetidine,	  the	  fractional	  clearance	  approached	  unity	  (Shemesh	  et	  al.,	  
1985).	  Thus,	   the	  overestimation	  of	  GFR	  by	  creatinine	  clearance	   is	  as	  a	  result	  of	   its	   tubular	  
secretion.	  The	   fractional	  secretion	  of	  creatinine	   (the	  proportion	  of	  creatinine	   in	  urine	  as	  a	  
result	  of	  tubular	  secretion	  relative	  to	  glomerular	  filtration)	  was	  shown	  to	  vary	  inversely	  with	  
GFR,	   making	   it	   much	   less	   reliable	   in	   patients	   with	   worse	   kidney	   function.	   	   The	   authors	  
emphasize	   the	   importance	   of	   accurate	   measurement	   of	   GFR	   in	   patients	   with	   glomerular	  
injury;	  GFR	  falls	  less	  than	  in	  proportion	  to	  the	  intrinsic	  injury	  to	  glomerular	  capillary	  wall	  due	  
to	   a	   compensatory	   increase	   in	   net	   ultrafiltration	   pressure.	   So,	   overestimation	   of	   GFR	  will	  
have	  the	  effect	  of	  significant	  underestimation	  of	  glomerular	  injury.	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1.17	  Extra	  renal	  excretion	  of	  creatinine	  
There	  are	  also	   reports	  of	  extrarenal	  excretion	  of	  creatinine	  which	   is	   significant	   in	  patients	  
with	   poor	   renal	   function.	   In	   this	   study	   radioactive	   carbon	   labelled	   creatinine	   was	  
administered	  and	  its	  extra-­‐	  renal	  excretion	  was	  assessed	  in	  breath	  and	  faeces.	  They	  showed	  
that	  15.5	  to	  65.7%	  of	  the	  creatinine	  formed	  is	  metabolised	  or	  excreted	  via	  extra-­‐renal	  routes	  
in	  patients	  with	  significant	  renal	  dysfunction(Jones	  and	  Burnett,	  1974).	  	  
	  
1.18	  Muscle	  mass	  and	  creatinine	  generation	  
While	   endogenous	   creatinine	   is	   formed	   from	   muscle	   metabolism,	   exogenous	   creatinine	  
comes	   from	   dietary	   ingestion,	   primarily	   from	   meat.	   The	   rate	   of	   creatinine	   generation	   is	  
dependent	  on	  muscle	  metabolism	  and	  diet	  (Levey,	  1990).	  Creatinine	  and	  muscle	  mass	  are	  so	  
closely	  related	  that	  it	  gave	  rise	  to	  a	  concept	  called	  “creatinine	  equivalence”;	  24	  hour	  urinary	  
creatinine	  has	  been	  used	  as	  an	  index	  of	  body	  muscle	  mass.	  Creatinine	  equivalence	  (muscle	  
mass	   in	   Kg	   /	   24	   hour	   urinary	   creatinine	   in	   grams)	   has	   been	   shown	   to	   be	   a	   constant	   rate	  
ranging	  between	  17	  and	  22	  in	  healthy	  adults	  (Heymsfield	  et	  al.,	  1983).	  
However,	   serum	   creatinine	   has	   become	   the	  most	  widely	   used	  measure	   of	   progression	   of	  
renal	  disease	  because	  of	  the	  following	  reasons(Levey,	  1990).	  	  Although	  it	  is	  not	  an	  accurate	  
measure	   of	   GFR,	   the	   changes	   in	   serum	   creatinine	   are	   a	   reasonably	   accurate	   reflection	   of	  
changes	   in	  GFR.	   The	  variability	  with	   time	  of	   serum	  creatinine	   is	   also	   lower	   than	  GFR.	   The	  
greatest	  advantage	  of	  serum	  creatinine	  is	  of	  course	  the	  ease	  with	  which	  it	  can	  be	  measured	  
in	  all	  clinical	  laboratories.	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1.19	  Estimated	  Glomerular	  Filtration	  Rate	  
	  A	   variety	   of	   methods	   have	   been	   used	   to	   estimate	   GFR.	   The	   Cockcroft-­‐Gault	   formula,	  
developed	  for	  estimation	  of	  Creatinine	  Clearance,	  not	  of	  GFR	  has	  been	  widely	  used	   in	  the	  
past.	  	  
The	  best-­‐validated	  methods	  for	  GFR	  estimation	  were	  derived	  from	  the	  Modification	  of	  Diet	  
in	  Renal	  Disease	  (MDRD)	  Study	  data.	  The	  authors	  enrolled	  1628	  patients	  from	  the	  original	  
MDRD	  study	  who	  had	  undergone	  GFR	  measurement	  by	  renal	  clearance	  of	  125I-­‐iothalamate	  
and	   randomly	   selected	   1070	   to	   the	   training	   sample	   and	   558	   to	   the	   validation	   sample.	  
Multiple	   stepwise	   linear	   regression	   analysis	   showed	   that	   seven	   independent	   factors	  were	  
associated	  with	  significantly	  lower	  GFR;	  higher	  serum	  creatinine,	  older	  age,	  female	  sex,	  non-­‐
black	   ethnicity,	   high	   blood	   urea	   nitrogen,	   lower	   serum	   albumin,	   and	   lower	   urine	   urea	  
excretion	  levels.	  The	  authors	  derived	  two	  six-­‐variable	  equations:	  	  
1. Equation that uses blood urea nitrogen 
GFR=198(Cr-0.858 X age-0.167) X BUN-0.293 X albumin -0.318 X (1.178 if black) X 
(0.822 if female) 
 
2. Equation that uses serum albumin 
 
GFR=170(Cr-0.999 X age-0.176) X BUN-0.170 X UUN-0.249 X (1.178 if black) X 
(0.822 if female)	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The	   2	   equations	   were	   then	   applied	   to	   the	   validation	   sample	   and	   a	   six-­‐variable	   equation	  
containing	  only	  demographic	  and	  serum	  variables	  were	  chosen	  to	  simplify	  the	  prediction	  of	  
GFR	   (Levey	   et	   al.,	   1999).	   	   In	   the	   year	   2000,	   Levey	   et	   al.	   published	   the	  MDRD4	   equation,	  
which	  is	  a	  simplified	  formula	  arrived	  at	  following	  a	  reanalysis	  of	  the	  original	  1628	  patients.	  
The	   analysis	   excluded	   urine	   urea,	   serum	   albumin,	   and	   blood	   urea.	   This	   formula	  was	   first	  
recommended	  for	  clinical	  use	  by	  2002	  national	  kidney	  disease	  practical	  guidelines:	  
GFR=186(Cr-1.154 X age-0.203) X (1.212 if black) X (0.742 if female)	  	  
The	   abbreviated	   or	   four-­‐variable	   equation	   which	   uses	   age,	   sex,	   creatinine,	   and	   race	   to	  
estimate	  GFR	  is	  now	  most	  commonly	  used	  (Levey	  AS,	  2000).	  In	  the	  UK	  and	  most	  parts	  of	  the	  
world,	  laboratories	  calculate	  eGFR	  on	  all	  samples	  sent	  for	  creatinine	  measurement	  and	  this	  
forms	  the	  basis	  of	  (CKD)	  chronic	  kidney	  disease	  staging.	  	  
	  
The	  Chronic	  Kidney	  Disease	  Epidemiology	  Collaboration	  (CKD-­‐EPI)	  investigators	  developed	  a	  
GFR	   estimating	   equation	   from	   a	   large	   database	   pooled	   from	   10	   studies.	   The	   CKD-­‐EPI	  
equation	  uses	  the	  same	  four	  variables	  as	  the	  MDRD	  study	  equation;	  serum	  creatinine	  level,	  
age,	  sex,	  and	  race.	  In	  some	  studies	  it	  has	  been	  shown	  to	  be	  more	  accurate	  than	  the	  MDRD	  
equation	  in	  estimating	  GFR,	  especially	  at	  higher	  GFR	  values	  (Levey	  and	  Stevens,	  2010).	  A	  6	  
year	   follow	   up	   study	   in	   2823	   patients	   showed	   that	   estimation	   of	   GFR	   using	   the	   CKD-­‐EPI	  
equation	  more	  appropriately	  stratifies	  patients	  with	  type	  2	  diabetes	  according	  to	  the	  risk	  of	  
all-­‐cause	  and	  cardiovascular	  mortality	  compared	  with	  the	  MDRD	  study	  equation	  (Targher	  et	  
al.,	  2012).	  The	  CKD-­‐EPI	  equation	  is	  discussed	  in	  detail	  in	  chapter	  4	  of	  this	  thesis.	  
	  
	  
47	  |	  P a g e 	  
	  
1.20	  Chronic	  kidney	  disease	  (CKD)	  definition	  and	  classification	  by	  the	  American	  National	  
Kidney	  Foundation,	  Kidney	  Disease	  Outcome	  Quality	  Initiative	  (KDOQI):	  
http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p1_exec.htm	  	  
1. Kidney	  damage	  for	  ≥	  3	  months,	  as	  defined	  by	  structural	  or	  functional	  abnormalities	  
of	  the	  kidney	  with	  or	  without	  decrease	  in	  glomerular	  filtration	  rate	  (GFR),	  manifest	  
either	   by	   pathological	   abnormalities	   or	   markers	   of	   kidney	   damage;	   including	  
abnormalities	  in	  the	  composition	  of	  blood	  or	  urine,	  or	  abnormalities	  in	  imaging	  tests,	  
or	  
2. GFR<	  60	  ml/min/1.73m2	  for	  ≥	  3	  months,	  with	  or	  without	  kidney	  damage.	  
	  
Table	  1.1:	  CKD	  classification	  
CKD	  Stage	   Description	   GFR	  (mL/min/1.73m2)	  
1.	   Kidney	  damage	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
with	  normal	  or GFR	  
90	  
2.	   Kidney	  damage	  
with	  mild GFR	  
60-­‐89	  
3.	   Moderate GFR	   (3a)	  44-­‐59	  	  
(3b)	  30-­‐43	  
4.	   Severe GFR	   15-­‐29	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Variability	  of	  creatinine	  and	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  Glomerular	  Filtration	  Rate	  
	  
1.21	  Variability	  in	  estimated	  GFR	  
The	  various	  CKD	  stages	   imply	  different	  prognosis	  and	  different	  degrees	  of	   intervention	  for	  
the	  patient.	   Treatment	   choices	   are	   also	  often	  determined	  by	   the	  estimated	  GFR	  and	  CKD	  
stage.	  So,	  it	  is	  vital	  that	  GFR	  estimation	  is	  as	  close	  to	  the	  actual	  measured	  GFR	  as	  possible.	  
There	   are	   many	   factors	   that	   can	   potentially	   introduce	   inaccuracies	   into	   GFR	   estimation:	  
These	  can	  be	  broadly	  classified	  into:	  
1. Inaccuracies	  resulting	  from	  the	  GFR	  estimating	  equation	  used	  
2. Pre-­‐analytical	  and	  analytical	  (Joffe	  et	  al.,	  2010)	  variability	  
3. Biological	   (Toffaletti	   and	   McDonnell,	   2008)	   variability	   in	   creatinine	   measurement,	  
muscle	  mass,	  exercise,	  and	  state	  of	  hydration.	  
	  
1.22	  Inaccuracies	  resulting	  from	  the	  GFR	  estimating	  equation	  used	  
These	  result	  from	  the	  fact	  that	  the	  commonly	  used	  4-­‐variable	  MDRD	  equation	  was	  derived	  
from	  a	   predominantly	   non-­‐diabetic	   population	  with	   chronic	   kidney	  disease.	   This	   equation	  
was	  developed	  from	  a	  population	  of	  1628	  patients	  with	  chronic	  kidney	  disease	  whose	  mean	  
weight	  was	  79.6	  ±	  16.8	  Kg,	  and	  only	  99	  (6%)	  had	  diabetes	   (Levey	  et	  al.,	  1999).	  The	  MDRD	  
formula	   and	   Cockcroft-­‐Gault	   introduced	   significant	   biases	   and,	   in	   average	   terms,	  
underestimated	  GFR.	  The	  Cockcroft-­‐Gault	  formula	  performed	  better	  with	  increasing	  weight	  
	  
	  
49	  |	  P a g e 	  
	  
and	   4-­‐variable	  MDRD	   equation	   performed	  worse	  with	   increasing	   body	  weight	   in	   patients	  
with	  newly	  diagnosed	  diabetes	  (Chudleigh	  et	  al.,	  2008).	  	  
GFR	  is	  traditionally	  indexed	  to	  body	  surface	  area	  (GFR	  corrected	  =	  GFRmeasured	  x	  (1.73/BSA	  m2))	  
and	   expressed	   as	   ml/minute/1.73m2.	   Indexing	   is	   performed	   so	   that	   renal	   functions	   of	  
individuals	  with	  varying	  sizes	  can	  be	  compared	  and	  also	  to	  allow	  for	  a	  single	  normal	  range	  to	  
be	   defined.	   Body	   Surface	   Area	   (BSA)	   was	   calculated	   based	   on	   the	   Du	   Bois	   and	   Du	   Bois	  
formula	  (BSA	  (m2)	  =	  [weight	  (kg)	  0.425]	  x	  [height	  (cm)	  0.725]	  x	  0.007184)	  (Du	  Bois	  D,	  1915).  
This	  reference	  method	  by	  DuBois	  and	  DuBois	  to	  measure	  BSA	  was	  developed	  in	  1915	  by	  the	  
following	  ingenious	  method,	  but	  has	  several	  limitations.	  	  They	  used	  a	  heterogeneous	  group	  
of	  9	  participants	   including	  a	  2	  year	  old	  child	  with	   rickets,	  a	  36	  year	  old	  man	  with	  physical	  
development	  of	  an	  8	  year	  old	  and	  an	  18	  year	  old	  subject	  with	  type	  1	  diabetes	  with	  very	  low	  
body	  mass	  index	  (this	  was	  before	  insulin	  was	  discovered	  as	  treatment	  for	  type-­‐1	  diabetes).	  
Participant’s	  bodies	  were	  covered	  with	  moulds	  of	  gummed	  Manila	  paper;	  the	  moulds	  were	  
cut	  open,	  placed	  flat	  on	  photographic	  paper	  and	  then	  exposed	  to	  sunlight.	  The	  unexposed	  
paper	  was	   cut	   and	  weighed.	   Knowing	   the	   density	   of	   the	   photographic	   area,	   the	   BSA	  was	  
deduced.	   They	   then	  developed	  a	   formula	  based	  on	  weight	   and	  height	   for	  BSA	  estimation	  
with	  this	  limited	  and	  very	  heterogeneous	  sample	  (Du	  Bois	  D,	  1915,	  Delanaye	  et	  al.,	  2005). 
Indexing	  is	  based	  on	  the	  assumption	  that	  the	  average	  BSA	  is	  1.73m2,	  but	  it	  is	  much	  higher	  in	  
the	  obese	  subjects.	  Indexing	  GFR	  to	  body	  surface	  area	  of	  1.73m2	  in	  obese	  patients	  has	  been	  
shown	   to	   significantly	   reduce	   the	   GFR	   and	   some	   authors	   have	   suggested	   that	   unindexed	  
GFR	  is	  preferable	  in	  routine	  practice	  and	  clinical	  studies	  for	  the	  obese	  population	  (Delanaye	  
et	  al.,	  2005)	  (Delanaye	  et	  al.,	  2009)	  (Peters	  and	  Glass,	  2010)BSA	  has	  been	  shown	  to	  increase	  
	  
	  
50	  |	  P a g e 	  
	  
with	   body	   weight	   in	   several	   studies	   (Delanaye	   et	   al.,	   2005).	   	   Schmieder	   investigated	   the	  
effect	   of	   indexing	   to	   BSA	   on	   renal	   plasma	   flow	   and	   suggested	   that	   similar	   consideration	  
should	   be	   made	   when	   adjusting	   GFR	   to	   body	   size.	   In	   this	   study	   renal	   plasma	   flow	   was	  
measured	  as	  single	  injection	  clearance	  of	  I131	  labelled	  para-­‐aminohippuric	  acid	  in	  215	  adults	  
with	  BMI	  ranging	  between	  17.5	  to	  45.9	  Kg/m2.	  Age,	  weight,	  and	  BP	  were	  the	  most	  powerful	  
determinants	  of	  renal	  plasma	  flow	  but	  obesity	  did	  not	  influence	  it.	  So	  the	  authors	  concluded	  
that	  correction	  of	  renal	  plasma	  flow	  by	  BSA	  was	  not	  supported	  by	  their	  data	  (Schmieder	  et	  
al.,	  1995).	  As	  the	  weight	  increases,	  although	  there	  is	  no	  increase	  in	  the	  number	  of	  nephrons,	  
the	   single	   nephron	   GFR	   increases	   probably	   due	   to	   increased	   trans-­‐capillary	   hydraulic	  
pressure.	   In	   a	   study	   by	   Chagnac	   with	   12	   obese	   subjects	   (with	   BMI>38)	   and	   9	   healthy	  
controls,	   the	   GFR	   and	   renal	   plasma	   flow	   in	   the	   obese	   exceeded	   controls	   by	   51	   and	   31%	  
respectively.	   The	   increase	   in	   renal	   plasma	   flow	   suggests	   a	   state	   of	   vasodilatation	   of	   the	  
afferent	  arterioles.	  The	  authors	  suggested	  that	  abnormal	  transmission	  of	  increased	  arterial	  
BP	   to	   the	  glomerular	   capillaries	   through	  a	  dilated	  afferent	  arteriole	   could	  account	   for	   the	  
increased	  trans	  capillary	  pressure	  (Chagnac	  et	  al.,	  2000).	  Hence	  indexing	  GFR	  to	  BSA	  (which	  
increases	  with	  obesity),	  leads	  to	  underestimation	  of	  GFR.	  
A	   cross-­‐sectional	   study	   of	   895	   adults	   who	   had	   their	   kidney	   function	   measured	   with	   51Cr	  
EDTA	  showed	  that	  GFR	  indexed	  to	  BSA	  in	  patients	  with	  a	  BSA	  <1.60	  m2	  overestimated	  GFR	  
with	  a	  bias	  of	  10.08	  ml/min	   (11.46%)	  and	  underestimated	  GFR	   in	   those	  with	  a	  BSA	  >2	  m2	  
with	  a	  bias	  up	   to	  −20.76	  ml/min	   (−23.59%).	  The	  authors	  proposed	   that	  BSA	   is	  not	  a	  good	  
normalization	   index	   in	   patients	  with	   extreme	  body	   sizes	   (Redal-­‐Baigorri	   et	   al.,	   2014).	   The	  
authors	   recommend	   that	  until	   a	  better	  normalization	   index	   is	   found,	   clinicians	   should	  use	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absolute	  GFR	  to	  calculate	  individual	  drug	  chemotherapy	  dosage	  as	  well	  as	  express	  individual	  
kidney	  function.  
This	   issue	  with	   inaccuracies	  due	   to	  a	  normalising	   index	  has	  been	  shown	  to	  be	  particularly	  
true	  in	  children	  and	  infants.	  In	  a	  study	  comparing	  BSA	  and	  vECF	  (extra	  cellular	  fluid	  volume)	  
as	  variables	  against	  which	  to	  index	  GFR	  found	  that	  vECF	  was	  more	  valid	  physiologically	  for	  
indexing	  GFR	  than	  BSA.	  A	  measurement	  of	  vECF	  (the	  ratio	  of	  administered	  radioactivity	  and	  
the	  zero	  time	  intercept	  of	  the	  terminal	  exponential)	  is	  however	  more	  difficult	  to	  obtain	  than	  
BSA	   (Peters	   et	   al.,	   2000).	   Several	   other	   parameters	   have	  been	  used	   to	   index	  GFR	   including	  
body	  weight,	  lean	  body	  mass,	  total	  body	  water	  and	  plasma	  volume.	  
In	   the	   normal	   sized	   adult	   population	   indexing	   for	   BSA	   does	   not	   cause	   any	   clinically	  
significant	   discrepancy	   between	   the	   absolute	   and	   indexed	  GFR	   (Peters	   et	   al.,	   2000).	   This	   is	  
believed	   to	  be	   the	   reason	  why	   indexing	   for	  BSA	  has	  been	  a	  widely	   accepted	  as	   a	   routine	  
process	  during	  GFR	  measurement.	  
 
1.23	  Pre-­‐analytical	  and	  analytical	  variability	  
Pre-­‐analytical	   variability	   mainly	   includes	   factors	   introduced	   during	   sample	   collection	   and	  
handling.	  These	  factors	  if	  considered	  and	  avoided	  can	  improve	  accuracy	  and	  reproducibility	  
of	  test	  results.	  A	  study	  by	  Shepherd	  et	  al.	  looked	  at	  the	  effects	  of	  delayed	  centrifugation	  of	  
blood,	  which	   is	   an	   important	   pre-­‐analytical	   variable.	  Multiple	   blood	   samples	  were	   drawn	  
from	  5	   subjects	   at	   the	   same	   time	  point	  but	   centrifugation	  was	  performed	  at	  prespecified	  
times	   ranging	   from	   immediate	   to	   over	   30	   hours	   after	   blood	   sampling.	   Delayed	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centrifugation	   of	   the	   blood	   sample	   was	   shown	   to	   introduce	   significant	   pre-­‐analytical	  
variability	  in	  creatinine	  values	  and	  miss-­‐classification	  of	  CKD	  (Shepherd	  et	  al.,	  2007).	  
Most	  laboratories	  across	  the	  world	  use	  Isotope	  Dilution	  Mass	  Spectrometry	  (IDMS)	  aligned	  
creatinine	  assay	  to	  limit	  the	  analytical	  variability	  of	  creatinine	  measurements.	  
The	   alkaline	   picrate	   assay	   or	   kinetic	   Jaffe	   method	   is	   used	   in	   most	   UK	   laboratories	   for	  
creatinine	   measurement.	   Many	   substances	   have	   been	   shown	   to	   interfere	   with	   the	   Jaffe	  
method	   including	  glucose	  and	  acetoacetate;	   this	   is	  an	   important	  consideration	  as	  patients	  
with	  diabetes	  form	  a	  good	  proportion	  of	  the	  CKD	  population	  (Myers	  et	  al.,	  2006,	  Da	  Rin	  G,	  
1995).	   Another	   commonly	   used	  methods	   are	   the	   enzymatic	   creatinine	   assays	  which	   have	  
been	  reported	  to	  have	  lesser	  degree	  of	  interferences	  compared	  to	  the	  Jaffe	  method	  in	  some	  
studies	   (Myers	   et	   al.,	   2006).	   Isotope	  dilution	  mass	   spectrometry	   (IDMS)	   is	   considered	   the	  
reference	  method	  for	  establishing	  the	  true	  concentration	  of	  creatinine	  in	  serum	  because	  of	  
its	   excellent	   specificity	   and	   relative	   SD	   <0.3%	   (Myers	   et	   al.,	   2006).	   This	   method	   is	   only	  
available	   in	   a	   few	   highly	   specialised	   laboratories	   worldwide.	   The	   manufacturer	   of	   assays	  
calibrates	   creatinine	   measured	   by	   other	   methods	   like	   the	   kinetic	   Jaffe	   and	   enzymatic	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1.24	  Biological	  variability	  in	  creatinine	  measurement	  and	  GFR	  
The	  main	   causes	   for	   biological	   variability	   in	   creatinine	   values	   are	   thought	   to	   be	   state	   of	  
hydration	  of	   the	   subject,	   cooked	  meat	   consumption,	  blood	  pressure,	   blood	  glucose	   levels	  
and	  exercise.	  
The	  percentage	  variation	  in	  creatinine	  due	  to	  time	  of	  the	  day	  was	  found	  to	  be	  very	  low	  at	  
1.4%	  in	  a	  study	  by	  Pocock	  et	  al	  in	  1989	  (S	  J	  Pocock,	  1989).	  This	  study	  measured	  creatinine	  on	  
non-­‐fasting	   blood	   and	   serum	   samples	   collected	   between	   9	   am	   and	   7	   pm	   from	   a	  
representative	  group	  of	  7685	  British	  middle-­‐aged	  men.	  
Heavy	  and	  prolonged	  exercise	   in	  healthy	  men	  have	   shown	   to	   significantly	   raise	   creatinine	  
levels	  (Refsum	  and	  Strömme,	  1974),	  this	  study	  however	  includes	  extreme	  sport	  of	  over	  50	  
miles	   of	   skiing.	   Although	   it	   is	   generally	   agreed	   that	   state	   of	   hydration	   affects	   creatinine	  
levels,	  the	  evidence	  for	  this	  is	  sparse	  (Sjöström	  et	  al.,	  1988).	  
Cooking	  meat	  converts	  creatine	  in	  skeletal	  muscles	  to	  creatinine	  and	  subsequently	  leads	  to	  
a	  rise	  in	  serum	  creatinine	  and	  fall	  in	  eGFR,	  which	  is	  considered	  in	  detail	  in	  the	  introduction	  
to	  chapter	  6	  in	  this	  thesis.	  	  
Protein	  intake	  is	  also	  known	  to	  cause	  a	  true	  increase	  in	  renal	  plasma	  flow	  and	  GFR.	  Bosch	  et	  
al	   showed	   significant	   increase	   in	   creatinine	   clearance	   with	   progressive	   increase	   in	   acute	  
protein	   load	   in	   healthy	   volunteers.	   The	   authors	   described	   this	   capacity	   of	   kidneys	   to	  
increase	  its	  function	  in	  response	  to	  a	  protein	  load	  as	  “renal	  functional	  reserve”.	  In	  this	  study	  
the	  healthy	  volunteers	  showed	  the	  maximum	  increase	  in	  GFR	  at	  two	  and	  a	  half	  hours	  after	  
the	  protein	  load	  (Bosch	  et	  al.,	  1983).	  GFR	  can	  be	  made	  to	  rise	  by	  several	  mechanisms;	  the	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most	   commonly	   used	   stimuli	   are	   high	   protein	  meal	   and	   intravenous	   amino	   acid	   infusion.	  
Dopamine	  infusion	   is	  also	  known	  to	   increase	  GFR	  by	  a	  different	  mechanism.	   It	   is	  generally	  
agreed	  that	  animal	  protein	  produces	  the	   largest	   increase	   in	  GFR.	  The	  main	  mechanism	  for	  
rise	   in	   renal	  plasma	  flow	  and	  consequent	  rise	   in	  GFR	   is	   thought	   to	  be	  renal	  vasodilatation	  
induced	   by	   amino	   acids.	   There	   is	   also	   some	   evidence	   for	   a	   rise	   in	   the	   trans-­‐capillary	  
hydraulic	  pressure	  gradient	  following	  a	  meal.	  Other	  possible	  mediators	  of	  renal	  reserve	  are	  
glucagon,	  prostaglandin	  and	  the	  renin	  angiotensin	  system	  (Thomas	  et	  al.,	  1994).	  
	  
1.25	  Diabetic	  nephropathy	  in	  Pima	  Indians	  
Diabetic	   nephropathy	   in	   Pima	   Indians	   is	   relevant	   to	   my	   thesis	   as	   they	   are	   a	   population	  
known	  to	  have	  high	  prevalence	  of	  obesity	  and	  diabetic	  nephropathy.	  Diabetic	  nephropathy	  
has	   been	   extensively	   studied	   in	   the	   Pima	   Indians	   of	   the	   Gila	   River	   community	   in	   Arizona	  
because	  of	  the	  following	  characteristics:	  	  
1. They	  have	  one	  of	   the	  highest	   incidences	  of	   type2	  diabetes	  and	  up	   to	  21%	  develop	  
diabetic	  nephropathy.	   In	  one	   study	   the	   Incidence	  of	  diabetes	  was	  19	   times	   that	   in	  
the	   predominantly	   white	   population	   of	   Rochester,	   Minnesota	   (95%	   confidence	  
Interval,	  16	  to	  22	  times)	  (Knowler	  et	  al.,	  1978).	  
2. They	  have	  2	  yearly	  OGTT	  performed	  systematically	  as	  part	  of	  a	  longitudinal	  study	  of	  
diabetes	  and	  its	  complications	  conducted	  in	  this	  community	  since	  1965;	  allowing	  for	  
the	   onset	   of	   type2	   diabetes	   to	   be	   documented.	   It	   is	   difficult	   to	   know	   the	   exact	  
duration	  of	  type2	  diabetes	  in	  less	  characterised	  populations	  due	  to	  late	  diagnosis.	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3. They	  develop	  diabetes	  in	  the	  3rd	  to	  5th	  decade	  of	  life,	  which	  reduces	  confounding	  due	  
to	   old	   age;	   aging	   can	   by	   itself	   lead	   to	   fall	   in	   GFR	   possibly	   related	   to	   age	   related	  
renovascular	  disease	  due	  to	  atherosclerosis.	  Unlike	  European	  populations	  with	  type	  
2	  diabetes	  renal	  involvement	  occurs	  relatively	  early	  in	  life	  in	  Pima	  Indians.	  
	  
Myers	  et	  al	  studied	  20	  Pima	  Indians	  diagnosed	  with	  type2	  diabetes	  within	  3	  years	  and	  28	  
controls	  with	  normal	  glucose	  tolerance	  tests	  from	  the	  same	  population.	  They	  measured	  
Iothalamate	   and	   PAH	   (para-­‐aminohippuric	   acid)	   clearance	   to	   represent	  GFR	   and	   renal	  
plasma	   flow	   respectively.	   The	   measured	   GFR	   averaged	   140±6	   ml/min	   in	   the	   diabetic	  
group,	   which	   was	   15%	   higher	   than	   controls	   suggesting	   hyper-­‐filtration.	   Standard	  
correction	   for	   BSA	   reduces	   this	   difference	   to	   only	   7%.	   Similarly	   the	   absolute	   renal	  
plasma	   flow	   was	   12%	   higher	   in	   the	   diabetes	   group	   but	   only	   5%	   difference	   remained	  
after	  correction	  for	  BSA.	  	  It	  is	  notable	  that	  in	  this	  study	  the	  mean	  BMI	  was	  31.6	  ±1.4	  in	  
the	   control	   group	   compared	   to	   37.3	   ±	   1.6	   in	   the	   diabetes	   group.	   This	   study	  
demonstrated	   an	   elevation	   of	   absolute	   GFR	   and	   a	   trend	   towards	   enhanced	   albumin	  
excretion	   rate	   fairly	   soon	   after	   diagnosis	   of	   type2	   diabetes.	   They	   also	   demonstrated	  
increased	   trans-­‐glomerular	   passage	   of	   dextran	   showing	   that	   there	   is	   a	   barrier	   size	  
selectivity	  dysfunction	  in	  early	  type2	  diabetes	  (Myers	  et	  al.,	  1991).	  
The	   Pima	   Indians	   in	   addition	   to	   having	   a	   high	   incidence	   of	   diabetic	   nephropathy	   also	  
have	   a	   higher	   rate	   of	   progression	   to	   develop	   renal	   function	   loss	   despite	   having	   lower	  
blood	  pressure	  and	   lipid	   levels.	  They	  have	  been	  found	  to	  have	  a	  combination	  of	   lower	  
number	   of	   glomeruli	   (inherited	   glomerulopaenia)	   and	   glomerulomegaly	   that	   results	   in	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greater	   incremental	   loss	   of	   single-­‐nephron	   GFR	   (SNGFR)	   with	   each	   nephron	   lost	   to	  
sclerosis.	  In	  a	  group	  of	  34	  Pima	  Indians	  the	  authors	  observed	  average	  rate	  of	  GFR	  loss	  of	  
13.8mls/min/1.73m2	  and	   the	  majority	   of	   these	   patients	   progressed	   to	   end	   stage	   renal	  
disease	  by	  10	  years	  of	  follow	  up	  (Lemley,	  2003).	  	  
	  Pima	  Indian	  studies	  also	  give	  us	  some	  insight	  into	  the	  phenomenon	  of	  hyper-­‐filtration	  in	  
early	  diabetic	  nephropathy.	  Nelson	  et	  al	  studied	  glomerular	  function	  in	  194	  Pima	  Indians	  
in	   different	   stages	   of	   development	   and	  progression	  of	   diabetic	   nephropathy.	  GFR	   and	  
renal	  plasma	  flow	  were	  measured	  using	  Iothalamate	  and	  PAH	  clearance	  respectively	  at	  
baseline,	   2	   years	   and	   4	   years.	   The	  GFR	   in	   the	   groups	  with	   newly	   diagnosed	   diabetes,	  
normo	  and	  microalbuminuria	  exceeded	  that	  in	  the	  group	  with	  normal	  glucose	  tolerance	  
by	   16%,	   24%	   and	   26%	   respectively.	   GFR	  was	   proportionally	  more	   elevated	   than	   renal	  
plasma	  flow	  in	  the	  normo	  or	  microalbuminuria	  group.	  On	  the	  other	  hand	  in	  the	  macro	  
albuminuria	  group	  the	  GFR	  and	  plasma	  renal	  flow	  was	  lower	  than	  the	  other	  groups.	  The	  
authors	   suggested	   that	   a	   progressive	   loss	   of	   intrinsic	   ultrafiltration	   capacity	   is	   the	  
predominant	  cause	  of	  declining	  GFR;	  and	  in	  subjects	  with	  macro-­‐albuminuria	  glomerular	  
hyper-­‐perfusion	  no	  longer	  compensates	  for	  the	  reduced	  ultrafiltration	  capacity	  (Nelson	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2.1	  Recruitment	  
Study	   subjects	  were	   recruited	   from	   the	  diabetes	   clinics	   at	  Aintree	  University	  Hospital	   and	  
the	   diabetic	   nephropathy	   clinics	   at	   St	   Helens	   and	   Knowsley	   hospital.	   Healthy	   volunteers	  
were	   recruited	   from	   amongst	   the	   staff	   and	   colleagues	   at	   Aintree	   university	   hospital.	   All	  
study	  participants	  received	  a	  patient	  information	  leaflet	  and	  gave	  written	  informed	  consent	  
before	  any	  study	  related	  intervention	  was	  undertaken.	  Liverpool	  Research	  Ethics	  Committee	  
and	  local	  R&D	  departments	  approved	  all	  the	  studies	  included	  in	  this	  thesis.	  
	  
2.2	  Subjects	  
Chronic	  kidney	  disease	  was	  defined	  as	  either	  kidney	  damage	  (pathological	  abnormalities	  or	  
markers	  of	  damage,	  including	  abnormalities	  in	  blood	  or	  urine	  tests	  or	  imaging	  studies)	  or	  
eGFR<	  60	  for	  >	  3	  months	  (KDOQI,	  2002).	  
Body	  mass	  index	  (BMI)	  was	  defined	  as	  weight	  (Kg)	  /	  height	  (m)	  2.	  The	  study	  participants	  
were	  divided	  into	  two	  categories	  based	  upon	  their	  BMI	  as	  follows:	  
BMI	  <30	  kg/m2	  and	  
BMI	  ≥30	  kg/m2	  (obese	  category)	  
Subject	  numbers	  and	  baseline	  characteristics	  were	  different	  in	  various	  studies	  and	  have	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2.3	  Sample	  handling	  and	  centrifugation	  
	  
Venous	   samples	  were	   drawn	   from	   an	   indwelling	   cannula	   and	   immediately	   centrifuged	   at	  
3000rpm	   for	   15	   minutes.	   This	   was	   to	   minimise	   the	   effect	   of	   delayed	   centrifugation	   on	  
measured	  variables	  particularly	  serum	  creatinine.	  The	  supernatant	  serum	  was	  extracted	  and	  
the	   rest	  discarded.	  One	   serum	  aliquot	  was	   sent	   to	  biochemistry	   laboratory	   and	   the	  other	  
frozen	  at	  -­‐80	  0C	  for	  future	  use.	  
First	   void	  morning	   urine	   sample	   was	   collected	   in	   universal	   urine	   containers	   and	   subjects	  
brought	   them	   in	   for	   study	   visits;	   an	   aliquot	   was	   frozen	   at	   -­‐80	   0C	   for	   future	   use.	   The	  
remaining	  sample	  was	  sent	  to	  biochemistry	  laboratory	  for	  albumin-­‐	  creatinine	  ratio	  (ACR).	  
	  
2.4	  Creatinine	  assay	  
Serum	   creatinine	   was	   measured	   using	   the	   kinetic	   alkaline	   picrate	   assay	   on	   an	   Olympus	  
AU640	  analyser.	  
Picric	  acid	  in	  an	  alkaline	  medium	  reacts	  with	  creatinine	  to	  form	  an	  orange	  coloured	  complex	  
and	  the	  intensity	  of	  the	  colour	  is	  proportional	  to	  the	  concentration	  of	  creatinine	  (Delanghe	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Figure	  2.1	  Kinetic	  alkaline	  picrate	  assays	  
	  
	  
The	  kinetic	  part	  means	  that	  the	  rate	  of	  formation	  of	  the	  product	  between	  two	  time	  points	  is	  
also	   considered	   which	   reduces	   assay	   interference.	  	   This	   is	   because	   acetoacetate	   may	  
interfere	  early	  in	  the	  reaction	  and	  protein	  may	  interfere	  later.	  	   
 
2.5	  Urine	  albumin	  -­‐	  creatinine	  ratio	  
We	   used	   albumin:	   creatinine	   ratio	   (ACR)	   which	   is	   a	   widely	   accepted	   surrogate	   for	   the	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2.6	  eGFR	  estimation	  
We	  used	  the	  four-­‐variable	  Modification	  of	  Diet	  in	  Renal	  Disease	  Study	  (MDRD)	  formula	  as	  
this	  was	  used	  in	  most	  laboratories	  including	  in	  our	  centre:	  
	  	  	  	  	  175	  x	  [{(serum	  creatinine	  (µmol/l)	  (-­‐intercept)/slope}	  x	  0.011312]-­‐1.154	  x	  	  	  
	  	  	  	  	  [Age]-­‐0.203	  x	  [0.742	  if	  	  	  female]	  x	  [1.212	  if	  AfroCarribean]	  (ml/min	  per	  
1.73m2)	  
This	   is	   traceable	   to	   IDMS-­‐creatinine	   and	   adjusted	   for	   Olympus	  methodology	   used	   in	   our	  




2.7	  Isotopic	  GFR	  measurement	  
We	  used	   51Chromium-­‐EDTA	   clearance	  method,	  which	  has	  been	   validated	  against	   the	   gold	  
standard	   inulin	   clearance	   (Ditzel	   et	   al.,	   1972,	   Brøchner-­‐Mortensen,	   1985).	   	   51Chromium-­‐
EDTA	   clearance	   is	   the	   most	   commonly	   used	   technique	   used	   in	   UK	   and	   also	   the	   rest	   of	  
Europe	  and	  has	  been	  well	  validated.	  It	  is	  also	  the	  technique	  recommended	  by	  the	  European	  
Association	   of	   Nuclear	   medicine	   and	   the	   British	   Nuclear	   Medicine	   Society	   (Piepsz	   et	   al.,	  
2005,	   Fleming	   et	   al.,	   2004).	   51Chromium	  has	   a	   relatively	   long	  half-­‐life	   of	   27.7	   days,	  which	  
allows	  a	  lot	  more	  time	  between	  blood	  sampling	  and	  counting	  of	  the	  samples	  compared	  to	  
other	  radionuclides	  used	  for	  GFR	  measurement	  (Murray	  et	  al.,	  2013).	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Figure	  2.2:	  The	  4	  stages	  of	  GFR	  measurement	  using	  radionuclide-­‐based	  studies	  of	  GFR	  are	  




1. Tracer	   Preparation:	   A	   stock	   solution	   is	   prepared	   as	   per	   manufacturer’s	  
recommendation	   and	   a	   patient	   dose	   and	   a	   standard	   dose	   are	   drawn	   into	   syringes	  
from	  it.	  The	  quantity	  of	  tracer	  in	  the	  2	  doses,	  the	  time	  of	  measurement,	  the	  weight	  
of	   the	   patient,	   and	   the	   standard	   doses	   are	   recorded	   before	   administration.	   The	  
standard	  dose	  is	  diluted	  in	  a	  1litre	  volumetric	  flask.	  
	  
The 4 stages of radionuclide-based GFR studies. Anthony W. Murray et al. J. Nucl. Med. Technol. 
2013;41:67-75 
(c) Copyright 2014 SNMMI; all rights reserved 
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2. Administration:	  Before	  administration	  of	  the	  dose	  the	  intravenous	  line	  is	  checked	  by	  
injecting	  10ml	  0.9%	  saline	  to	  reduce	  risk	  of	  extravasation.	  A	  bolus	  of	  3	   to	  3.5	  MBq	  
51Cr-­‐EDTA	  is	  administered	  to	  the	  subjects	  intravenously	  at	  0	  minutes.	  The	  weights	  of	  
the	  empty	  syringes	   from	  the	  patient	  and	  standard	  doses	  are	  recorded	  for	  residual-­‐
dose	  correction	  purposes.	  
3. Sampling:	   A	   cannula	   is	   inserted	   in	   the	   vein	   in	   the	   contralateral	   arm	   and	   2	   blood	  
samples	  (5	  ml	  of	  serum	  sample	  for	  creatinine	  estimation	  and	  4	  ml	  of	  blood	  in	  EDTA	  
tube	  for	  glycated	  haemoglobin)	  taken	  from	  this	  cannula	  at	  0	  hour	  (baseline).	  Three	  
further	  samples	  are	  taken	  at	  120,	  180	  and	  240	  minutes	  
4. Counting	   and	   GFR	   calculation:	   The	   whole	   blood	   is	   centrifuged	   at	   1000g	   for	   10	  
minutes	  to	  isolate	  plasma	  and	  then	  taken	  in	  1ml	  counting	  vials.	  The	  standard	  sample	  
is	   also	   prepared	   in	   1ml	   vial.	   Each	   vial	   is	   counted	   for	  more	   than	  10000	   counts	   in	   a	  
gamma	  counter.	  	  
The	   slope-­‐intercept	  GFR	  was	  measured	   from	   three	   samples	   taken	  at	   120,	   180	  and	  
240	  minutes.	  The	   slope	   intercept	  method	   is	  preferred	   to	   full	   area	  under	   the	  curve	  
method,	  which	  is	  too	  time	  consuming	  for	  routine	  use.	  This	  GFR	  is	  corrected	  for	  one-­‐
pool	   approximation	   using	   the	   quadratic	   Brøchner-­‐Mortensen	   equation	   (Fleming	   et	  
al.,	   2005)	   to	   correct	   for	   the	   relatively	   small	   fraction	  of	   the	  AUC	  missed	  due	   to	  not	  
including	   the	   fast	  exponential	   in	   the	  mesurements.	  GFR	   is	   indexed	  to	  body	  surface	  
area	   (GFR	   corrected=	   GFRmeasured	   x	   (1.73/BSA	   m2))	   and	   expressed	   as	   ml/minute	  
per1.73m2.	   Body	   Surface	   Area	   (BSA)	  was	   calculated	   based	   on	   the	   Du	   Bois	   and	  Du	  




64	  |	  P a g e 	  
	  
This	   radioisotope	   test	   to	   assess	   kidney	   function	   is	   routinely	   being	   performed	   in	   the	  
Department	  of	  nuclear	  medicine	  at	  Royal	   Liverpool	  University	  Hospital	   (RLUH).	   	   Following	  
the	   test	   participants	   were	   free	   to	   leave	   the	   hospital	   after	   each	   participant	   spending	  
approximately	  5	  hours	  at	  RLUH.	  	  
	  
2.8	  Cooked	  meals	  
Our	  hospital	  canteen	  cooked	  the	  meals	  for	  study	  participants	  as	  per	  instructions	  on	  the	  
packaging.	  The	  Aberdeen	  Angus	  beef	  burgers,	  which	  contain	  23	  grams	  of	  protein,	  were	  
grilled	  from	  frozen	  at	  moderate	  heat	  for	  25	  minutes.	  The	  meat	  free	  burgers	  containing	  21	  
grams	  of	  protein	  were	  grilled	  at	  moderate	  heat	  for	  15	  minutes	  as	  per	  cooking	  instruction.	  
These	  were	  served	  along	  with	  2	  buns	  and	  vegetable	  salad,	  followed	  by	  250	  mls	  of	  water.	  
	  
Statistical	  methods	  
Statistical	  analysis	  was	  carried	  out	  using	  SPSS	  (version	  17.0	  for	  Windows:	  SPSS,	  Chicago,	  IL)	  
and	  Microsoft	  offices	  excel	  2007.	  The	  4-­‐v	  MDRD	  eGFR	  results	  were	  compared	  with	  isotopic	  
GFR	   by	   means	   of	   two-­‐tailed	   paired	   and	   unpaired	   t	   tests	   as	   appropriate.	   Results	   are	  
presented	  as	  mean	  ±	  SD	  unless	  otherwise	  indicated.	  P	  <	  0.05	  was	  taken	  to	  indicate	  statistical	  
significance.	  
Bland	  Altman	  plots	  were	  constructed	  using	   the	  SPSS	  programme.	   It	   is	  a	  graphical	  method	  
used	   to	   compare	   two	   measures.	   The	   Bland	   Altman	   plot	   consists	   of	   the	   average	   of	   the	  
difference	   between	   paired	   values	   from	   each	  method	   on	   the	   x-­‐axis	   and	   the	   difference	   of	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each	  pair	  of	  readings	  on	  the	  y-­‐axis. It	  allows	  us	  to	  look	  for	  any	  systematic	  difference	  (fixed	  
bias)	  and	  also	  identifies	  outliers.	  This	  statistical	  method	  is	  proposed	  when	  a	  new	  measure	  is	  
to	   be	   evaluated	  by	   comparison	  with	   an	   existing	   technique.	   Bland	   and	  Altman	  explain	   the	  
importance	   of	   agreement	   rather	   than	   correlation	   when	   comparing	   two	   measurement	  
methods	   (Bland	   and	   Altman,	   1986).	   The	   Bland	   Altman	   plot	   analysis	   is	   a	   simple	   way	   to	  
evaluate	   a	   bias	   between	   the	   mean	   differences,	   and	   to	   estimate	   an	   agreement	   interval,	  
within	  which	  95%	  of	  the	  differences	  of	  the	  second	  method,	  compared	  to	  the	  first	  one,	  fall	  
(Giavarina,	  2015).	  The	  upper	  95%	  confidence	  interval	  was	  expressed	  as	  (standard	  deviation	  X	  
1.96)	  +	  mean	  and	  the	  lower	  95%	  confidence	  interval	  as	  mean-­‐	  (standard	  deviation	  X	  1.96).	  If	  
the	  differences	  within	  mean	  ±	  1.96	  SD	  are	  clinically	   insignificant,	  the	  two	  methods	  may	  be	  
used	  interchangeably.	  The	  mean	  paired	  difference	  between	  the	  two	  measurements	  is	  called	  
the	  “bias”	  quantifies	  how	  much	  higher	  (i.e.,	  positive	  bias)	  or	  lower	  (i.e.,	  negative	  bias)	  values	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Diabetic	  nephropathy	  affects	  25-­‐40%	  of	  diabetic	  patients	  and	   is	   the	   leading	  cause	  of	  end-­‐
stage	   renal	   disease	   in	   the	  United	   States	   and	   Europe	   (Molitch	   et	   al.,	   2004).	   The	   increased	  
cardiovascular	   disease	   risk	   in	   diabetes	   is	   known	   to	   multiply	   in	   the	   presence	   of	   diabetic	  
nephropathy	   (Valmadrid	   et	   al.,	   2000)	   (M	   B	   Mattock,	   1992)	   (Buckley	   et	   al.,	   2009).It	   is	  
important	   to	   be	   able	   to	   screen	   and	   accurately	   stage	   patients	   with	   diabetes	   and	   chronic	  
kidney	   disease	   to	   enable	   timely	   intervention	   to	   delay	   progression	   as	   recommended	   by	  
national	  and	  international	  guidelines	  (KDOQI,	  2007,	  RCP,	  2006).	  	  
The	   US	   National	   Kidney	   Foundation	   recommends	   estimating	   eGFR	   in	   subjects	   at	   risk	   of	  
kidney	  disease	  such	  as	  patients	  with	  diabetes.	  Patients	  with	  CKD	  are	  classified	  primarily	  on	  
the	  basis	  of	   the	  eGFR	   into	  different	   stages	  of	   severity.	  This	  has	  been	  endorsed	   in	   the	  UK.	  	  
Furthermore,	   in	   patients	   with	   CKD,	   it	   is	   recommended	   that	   kidney	   function	   be	   followed	  
regularly	  every	  6	  or	  12	  months	  in	  stable	  patients,	  depending	  on	  the	  stage	  of	  CKD.	  	  
Renal	   Association	   and	   the	  Department	   of	   Health,	   UK	   has	   recommended	   using	   the	  MDRD	  
equation	   for	   estimating	   eGFR,	   as	   this	   equation	  was	   found	   to	   be	   superior	   to	   the	   previous	  
estimates.	   The	  MDRD	   equation	   (Levey	   et	   al.,	   1999)	   takes	   into	   account	   the	   fact	   that	   the	  
relationship	   between	   serum	   creatinine	   and	   GFR	   differs	   between	   Caucasians	   and	   African-­‐
Americans.	   Africans	   have	   a	   proportionally	   higher	   muscle	   mass	   compared	   to	   Asians	   and	  
Caucasians,	  so	  for	  the	  same	  GFR	  the	  creatinine	  may	  be	  higher.	  
This	  equation	  was	  derived	  from	  a	  population	  with	   impaired	  renal	   function	  and	  only	  6%	  of	  
patients	  had	  type2	  diabetes	  mellitus	  (Levey	  et	  al.,	  1999),	  this	  may	  explain	  the	  limitation	  of	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the	  equation	   in	  predicting	  renal	   function	   in	  healthy	  subjects	  and	   in	  patients	  with	  diabetes	  
mellitus.	  
	  Historically,	   proteinuria	   (and	   microalbuminuria)	   have	   been	   used	   to	   diagnose	   and	   assess	  
progression	   of	   diabetic	   kidney	   disease,	   but	   there	   is	   increasing	   recognition	   of	   the	   high	  
prevalence	   of	   non-­‐proteinuric	   diabetic	   kidney	   disease	   (Pugliese	   G,	   2010)	   and	   of	   the	  
importance	   of	   Glomerular	   filtration	   rate	   (GFR)	   	   as	   a	   predictor	   of	   cardiovascular	   events,	  
independent	   of	   proteinuria	   status	   (Florenz	   H,	   2010).	   Moreover,	   treatment	   choices	   for	  
concomitant	  conditions	  are	  also	  often	  influenced	  by	  estimates	  of	  renal	  function.	  GFR	  is	  a	  key	  
indicator	  of	  kidney	  function,	  but	  measuring	  it	  with	  inulin	  clearance	  or	  isotopic	  methods	  are	  
time	   consuming,	   expensive	   and	   clinically	   inapplicable.	   Hence	   kidney	   function	   is	   now	  
commonly	   assessed	   and	   monitored	   using	   creatinine	   based	   estimated	   GFR	   (eGFR).	   When	  
compared	   to	   the	   renal	   clearance	   of	   125I-­‐Iothalamate,	   the	   equation	   developed	   from	   the	  
Modification	  of	  Diet	  in	  Renal	  Disease	  (MDRD)	  study	  was	  shown	  to	  provide	  a	  more	  accurate	  
estimate	   of	   GFR	   than	   measured	   creatinine	   clearance	   or	   other	   commonly	   used	  
equations(Levey	   et	   al.,	   1999).	   Currently,	   the	   4-­‐variable	   MDRD	   formula,	   based	   on	   serum	  
creatinine,	   age,	   sex,	   and	   race	   is	   the	   most	   widely	   employed	   (Carter	   et	   al.,	   2006).	   Most	  
biochemistry	   laboratories	   now	   routinely	   report	   estimated	   GFR	   on	   samples	   sent	   for	  
measurement	  of	  renal	  function.	  
A	   study	   by	   Chudleigh	   et.al,	   measured	   GFR	   in	   293	   subjects	   with	   newly	   diagnosed	   type	   2	  
diabetes	  by	  51Chromium-­‐EDTA	  clearance	  method	  and	  compared	  it	  with	  estimated	  GFR	  using	  
Cockcroft-­‐Gault	   equation	   and	   the	   4-­‐variable	  MDRD	  equation.	   The	  MDRD	   formula	   showed	  
significant	  underestimation	  of	  GFR	  in	  subjects	  with	  newly	  diagnosed	  type2	  diabetes	  without	  
proteinuria	  and	  this	  bias	  increased	  with	  increasing	  body	  weight	  (Chudleigh	  et	  al.,	  2008).	  We	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speculated	  that	  this	  bias	  continues	  into	  later	  stages	  of	  diabetic	  chronic	  kidney	  disease.	  This	  
will	   have	   significant	   implications	   for	  management	   of	   patients	   with	   Type	   2	   diabetes,	   over	  
85%	  of	  whom	  are	  overweight	  or	  obese,	  where	  treatment	  choices	  are	  influenced	  by	  GFR.	  For	  
example,	   metformin,	   a	   drug	   with	   proven	   cardiovascular	   benefits	   to	   overweight	   Type	   2	  
diabetic	  patients(UKPDS,	  1998)	  may	  be	  denied	  to	  them	  due	  to	  GFR	  underestimation.	  	  
The	  aim	  of	  the	  present	  study	  was	  to	  estimate	  the	  bias	  between	  isotopic	  glomerular	  filtration	  
rate	  (GFR)	  and	  eGFR	  in	  patients	  with	  Type	  2	  diabetes	  and	  relate	  it	  to	  their	  body	  mass	  indices	  
(BMI).	  We	  used	  non-­‐corrected	  GFR	  measured	  using	   51Cr	   EDTA	  method	   and	   calculated	  4v-­‐
MDRD	   eGFR	   using	   IDMS	   calibrated	   creatinine	   which	   has	   been	   proposed	   as	   a	   robust	  
methodology	  to	  highlight	  the	  bias	  between	  GFR	  and	  eGFR	  (Delanaye	  et	  al.,	  2006).	  
Indexing	   GFR	   to	   body	   surface	   area	   in	   obese	   patients	   has	   been	   shown	   to	   introduce	  
underestimation	   of	   the	   GFR.	   Because	   the	   number	   of	   nephrons	   does	   not	   increase	   with	  
increasing	  body	  fat,	  increasing	  obesity	  must	  result	  in	  an	  increase	  in	  the	  single-­‐nephron	  GFR.	  
This	  has	  been	  discussed	  previously	  in	  the	  general	  introduction	  in	  the	  context	  of	  Pima	  Indian	  
studies.	  Absolute	  GFR	  reflects	  this	  phenomenon	  whereas	  correcting	  GFR	  for	  BSA	  obscures	  it.	  
Nyengaard	   and	   Bendsten	   estimated	   glomerular	   number	   in	   autopsy	   specimen	   using	   a	  
method	  called	  unbiased	  stereological	  method	  and	  found	  the	  average	  glomerular	  number	  to	  
be	   617000.	   Glomerular	   number	   showed	   a	   negative	   correlation	   to	   age	   of	   the	   subject	   and	  
positive	  correlation	   to	  kidney	  weight.	  BSA	  correlated	  positively	   to	  kidney	  weight	  and	  total	  
glomerular	   volume	   but	   not	   to	   number	   of	   glomeruli	   (Nyengaard	   and	   Bendtsen,	   1992).	  
Another	  autopsy	  study	  on	  35	  neonates	  who	  died	  within	  2	  weeks	  of	  birth	  showed	  a	  negative	  
correlation	  between	  glomerular	  number	  and	  size	  with	  low	  birth	  weight.	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It	  has	  been	  proposed	  that	  being	  born	  with	  decreased	  number	  of	  nephrons	  (Nephron	  under-­‐
endowment)	   may	   increase	   risk	   from	   hypertension	   and	   the	   rate	   of	   progression	   of	   renal	  
disease	  (Manalich	  et	  al.,	  2000).	  
Previous	   studies	   have	   recommended	   that	   uncorrected	   GFR	  must	   be	   preferred	   in	   routine	  
practice	  and	  clinical	  studies	  for	  the	  obese	  population	  (Delanaye	  et	  al.,	  2005)	  (Delanaye	  et	  al.,	  
2009).	   We	   report	   both	   uncorrected	   GFR	   and	   GFR	   indexed	   to	   BSA	   and	   also	   examine	   the	  
difference	  between	  them	  in	  the	  obese	  and	  non-­‐obese	  categories.	  
	  
3.2	  RESEARCH	  DESIGN	  AND	  METHODS	  
Study	  population	  
The	  study	  population	  comprised	  of	  111	  Caucasian	  subjects,	  55	   females	  and	  56	  males	  with	  
type	   2	   diabetes	   recruited	   from	  diabetes	   clinics	   at	   Aintree	  University	  Hospital.	   They	   had	   a	  
median	  age	  of	  66,	  median	  HbA1c	  of	  8.1%	  and	  median	  serum	  creatinine	  of	  98	  µmol/l.	  The	  
eGFR	  (4v-­‐MDRD)	  ranged	  between	  18.5-­‐to	  124.8	  mls/min/1.73	  m2.	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Serum	  Creatinine	  assay	  and	  eGFR	  calculation	  
Serum	   creatinine	   was	   measured	   using	   the	   kinetic	   alkaline	   picrate	   assay	   on	   an	   Olympus	  
AU640	  analyser.	  	  
The	   modified	   MDRD	   equation	   traceable	   to	   IDMS-­‐creatinine	   and	   adjusted	   for	   Olympus	  
methodology	  (ml/min	  per	  1.73m2):	  	  	  
175	  x	  [((serum	  creatinine	  -­‐16.14)/0.955)	  x	  0.011312]-­‐1.154	  x	  	  	  	  	  [age]-­‐0.203	  x	  [0.742	  if	  	  	  




We	  used	  51Chromium-­‐EDTA	  clearance	  method,	  which	  is	  discussed	  in	  the	  method	  section.	  
Statistical	  analysis	  
The	  4-­‐v	  MDRD	  eGFR	  results	  were	  compared	  with	  isotopic	  GFR	  by	  means	  of	  two-­‐tailed	  paired	  
and	  unpaired	  t	   tests	  as	  appropriate.	  Results	  are	  presented	  as	  mean	  ±	  SD	  unless	  otherwise	  
indicated.	  P	   <	   0.05	  was	   taken	   to	   indicate	   statistical	   significance.	  A	  Bland	  Altman	  plot	  was	  
constructed	  using	  the	  SPSS	  programme	  to	  plot	  the	  difference	  and	  mean	  of	  the	  indexed	  GFR	  









Table	  3.1:	  	  Demographics	  and	  Bias	  between	  eGFR	  and	  measured	  GFR	  from	  all	  subjects	  
	  
N	   111	  
Male/female	   56/55	  
Age	  (years)	   65.7±10.7	  (66.0[58.0-­‐74.0])	  
Weight	  (Kg)	   90.74±22.4	  (87.9[73.9-­‐102.8])	  
BMI	  (Kg/m2)	   33.0±7.3	  (32.3	  [27.7-­‐37.5])	  
BSA	  (m2)	   1.97±0.25	  (1.95[1.7-­‐2.1])	  
HbA1c	  (%)	   8.3±1.6	  (8.1	  [7.1-­‐9.4])	  
Creatinine	  (µmol/L)	   107.6±31.8	  (98.0	  [87-­‐126])	  
Uncorrected	  	  GFR	   85.4±38.8	  (76.6	  [56.7-­‐108.0])	  
Indexed	  	  GFR	   75.1±32.1	  (68.8[51-­‐91.5])	  
eGFR	   66.7±24.2	  (65.6[47.9-­‐84.6])	  
Bias	  1	  (95%	  CI)	   -­‐18.70(-­‐26.9	  to	  -­‐10.4)	  p=0.000	  
Bias	  2	   -­‐8.45	  (-­‐15.7	  to	  -­‐1.1)	  p=0.024	  
Demographics	  and	  Bias	  between	  eGFR	  and	  measured	  GFR	  
Data	   presented	   as	  means	   ±SD	   (median	   [interquartile	   range]).	   Bias1	   is	   the	  mean	  
difference	   between	   eGFR	   and	   uncorrected	   measured	   GFR.	   Bias2	   is	   the	   mean	  
difference	  between	  eGFR	  and	  indexed	  GFR.	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Table	  3.2:	  Demographics	  and	  Bias	  between	  eGFR	  and	  measured	  GFR	  from	  non-­‐obese	  
subjects	  (BMI<30)	  
	  
N	   37	  
Male/female	   23/14	  
Age	  (years)	   69.3±11.2	  (72[63-­‐77])	  
Weight	  (Kg)	   71.9±11.5	  (71.0[63.1-­‐80.3])	  
BMI	  (Kg/m2)	   25.3±2.8	  (25.9	  [23.2-­‐27.9])	  
BSA	  (m2)	   1.81±0.17	  (1.82	  [1.6-­‐1.9])	  
HbA1c	  (%)	   8.7±1.7	  (8.3	  [7.4-­‐9.5])	  
Creatinine	  (µmol/L)	   103±23.3	  (99.0	  [87.5-­‐113.0])	  
Uncorrected	  	  GFR	   74.6±24.7	  (71.4	  [54.9-­‐86.9])	  
Indexed	  	  GFR	   71.4±24.1	  (65.9	  [51.4-­‐83.3])	  
eGFR	   68.6±23.0	  (69.4	  [52.9-­‐87.2])	  
Bias	  1	  (95%	  CI)	   -­‐6.04	  (-­‐17.6	  to-­‐	  5.5)	  p=0.299	  
Bias	  2	   -­‐2.86	  (-­‐14.1	  to	  8.3)	  p=0.609	  
Demographics	  and	  Bias	  between	  eGFR	  and	  measured	  GFR	  
Data	   presented	   as	  means	   ±SD	   (median	   [interquartile	   range]).	   Bias1	   is	   the	  mean	  
difference	   between	   eGFR	   and	   uncorrected	   measured	   GFR.	   Bias2	   is	   the	   mean	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Table	  3.3:	  Demographics	  and	  Bias	  between	  eGFR	  and	  measured	  GFR	  from	  obese	  subjects	  
	  
N	   74	  
Male/female	   33/41	  
Age	  (years)	   63.9±10.0	  (64.0	  [57.0-­‐73.0])	  
Weight	  (Kg)	   100±20.6	  (97.2	  [86.1-­‐112.7])	  
BMI	  (Kg/m2)	   36.8±5.6	  (35.1	  [32.3-­‐40.3])	  
BSA	  (m2)	   2.05±0.24	  (2.02	  [1.89-­‐2.21])	  
HbA1c	  (%)	   8.1±1.5	  (8.0	  [6.8-­‐9.3])	  
Creatinine	  (µmol/L)	   109.6±35.2	  (97.5	  [84.5-­‐128.0])	  
Uncorrected	  	  GFR	   90.8±43.4	  (88.4	  [58.0-­‐110.8])	  
Indexed	  	  GFR	   77.0±35.4	  (71.1	  [49.4-­‐97.0])	  
eGFR	   65.7±24.9	  (62.1	  [46.2-­‐84.9])	  
Bias	  1	  (95%	  CI)	   -­‐25.02	  (-­‐35.9	  to	  -­‐14.1)	  p=0.000	  
Bias	  2	   -­‐11.25	  (-­‐20.7	  to	  -­‐1.7)	  p=0.021	  
	  
Data	   presented	   as	  means	   ±SD	   (median	   [interquartile	   range]).	   Bias1	   is	   the	  mean	  
difference	   between	   eGFR	   and	   uncorrected	   measured	   GFR.	   Bias2	   is	   the	   mean	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The	  4-­‐v	  MDRD	  formula	  significantly	  underestimates	  GFR	  in	  the	  obese	  patients	  with	  Type	  2	  
diabetes	  as	  shown	   in	  Fig.3.1	   (a).	  A	  significant	  bias	  persisted	   into	  CKD	  stage	  3	   in	   the	  obese	  






(a)	  Showing	  the	  bias	  in	  the	  obese	  and	  
non-­‐obese	  categories.	  The	  figure	  also	  
shows	  significant	  reduction	  in	  
measured	  GFR	  when	  it	  is	  indexed	  to	  
BSA	  in	  the	  obese	  population.	  
(b)	  Shows	  the	  bias	  in	  chronic	  kidney	  
disease	  stages	  1-­‐4	  in	  the	  obese	  











Figure	  3.2:	  Graph	  above	  shows	  a	  significant	  positive	  correlation	  between	  the	  difference	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It	   was	   also	   noted	   that	   the	  mean	   body	   surface	   area	   increased	  with	   increasing	   body	  mass	  
indices	   and	   was	   2.05±0.24	   m2	   in	   the	   obese	   subjects.	   The	   mean	   difference	   between	   the	  
uncorrected	   GFR	   and	   the	   corrected	   GFR	   (indexed	   GFR)	   was	   13.02±53.2	   (p=0.039)	   in	   the	  
obese	  subjects.	  This	  discrepancy	  between	  the	  measured	  GFR	  before	  and	  after	  indexing	  to	  a	  





Figure	  3.3:	  Bland	  Altman	  plot	  of	  the	  difference	  between	  indexed	  GFR	  and	  4-­‐v	  MDRD	  eGFR	  
and	  the	  mean	  of	  the	  two	  measurements	  from	  the	  whole	  study	  population.	  The	  continuous	  
line	  represents	  the	  mean	  of	   the	  difference	  between	  the	  2	  measure	  and	  the	  dotted	   lines	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3.4	  DISCUSSION	  
Our	  study	  shows	  that	  the	  4-­‐v	  MDRD	  formula	  underestimates	  GFR	  in	  overweight	  and	  obese	  
patients	  with	  Type	  2	  diabetes.	  The	  bias	  between	  estimated	  and	  measured	  GFR	  in	  the	  obese	  
type	  2	  diabetic	  subjects	  persists	  across	  the	  range	  of	  CKD	  stages.	  This	  may	  have	  Implications	  
for	   management	   of	   obese	   patients	   with	   Type	   2	   diabetes,	   where	   treatment	   decisions	   in	  
relation	  to	  management	  of	  hyperglycaemia,	  hypertension	  and	  other	  concomitant	  conditions	  
are	  often	  determined	  by	  estimation	  of	  GFR.	  
The	   bias	   between	  measured	   and	   estimated	   GFR	   translates	   to	   a	  misclassification	   of	   study	  
subjects	  in	  the	  obese	  category	  into	  higher	  CKD	  groups.	  40%	  of	  subjects	  in	  CKD	  stage	  2	  were	  
misclassified	  into	  stage	  3	  and	  54%	  from	  stage	  3A	  to	  stage	  3B.	  
One	   of	   the	   limitations	   of	   the	   study	   is	   that	   GFR	   measurement	   using	   the	   slope	   intercept	  
method	  may	  not	  be	  accurate	  in	  patients	  with	  GFR	  less	  than	  30	  mls/min/1.73m2.	  The	  tracer	  
is	   substantially	   equilibrated	   by	   2	   hours	   in	   the	   normal	   subject,	   but	   complete	   equilibration	  
could	  take	  much	  longer.	  But	  the	  fraction	  not	  equilibrated	  by	  2	  hours	  is	  relatively	  very	  small	  
and	   is	   insignificant	   (Chantler	   and	   Barratt,	   1972).	   However,	   in	   the	   presence	   of	   renal	   failure	  
defined	  as	  GFR	   less	   than	  15	  mls/min/1.73m2,	   the	  apparent	  clearance	  of	   the	  small	   fraction	  
becomes	  more	   important.	   Some	  author	   recommends	  plasma	  sampling	   for	  6	   to	  8	  hours	   in	  
these	   circumstances	   (Maisey	  et	   al.,	   1969).	   This	  might	  have	   contributed	  partially	   to	   the	   very	  
high	  bias	  that	  we	  saw	  in	  our	  cohort	  of	  patients	  with	  CKD	  stage	  4.	  
Rule	  et	  al.	  studied	  MDRD	  equation	   in	  CKD	  with	  healthy	  kidney	  donors	  all	  of	  whom	  had	  an	  
Iothalamate	   clearance	   GFR	   measurement.	   These	   analyses	   indicate	   that	   although	   the	  
abbreviated	   MDRD	   equation	   was	   reasonably	   accurate	   in	   patients	   with	   chronic	   kidney	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disease,	   it	  significantly	  underestimated	  GFR	  in	  healthy	  persons.	  The	  authors	  proposed	  that	  
this	  was	  probably	  due	  to	  the	  exclusion	  of	  healthy	  persons	  from	  the	  study	  participants	  used	  
to	  develop	  this	  equation	  (Rule	  et	  al.,	  2004).	  The	  study	  by	  Chudleigh	  et	  al.	  also	  with	  subjects	  
with	   newly	   diagnosed	   diabetes	   and	   no	   known	   kidney	   disease	   showed	   significant	   bias	  
between	   MDRD	   eGFR	   and	   measured	   GFR.	   Our	   study	   complements	   these	   results	   by	  
examining	  the	  bias	  between	  measured	  and	  estimated	  GFR	  in	  subjects	  with	  CKD	  stages	  1	  to	  
4,	  which	   include	  the	  particularly	   important	  category	  with	  eGFR	  between	  30	  and	  60	  where	  
treatment	  decisions	  are	  often	  determined	  by	  an	  eGFR	  cut-­‐off	  value.	  Also	  unlike	  in	  the	  early	  
CKD	  stages,	  a	  percentage	  bias	  in	  the	  more	  advanced	  CKD	  stages	  will	  have	  significant	  clinical	  
implications.	  
The	   Cockcroft-­‐Gault	   formula	   (140-­‐age)	   X	   body	   weight/plasma	   creatinine	   X	   72	   X	   (0.85	   if	  
female)	  was	  established	  in	  1976	  to	  predict	  creatinine	  clearance	  (Cockcroft	  and	  Gault,	  1976).	  As	  
body	  weight	  is	  factored	  in	  the	  numerator	  in	  this	  formula,	  it	  overestimates	  clearance	  in	  the	  
obese	  subjects.	  In	  a	  cross	  sectional	  study	  using	  data	  from	  271	  potential	  kidney	  donors	  who	  
underwent	   GFR	   measurement	   using	   125I	   Iothalamate	   clearance	   method,	   Cockcroft-­‐Gault	  
formula	  had	  significantly	  higher	  bias	   than	  MDRD	  or	  CKD-­‐EPI	   formulae	   in	  patients	  with	   the	  
highest	  BMI.	  MDRD	  provided	  97%	  accuracy	  compared	  to	  the	  measured	  GFR	  while	  Cockcroft-­‐
Gault	  formula	  only	  provided	  57%	  in	  the	  obese	  subjects	  (Michels	  et	  al.,	  2010).	  Another	  study	  
comparing	  Cockcroft-­‐Gault	  and	  MDRD	  equations	  with	  GFR	  measured	  by	  99Tc	  DTPA	  showed	  
that	   Cockcroft-­‐Gault	   underestimates	   GFR	   in	   lean	   people	   (-­‐13	   mls/min/1.73m2)	   and	  
overestimates	  GFR	   in	   the	   overweight	   (+10	  mls/min/1.73m2)	   (Verhave	   et	   al.,	   2005).	   These	  
observations	   suggest	   that	   Cockcroft-­‐Gault	   formula	  may	   not	   be	   suitable	   for	   use	   in	   people	  
with	  high	  BMI.	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Most	  national	  and	  international	  guidelines	  advise	  close	  monitoring	  of	  patients	  on	  metformin	  
if	  eGFR	  is	  less	  than	  45ml/min/1.73m2.	  More	  than	  half	  of	  our	  obese	  subjects	  with	  eGFR	  >45	  
were	  misclassified	  into	  the	  lower	  category	  by	  the	  4v-­‐MDRD	  equation.	  This	  can	  lead	  to	  earlier	  
than	  necessary	  initiation	  of	  insulin	  in	  these	  patients	  with	  possible	  adverse	  effects	  like	  weight	  
gain	  and	  hypoglycaemia.	  Obesity	  is	  associated	  with	  significant	  reduction	  in	  insulin	  sensitivity	  
(Jallut	   et	   al.,	   1990).	   	   The	   dose	   of	   insulin	   required	   is	   hence	   often	   very	   high	   in	   the	   obese	  
patients	   which	   lead	   to	   further	   cost	   escalation.	   As	   we	   move	   away	   from	   a	   glucocentric	  
approach	   to	   managing	   basic	   pathophysiology	   in	   type	   2	   diabetes	   (Defronzo,	   2009),	   the	  
overweight	  and	  obese	  patients	  may	  be	  denied	  important	  therapeutic	  options	  because	  of	  an	  
underestimated	  GFR.	  
This	  study	  also	  highlights	  the	  problem	  with	  indexing	  measured	  GFR	  as	  it	  is	  practiced	  now	  in	  
the	  obese	  population.	  Indexing	  is	  based	  on	  the	  assumption	  that	  the	  average	  BSA	  is	  1.73m2	  
but	   our	   study	   shows	   it	   to	   be	   much	   higher	   in	   the	   obese	   subjects.	   As	   GFR	   is	   indexed	   by	  
multiplying	  it	  by	  a	  factor	  of	  1.73/BSA,	  the	  higher	  the	  BSA	  the	  lower	  will	  be	  the	  indexed	  GFR.	  
This	   practice	   of	   indexing	   does	   not	   cause	   major	   difference	   in	   the	   normal	   weight	   and	   the	  
slightly	  overweight	  populations,	  but	  it	  leads	  to	  significant	  underestimation	  of	  the	  GFR	  in	  the	  
obese	   subjects.	   Our	   obese	   study	   subjects	   had	   an	   average	   BSA	   of	   1.9m2.	   Part	   of	   the	  
underestimation	  of	  GFR	  in	  obesity	  by	  the	  MDRD	  equation	  is	  likely	  to	  be	  due	  to	  the	  fact	  that	  
it	  was	  derived	  from	  indexed	  GFR.	  Our	  data	  shows	  worse	  bias	  when	  MDRD	  eGFR	  is	  compared	  
with	  unidexed	  GFR.	  
In	   conclusion,	   the	   4-­‐variable	   MDRD	   equation	   significantly	   underestimates	   GFR	   in	   obese	  
patients	  with	  type2	  diabetes.	  There	  is	  a	  need	  for	  better	  equations	  for	  estimating	  GFR	  in	  the	  
obese	  subjects	  which	  are	  validated	  against	  the	  gold	  standard	  isotopic	  GFR	  in	  this	  population.	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Until	  such	  an	  equation	  becomes	  available,	  clinicians	  should	  consider	  this	  bias	  when	  making	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4.1	  Introduction	  
The	  Chronic	  Kidney	  Disease	  Epidemiology	  collaboration	  formula	  was	  developed	  to	  improve	  
estimation	   of	   GFR	   from	   serum	   creatinine	   and	   other	   readily	   available	   clinical	   parameters	  
especially	  when	  GFR	   is	  >60	  mL/min	  per	  1.73m2.	  There	  are	   several	   studies	   showing	  MDRD	  
equation	  to	  have	  significant	  bias	  in	  patients	  with	  higher	  GFR.	  
Poggio	  et	  al.	   compared	  MDRD	  and	  CG	   formulae	  against	  measured	   125I-­‐iothalamate	  GFR	   in	  
828	  patients	  with	  chronic	  kidney	  disease	  and	  457	  potential	  kidney	  donors	  with	  normal	  GFR.	  
In	  the	  kidney	  donor	  group,	  MDRD	  equation	  significantly	  underestimated	  the	  measured	  GFR	  
when	  compared	  with	   the	  CG	   formula,	  with	  a	  bias	  of	  −9.0	  versus	  1.9	  ml/min	  per	  1.73	  m2,	  
respectively	   (P	   <	   0.01).	   In	   this	   study	   neither	   the	   MDRD	   equation	   nor	   the	   CG	   formula	  
adequately	   represented	   the	   relationship	   between	  measured	  GFR	   and	   serum	   creatinine	   in	  
kidney	  donors.	   The	  authors	   concluded	   that	   this	   is	   probably	  due	   to	   the	  narrower	   range	  of	  
renal	   function	   in	   the	  donors	   than	   the	  CKD	  group	  and	  also	  differences	   in	   serum	  creatinine	  
between	   two	   donor	   patients	   are	   likely	   to	   predominantly	   reflect	   measurement	   error	   and	  
non-­‐renal	  biologic	  factors	  (Poggio	  et	  al.,	  2005).	  
Ibrahim	  et	  al.	  sowed	  similar	  bias	   in	  a	  study	  comparing	  the	  performance	  of	  Modification	  of	  
Diet	   in	  Renal	  Disease	   (MDRD)	  and	   the	  Cockcroft-­‐Gault	   formulae	  against	  GFR	  measured	  by	  
Iothalamate	  clearance	  in	  1286	  individuals	  from	  the	  Diabetes	  Control	  and	  Complications	  Trial	  
(DCCT).	   The	   DCCT	   participants	   had	   normal	   serum	   creatinine	   and	   were	   also	   younger	  
compared	  to	  MDRD	  study	  population,	  which	  led	  to	  biased	  and	  highly	  variable	  estimates	  of	  
GFR	  when	  these	  formulae	  were	  applied	  to	  the	  DCCT	  subjects.	  In	  the	  range	  of	  GFR	  observed	  
in	   the	  DCCT	  population	  and	  analyzed	   for	   this	  validation	  effort	   (60	   to	  300	  ml/min	  per	  1.73	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m2),	   the	  MDRD	   and	   the	   CG	   formulas	   underestimated	   renal	   function	   at	   levels	   of	  GFR	   that	  
were	  <120	  ml/min	  per	  1.73	  m2	  and	  so	  individuals	  with	  levels	  of	  renal	  function	  between	  60	  
and	  120	  ml/min	  per	  1.73	  m2	  are	  more	  likely	  to	  have	  a	  measured	  GFR	  that	  is	  higher	  than	  that	  
predicted	  by	  the	  equations	  (Ibrahim	  et	  al.,	  2005).	  
Levey	  et	  al.	  developed	  a	  new	  equation	  to	  estimate	  GFR	  called	  the	  CKD-­‐EPI	  (Chronic	  Kidney	  
Disease	   Epidemiology	   Collaboration)	   equation	   (Levey	   et	   al.,	   2009).	   They	   intended	   to	  
respond	  to	  the	  limitations	  of	  MDRD	  equation	  in	  estimating	  GFR	  in	  the	  normal	  renal	  function	  
range.	  Their	  aim	  was	  to	  develop	  a	  new	  equation	  that	  worked	  as	  well	  as	  the	  MDRD	  equation	  
at	  GFR	  less	  than	  60-­‐ml/min/1.73	  m2	  and	  more	  accurately	  at	  higher	  GFR.	  Data	  were	  obtained	  
from	   clinical	   studies	   and	   clinical	   populations	   who	   had	   their	   GFR	   measured	   using	   an	  
exogenous	   filtration	   marker.	   They	   had	   8254	   participants	   for	   development	   (5504	  
participants)	  and	   internal	  validation	  (2750	  participants)	  and	  3896	  participants,	   for	  external	  
validation.	   They	   used	   linear	   regression	   analyses	   to	   relate	   measured	   GFR	   and	   available	  
clinical	   characteristics.	   The	   independent	   variables	   included	   were	   serum	   creatinine,	   age,	  
race,	   and	   gender	   in	   all	  models	   as	   in	   the	   original	  MDRD	   study	   equation	   derivation.	   Some	  
models	   also	   included	   diabetes	   [yes/no],	   previous	   organ	   transplantation	   [yes/no],	   and	  
weight.	   Performance	   of	   these	   models	   were	   compared	   with	   each	   other	   and	   the	   MDRD	  
equation,	  and	  based	  on	  performance	  and	  ease	  of	  application,	  they	  selected	  a	  single	  model	  
as	   the	   best	   equation	   for	   general	   use	   called	   the	   CKD-­‐EPI	   equation.	   Although	   other	   factors	  
such	  as	  weight,	  diabetes,	   and	   transplant	  were	   considered	  as	  potential	   variables	  during	   its	  
derivation,	  the	  final	  equation	  that	  was	  proposed	  had	  the	  same	  four	  variables	  as	  the	  MDRD	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The	  CKD-­‐EPI	  equation	  is	  expressed	  as:	  
GFR	  =	  141	  X	  min	  (Scr/κ,	  1)α	  X	  max(Scr/κ,1)-­‐1.209	  X	  0.993Age	  X	  1.018	  [if	  female]	  X	  1.159	  [if	  
black]	  
Where	  Scr	  is	  serum	  creatinine	  (mg/dL),	  κ	  is	  0.7	  for	  females	  and	  0.9	  for	  males,	  α	  is	  –0.329	  for	  
females	  and	  –0.411	  for	  males,	  min	  indicates	  the	  minimum	  of	  Scr/κ	  or	  1,	  and	  max	  indicates	  




Figure	   4.1:	   (reproduced	   with	   permission)	   shows	   improvement	   in	   the	   bias	   between	  
estimated	   and	   measured	   GFR	   in	   the	   >60	   ml/min/1.73m2	   group	   of	   subjects	   in	   the	   first	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The	   CKD-­‐EPI	   equation	   has	   been	   evaluated	   in	   a	   large	   metaanalysis	   by	   the	   CKD	   prognosis	  
consortium.	  To	  be	   included	   in	  the	  consortium	  a	  study	  had	  to	  have	  over	  1000	  participants,	  
have	  information	  at	  baseline	  of	  eGFR	  and	  urine	  albumin	  levels	  and	  a	  minimum	  of	  50	  events	  
for	  any	  of	  the	  outcomes	  of	  interest	  (all	  cause/CV	  mortality	  and	  ESRD).	  The	  metaanalysis	  of	  
data	  from	  1.1	  million	  adults	  from	  25	  general	  population	  cohorts,	  7	  high	  risk	  cohorts	  and	  13	  
CKD	   cohorts	   showed	   that	   CKD-­‐EPI	   equation	   classified	   fewer	   individuals	   as	   CKD	   and	  more	  
accurately	  categorised	  the	  risk	  of	  mortality	  and	  ESRD	  than	  MDRD	  equation.	  The	  mean	  eGFR	  
was	  higher	  with	  CKD-­‐EPI	  than	  MDRD	  equation	  in	  the	  general	  population	  but	  comparable	  in	  
the	  CKD	  cohort.	  Also	   the	  participants	   reclassified	  upwards	  had	   lower	   risk	  of	  mortality	  and	  
ESRD	  and	   the	   authors	   concluded	   that	   CKD-­‐EPI	   is	   a	   better	   predictor	   of	   risk	   factors.	   As	   the	  
equation	  has	   the	   same	  variables	  as	   the	  MDRD	  equation,	   there	   is	  no	  additional	   laboratory	  
costs	  involved	  its	  implementation.	  They	  also	  suggest	  that	  estimated	  GFR	  reporting	  by	  CKD-­‐
EPI	  equation	  could	  contribute	  to	  more	  efficient	  and	  targeted	  prevention	  and	  management	  
of	  CKD-­‐related	  outcomes	  (Matsushita	  et	  al.,	  2012).	  
Camargo	   et	   al.	   analyzed	   the	   performances	   of	   Chronic	   Kidney	   Disease	   Epidemiology	  
Collaboration	   (CKD-­‐EPI)	   and	   of	   Modification	   of	   Diet	   in	   Renal	   Disease	   (MDRD)	   study	  
equations	   to	   estimate	   glomerular	   filtration	   rate	   (GFR)	   in	   56	   patients	  with	   Type2	   diabetes	  
mellitus	  with	  GFRs	   >60	  ml/min,	   and	   55	   healthy	   volunteers.	   Glomerular	   filtration	   rate	  was	  
measured	  by	  the	  51Cr-­‐EDTA	  single-­‐injection	  method	  (51Cr-­‐GFR).	  In	  diabetic	  individuals,	  51Cr-­‐
GFR	   was	   106	   ±	   27ml/min/1.73	   m2,	   CKD-­‐EPI-­‐estimated	   GFR	   82	   ±	   18	   ml/min/1.73	   m2	   and	  
MDRD-­‐estimated	   GFR	   80	   ±	   21	   ml/min/1.73	   m2	   (P	   <	   0.001).	   In	   healthy	   volunteers,	   the	  
corresponding	  values	  were	  98	  ±	  20,	  89	  ±	  13	  and	  84	  ±	  14	  ml/min/1.73	  m2	   (P	  <	  0.001).	  The	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accuracy	  of	  CKD-­‐EPI	  was	  higher	  in	  healthy	  volunteers	  than	  in	  diabetic	  patients	  (90	  vs.	  66%,	  
respectively,	  P	  <	  0.001).	  They	  concluded	  that	  CKD-­‐EPI	  equation	  performed	  as	  poorly	  as	  the	  
MDRD	  equation	  in	  individuals	  with	  Type	  2	  diabetes	  (Camargo	  et	  al.,	  2011).	  
The	  aim	  of	  our	  study	  was	  to	  examine	  the	  bias	  between	  measured	  and	  estimated	  GFR	  (using	  
CKD-­‐Epi	  and	  MDRD	  equations)	  in	  the	  obese	  and	  non-­‐obese	  groups	  in	  our	  Database.	  
	  
4.2	  Methods	  and	  Results	  
We	  investigated	  the	  bias	  between	  4	  variable	  MDRD	  eGFR	  and	  measured	  GFR	  in	  111	  patients	  
with	   type	   2	   diabetes	   who	   had	   chronic	   kidney	   disease	   stages	   1	   to	   4	   (S	   Nair,	   2011).	   We	  
measured	   GFR	   using	   our	   reference	   method	   of	   51Cr-­‐EDTA	   plasma	   clearance	   method	   and	  
indexed	   it	   to	   a	   BSA	   of	   1.73m2.	   Serum	   creatinine	  was	  measured	   using	   the	   kinetic	   alkaline	  
picrate	   assay	   on	   an	  Olympus	   AU640	   analyser.	   The	  modified	  MDRD	   equation	   traceable	   to	  
IDMS-­‐creatinine	  and	  adjusted	   for	  Olympus	  methodology	  was	  used	   for	  estimating	  GFR	  and	  
expressed	  as	  ml/min	  per	  1.73m2.	  We	  calculated	  GFR	  using	  the	  CKD-­‐EPI	  equation	  (Levey	  and	  
Stevens)	  and	  also	   its	  bias	  when	  compared	   to	  GFR	  and	  GFR	   indexed	   to	  a	  BSA	  of	  1.73m2	  as	  
shown	  in	  the	  table	  1.	  
The	  study	  population	  comprised	  of	  111	  Caucasian	  subjects,	  55	   females	  and	  56	  males	  with	  
type	   2	   diabetes	   recruited	   from	  diabetes	   clinics	   at	   Aintree	  University	  Hospital.	   They	   had	   a	  
median	   age	  of	   66,	  median	  HbA1c	  of	   8.1%	  and	  median	   serum	  creatinine	  of	   98µmol/l.	   The	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Table	  4.1:	  MDRD	  vs	  CKD	  Epi	  equation	  
	   4	  v	  MDRD	  equation	   CKD	  Epi	  equation	  
eGFR	   67.2	  ±	  27.3	   51.13	  ±	  17.7	  
eGFR–	  GFR	   -­‐16.9	  (-­‐25.0,	  -­‐8.4)	  p<0.001	   -­‐34.2	  (-­‐41.7,	  -­‐26.7)	  p=0.024	  




One	   of	   the	   criticisms	   of	   the	   CKD-­‐EPI	   equation	   is	   that	   high-­‐risk	   patients	  with	   clinical	   CKD,	  
characterized	   by	   an	   average	  measured	  GFR	   <60	  ml/min	   per	   1.73	  m2	  constituted	  71%	   (n	   =	  
5858)	   of	   the	   development	   population.	   This	   is	   despite	   the	   fact	   that	   the	   equation	   was	  
expected	  to	  improve	  estimation	  of	  higher	  GFR.	  The	  external	  validation	  was	  performed	  using	  
a	  sample	  size	  of	  3896,	  72%	  (n	  =	  2810)	  of	  whom	  came	  from	  high-­‐risk	  populations	  and	  the	  rest	  
had	  GFR>60	  ml/min	  per	  1.73	  m2.	  This	  may	  be	  the	  reason	  the	  CKD-­‐EPI	  equation	  performed	  
better	  in	  the	  external	  validation	  sample	  than	  MDRD	  equation	  that	  was	  derived	  using	  only	  a	  
high-­‐risk	  population.	  However	   the	  authors	   recognized	   that	  a	   single	  equation	   is	  unlikely	   to	  
work	  equally	  well	  in	  all	  populations	  (Rule,	  2010).	  
As	  shown	  by	  Camargo	  et	  al,	  analysis	  of	  our	  study	  cohort	  also	  shows	  significantly	  worsened	  
bias	   when	   eGFR	   was	   calculated	   using	   the	   CKD-­‐Epi	   compared	   to	   the	   4	   variable	   MDRD	  
formulas	  in	  patients	  with	  type2	  diabetes	  and	  chronic	  kidney	  disease.	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The	  bias	   is	  potentially	  multifactorial;	   in	   the	  original	  MDRD	  study	   (Levey	  et	  al.,	   1999)	   from	  
which	  the	  equation	  was	  derived	  the	  mean	  body	  weight	  was	  79.6	  ±	  16.8	  kg	  and	  hence	  not	  
typical	   of	   a	   type	   2	   diabetic	   patient	   population,	   the	   other	   factor	   is	   the	   inaccuracies	  
introduced	  by	  indexing	  glomerular	  filtration	  rate	  to	  body	  surface	  of	  1.73m2.	  The	  mean	  body	  
surface	   area	   in	   our	   obese	   category	  was	  much	  higher	   at	   2.05±0.24.	  We	  would	   also	   like	   to	  
point	  out	  that	  the	  study	  population	  in	  our	  study	  had	  a	  much	  higher	  BMI	  at	  36.8±5.6	  and	  a	  
wider	   range	   of	   eGFR	   66.6±25.0,	   which	   may	   account	   for	   the	   differences	   observed	   by	  
Camargo	  et	  al.	  (Camargo	  et	  al.,	  2011).	  
Our	  study,	   suggests	   this	  may	  be	  due	   to	  high	   rates	  of	  obesity	   in	   type2	  diabetes.	  Our	  study	  
population	   is	   also	   different	   to	   the	   CKD-­‐EPI	   population	   in	   some	   important	   baseline	  
characteristics.	   The	   patients	   with	   diabetes	   only	   accounted	   for	   30%	   of	   the	   CKD-­‐EPI	  
population;	  they	  had	  a	  mean	  BMI	  of	  28	  and	  BSA	  of	  1.93m2.	   In	  comparison	  all	  our	  patients	  
had	  diabetes,	  the	  mean	  BMI	  was	  33	  and	  mean	  BSA	  was	  1.97	  m2.	  	  The	  mean	  GFR	  in	  the	  CKD-­‐
EPI	   population	   was	   68	   mls/min/1.73	   m2	   compared	   to	   our	   study	   population	   which	   had	   a	  
mean	  GFR	  of	  85.4	  mls/min/1.73	  m2.	   It	   is	  possible	   that	  having	  more	   subjects	   in	   the	  higher	  
GFR	  range	  (>60	  mls/min/1,	  73	  m2)	  in	  our	  study	  makes	  the	  CKD-­‐EPI	  equation	  less	  reliable.	  	  
Although	   CKD-­‐EPI	   was	   proposed	   to	   be	   more	   generalizable	   than	  MDRD	   in	   various	   clinical	  
settings,	   it	  has	   the	  same	  4	  variables	  as	   the	  MDRD	  equation.	   It	  was	  also	  developed	   from	  a	  
population	   of	   which	   >70%	   were	   high	   risk	   (defined	   by	   GFR<60	   mls/min/1.73	   m2).	   Some	  
authors	  believe	  that	  CKD-­‐EPI	  performed	  better	  than	  MDRD	  in	  the	  validation	  cohort	  purely	  
because	  MDRD	  was	  derived	  exclusively	  from	  a	  high-­‐risk	  population	  (Rule,	  2010).	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The	  authors	  of	  CKD-­‐EPI	  equation	  did	  suggest	  that	  a	  single	  equation	  is	  unlikely	  to	  work	  for	  all	  
populations.	  Our	   study	  population	  of	  patients	  with	   type2	  diabetes	   is	   likely	   to	  be	  different	  




























DERIVATION	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  OBESITY	  CORRECTION	  EQUATION	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The	  aim	  of	  the	  present	  study	  was	  to	  measure	  the	  effect	  of	  obesity	  on	  estimate	  GFR	  and	  to	  
derive	  a	   ‘correction	   factor’	   for	   the	  4-­‐variable	  MDRD	  equation	   to	  adjust	   for	   the	  equation’s	  
underestimation	  of	  true	  (isotopic)	  GFR	  in	  obese	  subjects	  with	  Type	  2	  diabetes.	  	  We	  studied	  
diabetic	   subjects	   with	   CKD	   stages	   1	   to	   4	   (eGFR	   90	   to	   30	   mls/min	   per	   1.73	   m2),	   where	  
treatment	  decisions	  may	  be	  influenced	  by	  eGFR	  and	  formulated	  linear	  non-­‐linear	  regression	  
equations	   to	   correct	   the	   bias	   between	   estimated	   and	   measured	   GFR	   in	   our	   study	  
population.	   Correction	   coefficients	   for	   the	   MDRD	   equation	   for	   Chinese	   and	   Japanese	  
ethnicity	  have	  been	  reported	  previously	  (Ma	  et	  al.,	  2006,	  Matsuo	  et	  al.,	  2009),	  but	  there	  are	  
no	  established	  correction	  factors	  for	  the	  obese.	  
	  Saracino	  et	  al.	  proposed	  a	  correction	  factor	  for	  the	  overestimation	  of	  creatinine	  clearance	  
by	  Cockcroft	  Gault	  formula	  in	  obesity.	  They	  simultaneously	  determined	  creatinine	  clearance	  
using	  24-­‐hour	  urine	  collection	  (Cr-­‐cl)	  and	  the	  Cockcroft	  Gault	  clearance	  (CG-­‐cl)	  in	  52	  subjects	  
with	   a	   body	  mass	   index	   (BMI)	   >	   25.	   The	  percentage	  difference	  between	   the	   2	   clearances	  
(delta	  %)	  was	  correlated	  with	  BMI	   for	  each	  patient	  using	   simple	   linear	   regression	  analysis	  
and	  derived	  the	  following	  CG-­‐cl	  correction	  formula	  for	  obese	  subjects:	  Corrected	  CG-­‐cl	  =	  CG-­‐
cl	  (1.25	  -­‐	  0.012	  BMI).	  This	  was	  validated	  in	  20	  subjects	  with	  BMI>25	  and	  shown	  to	  correlate	  
well	  with	  24-­‐hour	  urine	  collection	  creatinine	  clearance	  (Saracino	  et	  al.,	  2004)	  
We	   also	   used	   our	   correction	   equations	   in	   an	   external	   dataset	   to	   establish	   their	   external	  








5.2	  RESEARCH	  DESIGN	  AND	  METHODS	  
5.2.1	  Study	  population	  
The	  study	  population	  comprised	  55	  females	  and	  56	  males	  with	  type2	  diabetes.	  They	  had	  a	  
mean	  age	  of	  65.7±10.7,	  median	  HbA1c	  of	  8.1%	  and	  median	  serum	  creatinine	  of	  98	  µmol/l.	  
The	  mean	  eGFR	  (4v-­‐MDRD)	  was	  67.29	  ±	  24.32.	  	  
An	  external	  dataset	  with	  169	  obese	  subjects	  with	  newly	  diagnosed	  type	  2	  diabetes	  from	  a	  
study	  conducted	   in	  Wales	   (Chudleigh	  et	  al.,	  2008)	  with	  similar	  methodology	  served	  as	   the	  
“validation	  set”.	  The	  study	  subjects	  had	  a	  mean	  age	  of	  55.2,	  mean	  BMI	  of	  31.52,	  HbA1c	  of	  
7.79	  and	  Creatinine	  of	  80.	  The	  mean	  eGFR	  was	  114.86	  ±	  22.35.	  
Serum	  Creatinine	  assay	  and	  eGFR	  calculation	  
Serum	   creatinine	   was	   measured	   using	   the	   kinetic	   alkaline	   picrate	   assay	   on	   an	   Olympus	  
AU640	  analyser.	  
The	  modified	  MDRD	  equation	  traceable	  to	  IDMS-­‐creatinine	  and	  adjusted	  for	  Olympus	  
methodology	  (ml/min	  per	  1.73m2):	  	  	  
175	  x	  [((serum	  creatinine	  -­‐16.14)/0.955)	  x	  0.011312]-­‐1.154	  x	  	  	  	  	  [age]-­‐0.203	  x	  [0.742	  if	  	  	  
female]	  x	  [1.212	  if	  AfroCarribean]	  was	  used	  to	  calculate	  eGFR	  (Reynolds	  and	  Twomey,	  2007).	  	  
This	  equation	  has	  a	  power	  law	  dependence	  on	  serum	  creatinine	  and	  age	  (i.e.,	  eGFR	  varies	  as	  
a	  power	  of	  creatinine	  and	  age.	  Relatively	  small	  changes	  to	  creatinine	  and	  age	  could	  have	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disproportionately	  high	  effect	  on	  eGFR),	  together	  with	  ratio	  correction	  factors	  for	  gender	  
and	  ethnicity	  
The	  external	  dataset	  serum	  creatinine	  was	  measured	  using	  the	  OCD	  dry-­‐slide	  system	  on	  the	  
Vitros	  750	  X	  RC	  and	  950analyser	  (HP12	  4DP:	  Johnson	  &	  Johnson,	  High	  Wycombe,	  UK).	  The	  
correction	  factor	  for	  creatinine	  for	  the	  OCD	  dry-­‐ice	  method	  is	  (Creatinine	  –	  7.71)/0.988.	  So	  
the	  eGFR175	  MDRD	  equation	  used	  was:	  	  
175	  x	  [{(serum	  creatinine	  –	  7.71)/0.988}	  x	  0.011312]-­‐1.154	  x	  	  	  [age]-­‐0.203	  x	  [0.742	  if	  	  	  female]	  x	  




We	  used	  51Chromium-­‐EDTA	  clearance	  method	  to	  measure	  GFR,	  which	  is	  discussed	  in	  detail	  
in	  the	  methods	  section	  of	  this	  thesis.	  Measure	  GFR	  indexed	  to	  BSA	  is	  referred	  to	  as	  iGFR	  in	  
the	  subsequent	  regression	  analyses.	  
GFR	  measurement	  in	  the	  external	  dataset	  was	  also	  using	  the	  51Chromium-­‐EDTA	  clearance	  
method	  and	  corrected	  for	  BSA.	  
	  
5.2.2	  Statistical	  analysis	  
Statistical	  analysis	  was	  carried	  out	  using	  SPSS	  (version	  16.0	  for	  Windows:	  SPSS,	  Chicago,	  IL)	  
and	  Microsoft	  Office	  Excel	  2007.	  Differences	  in	  bias	  with	  various	  equations	  were	  compared	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using	  Student’s	  t	  test	  for	  paired	  samples.	  Pearson’s	  correlation	  coefficients	  were	  calculated	  
to	  estimate	  the	  linear	  correlations	  between	  measured	  GFR	  and	  eGFR	  corrected	  using	  the	  
various	  equations.	  	  
Bland	  Altman	  plots	  were	  also	  constructed	  using	  SPSS	  software	  by	  plotting	  the	  mean	  of	  the	  
two	  measurements	  on	  the	  x-­‐axis	  and	  the	  paired	  difference	  between	  them	  on	  the	  y-­‐axis.	  
	  
5.3	  RESULTS	  
The	   4-­‐v	   MDRD	   formula	   underestimates	   GFR	   in	   overweight	   /obese	   patients	   with	   Type	   2	  
diabetes.	   This	   bias	   is	   greatest	   in	   the	   obese	   and	   persists	   after	   correction	   for	   body	   surface	  
area.	  
5.3.1	  Correction	  of	  the	  bias	  using	  linear	  non-­‐linear	  equations	  	  
Given	  the	  form	  of	  the	  MDRD	  formula,	  it	  is	  mathematically	  appropriate	  to	  fit	  the	  measured	  
GFR	  against	  eGFR	  and	  the	  corrective	  factor	  BMI,	  using	  an	  additive	  linear	  model	  and	  also	  to	  
fit	  the	  relation	  of	  measured	  to	  estimated	  GFR	  with	  additive	  or	  power	  law	  models.	  Applying	  
this	  approach	  led	  us	  to	  derive	  the	  following	  3	  possible	  correction	  equations	  from	  our	  data.	  
The	  three	  proposed	  predictive	  equations	  along	  with	  their	  Pearson’s	  correlation	  coefficients	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1. Multiple	  linear	  regression	  analysis	  with	  iGFR	  as	  the	  outcome	  variable	  and	  	  	  	  
	  	  	  	  	  eGFR	  and	  BMI	  as	  the	  independent	  variables	  produced	  this	  correction	  	  	  
	  	  	  	  equation	  to	  predict	  GFR	  
	  	  	  	  	  	  	  	  	  	  Predicted	  (p)	  GFR-­‐1	  =	  0.88*(BMI)+0.88*(eGFR)-­‐15.6	  




Fig	  5.1:	  Bland	  Altman	  plot	  between	   the	  difference	  and	  mean	  between	   indexed	  GFR	  and	  
the	   predictive	   equation	   1.	   The	   bold	   line	   is	   the	   mean	   and	   dotted	   lines	   are	   the	   95%	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2. This	  model	  was	  obtained	  by	  fitting	  the	   log	  (iGFR)	  using	   log	  (BMI)	  and	  log	  (eGFR)	  as	  
independent	   covariates:	   Log	   (pred_GFR)	  =	   log	   (BMI)	   x	  0.322	  +	   log	   (eGFR)	  x	  0.812	   -­‐
0.264,	  leading	  to	  temp=	  bmi0.32	  x	  egfr0.81	  	  and	  consequently	  to	  	  
	  	  	  	  	  	  	  pGFR-­‐2	  =	  0.808*bmi0.32	  x	  egfr.812	  -­‐0.599	  




Figure	  5.2:	  Bland	  Altman	  plot	  between	  the	  difference	  and	  mean	  between	  indexed	  GFR	  and	  
the	   predictive	   equation	   2.	   The	   bold	   line	   is	   the	   mean	   and	   dotted	   lines	   are	   the	   95%	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3. A	   ratio	   model	   obtained	   by	   modelling	   iGFR/eGFR	   as	   a	   linear	   function	   of	   BMI	   and	  
slightly	  approximating	   the	  parameters:	  0.0062-­‐>0.005	  and	  0.8889-­‐>1.	  	  This	   reduces	  
the	  correlation	  coefficient	  with	   rGFR	  by	  only	  ½	  of	  1	  %,	   from	  0.7983	   to	  0.7943	  and	  
provides	  a	  much	  simpler	  equation:	  
	  	  	  	  	  	  	  	  	  	  	  	  pGFR-­‐3	  /	  eGFR	  =	  0.010	  *	  BMI	  +0.792	  




Figure	  5.3:	  Bland	  Altman	  plot	  between	  the	  difference	  and	  mean	  between	  indexed	  GFR	  and	  
the	   predictive	   equation	   3.	   The	   bold	   line	   is	   the	   mean	   and	   dotted	   lines	   are	   the	   95%	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Figure	   5.4:	   shows	   the	   reduction	   in	   bias	   by	   3	   predictive	   equations	   compared	   to	   the	   4v-­‐
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5.3.2	  Validation	  in	  the	  external	  dataset	  
We	   validated	   the	   linear	   and	   2	   non-­‐linear	   equations	   in	   the	   external	   dataset,	   all	   of	   which	  
showed	   significant	   reduction	   in	   the	   bias	   in	   the	   obese	   subjects	   as	   shown	   in	   figure	   3.	   The	  
predictive	  equations	  reduced	  bias	  by	  17.5%,	  22.5%	  and	  59.1%	  respectively	  compared	  to	  the	  
4v-­‐MDRD	  equation.	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5.4	  DISCUSSION	  AND	  CONCLUSIONS	  
In	  this	  study	  we	  derived	  equations	  employing	  regression	  analysis	  from	  our	  dataset	  of	  obese	  
patients	  with	  type	  2	  diabetes	  and	  various	  stages	  of	  CKD	  to	  correct	  underestimation	  of	  GFR	  
by	   the	   4v-­‐MDRD	   equation	   in	   this	   population.	   Our	   study	   as	   in	   chapter	   3,	   confirms	  
observations	  made	  by	  others	  that	  the	  4-­‐v	  MDRD	  formula	  underestimates	  GFR	  in	  overweight	  
and	  obese	  patients	  with	  Type2	  diabetes.	  The	  bias	  between	  estimated	  and	  measured	  GFR	  is	  
greatest	   in	   the	   obese	   and	   persists	   after	   correction	   for	   body	   surface	   area.	   This	  may	   have	  
Implications	   for	   management	   of	   obese	   patients	   with	   Type	   2	   diabetes,	   where	   treatment	  
decisions	   in	   relation	   to	   management	   of	   hyperglycaemia,	   hypertension	   and	   other	  
concomitant	  conditions	  are	  often	  determined	  by	  estimation	  of	  GFR.	  
The	   linear	   and	   non-­‐linear	   equations	   derived	   from	   our	   study	   reduce	   the	   bias	   between	  
measured	  and	  estimated	  GFR	  significantly	   in	  the	  external	  dataset;	  this	   improvement	  being	  
more	  pronounced	  in	  the	  obese	  subjects	  and	  is	  best	  achieved	  by	  the	  ratio	  model	  equation.	  
This	  equation	  is	  the	  only	  predictor	  to	  score	  consistently	  well	  across	  all	  three	  ranges	  of	  GFR	  
studied,	   including	   good	  positive	  predictive	   value	   in	   CKD	   stage	  3	   in	   the	  obese.	   This	   simple	  
corrective	   factor,	   which	   we	   have	   externally	   validated,	   can	   be	   used	   when	   making	  
management	  decisions	  in	  the	  obese	  with	  type2	  diabetes	  based	  on	  eGFR.	  This	  is	  particularly	  
relevant	  when	  contemplating	  starting	  or	  withdrawing	  drugs	  such	  as	  metformin	  or	  the	  newer	  
GLP-­‐1	   based	   agents	   in	   the	   overweight	   /	   obese	   patients	   with	   type	   2	   diabetes.	   This	   study	  
highlights	   the	   significant	   problem	   of	   underestimation	   of	   GFR	   in	   the	   obese	   with	   type2	  
diabetes	  and	  proposes	  a	  possible	  solution	  using	  a	  mathematical	  correction	  factor.	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As	  discussed	  in	  previous	  sections,	   it	   is	   important	  to	  be	  able	  to	  screen	  and	  accurately	  stage	  
patients	  with	  chronic	  kidney	  disease	  (CKD)	  and	  intervene	  as	  recommended	  by	  national	  and	  
international	  guidelines	  (KDOQI,	  2007,	  RCP,	  2006).	  	  
Variations	  in	  serum	  creatinine	  could	  lead	  to	  misclassification	  of	  patients	  to	  a	  particular	  CKD	  
stage	  with	  clinical	  implications	  to	  the	  patient	  and	  cost	  implications	  to	  services.	  Some	  of	  the	  
factors	  known	  to	  be	  responsible	  for	  biological	  variability	  in	  Creatinine	  values	  are:	  ingestion	  
of	  cooked	  meat,	  fluid	  status,	  diurnal	  variation	  and	  delay	  in	  centrifugation	  of	  blood	  samples	  
(Diskin,	   2007).	   	   Most	   blood	   samples	   in	   the	   original	   modification	   of	   diet	   in	   renal	   disease	  
(MDRD)	   study	   were	   drawn	   after	   overnight	   fasting	   (Preiss	   et	   al.,	   2007).	   This	   is	   however	  
overlooked	   in	   most	   clinical	   situations,	   and	   laboratories	   calculate	   eGFR	   routinely	   from	   all	  
blood	  samples	  sent	  for	  renal	  function	  tests.	  	  
The	  intra	   individual	  biological	  variation	  in	  creatinine	  measurement	   is	  significantly	  higher	   in	  
people	  with	  CKD	  (CV=	  5.3%)	  than	  in	  healthy	  people	  (CV=2.7%)	  (Holzel,	  1987).	  
Creatine	   is	   stored	   in	   muscle	   as	   phosphocreatine	   and	   is	   an	   important	   source	   of	   energy.	  
Creatine	   turns	   into	   creatinine	   in	  muscle	   by	   removal	   of	  water	   and	   the	   formation	  of	   a	   ring	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Figure	  6.1:	  Schematic	  showing	  conversion	  of	  Creatine	  to	  creatinine	  	  
	  
	  
Cooking	   meat	   converts	   creatine	   in	   skeletal	   muscles	   to	   creatinine.	   Studies	   looking	   at	   the	  
effect	  of	  cooking	  on	  acid-­‐extractable	  chemical	  constituents	  of	  beef	  have	  shown	  significant	  
increase	  in	  creatinine	  and	  decrease	  in	  eGFR	  levels(Robert,	  2006)	  (Purchas,	  2004).	  Ingestion	  
of	   meals	   containing	   cooked	   meat	   caused	   a	   marked	   postprandial	   increase	   in	   serum	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creatinine	  concentration,	  whereas	  ingestion	  of	  raw	  meat	  had	  no	  effect	  on	  serum	  creatinine	  
in	  normal	  human	  subjects	   (Jacobsen	  et	  al.,	  1979).	  A	   large	  cooked	  meat	  meal	   (225gm)	  was	  
shown	  to	  cause	  an	  average	  increase	  of	  52%	  in	  creatinine	  compared	  to	  the	  mean	  value	  on	  a	  
control	  meal	  in	  6	  healthy	  individuals	  (Mayersohn	  et	  al.,	  1983).The	  maximum	  concentration	  
of	  serum	  creatinine	  was	  achieved	  2	  hours	  after	  the	  cooked	  meat	  meal.	  
A	  study	   looking	  at	   the	  effect	  of	  acute	  protein	   load	  with	  a	  0.75	  gm.	  per	  Kg	  body	  weight	  of	  
cooked	   meat	   in	   renal	   transplant	   and	   healthy	   controls	   showed	   30%	   increase	   in	   serum	  
creatinine	   levels,	  with	   the	   rise	   in	   absolute	   terms	  being	   higher	   in	   the	   transplant	   group.	   	   A	  
significant	   rise	   in	   creatinine	  was	   observed	   in	   the	   transplant	   group	   at	   3	   and	   8	   hours	   after	  
meal	   but	   only	   at	   3	   hours	   in	   the	   control	   group.	   The	   authors	   suggest	   that	   the	   “functional	  
reserve”	  to	  deal	  with	  a	  protein	   load	   is	  reduced	  when	  renal	   function	   is	   impaired	   leading	  to	  
this	  difference	  between	  the	  transplant	  and	  control	  groups	  (Sterner,	  1991).	  Hence	  the	  effect	  
of	   cooked	   meat	   on	   serum	   creatinine	   level	   is	   likely	   to	   be	   higher	   in	   subjects	   with	   more	  
advanced	  CKD	  stages.	  Moreover,	  patients	  with	  chronic	  kidney	  disease	  have	  been	  shown	  to	  
be	   unable	   to	   increase	   their	   urinary	   creatinine	   excretion	   in	   response	   to	   a	   protein	   load	  
compared	  to	  normal	   individuals	   (Herrera	  and	  Rodríguez-­‐Iturbe,	  1998).	  Hence	  the	  effect	  of	  
cooked	  meat	  on	  serum	  creatinine	  level	  is	  likely	  to	  be	  higher	  in	  subjects	  with	  more	  advanced	  
CKD	  stages.	  Patients	  with	  chronic	  kidney	  disease	  have	  been	  shown	  to	  be	  unable	  to	  increase	  
their	   urinary	   creatinine	   excretion	   in	   response	   to	   a	   protein	   load	   compared	   to	   normal	  
individuals	  (Herrera	  and	  Rodríguez-­‐Iturbe,	  1998).	  
A	   more	   recently	   reported	   study	   by	   Preiss	   et	   al.	   found	   a	   median	   serum	   creatinine	  
concentration	   increase	   from	  80.5	  micromoles/L	   pre-­‐prandial	   to	   101.0	  micromoles/L	   1-­‐2	   h	  
postprandially,	  and	  99.0	  micromoles/L	  3-­‐4	  h	  postprandially.	  Median	  eGFR	  decreased	   from	  
	  
	  
106	  |	  P a g e 	  
	  
84.0	  mL/min/1.73	  m2	  pre-­‐prandial	  to	  59.5	  mL/min/1.73	  m2	  1-­‐2	  h	  postprandially	  (P<0.0001),	  
and	   64.0	   mL/min/1.73	   m2	   3-­‐4	   h	   postprandially	   (P<0.0001)	   following	   intake	   of	   a	   normal	  
helping	   of	   cooked	   meat	   (Preiss	   et	   al.,	   2007).	   This	   study	   was	   conducted	   on	   17	   healthy	  
volunteers	  and	  15	  randomly	  selected	  patients	  from	  a	  care	  of	  the	  elderly	  day	  unit,	  who	  had	  
chronic	   kidney	   disease	   stages	   3	   or	   less.	   The	   study	   showed	   that	   the	   rise	   in	   creatinine	  
measured	   by	   three	   different	   methods	   (kinetic	   Jaffe,	   IDMS	   and	   enzymatic	   methods)	   was	  
similar	  after	  a	  cooked	  meat	  meal.	  
	  None	  of	   the	  previously	   published	   studies	   have	   looked	   into	   the	   effect	   of	   cooked	  meat	  on	  
creatinine	   in	   a	   well	   defined	   patient	   population	   with	   different	   stages	   of	   diabetes	  mellitus	  
related	   CKD.	   The	   effect	   of	   a	   cooked	   meat	   meal	   on	   creatinine	   levels	   more	   than	   4	   hours	  
postprandially	   is	  also	  uncertain.	   	   In	   the	  above	  study	  the	  difference	  between	  2	  hrs	  &	  4	  hrs	  
post	   prandial	   values	   of	   creatinine	   were	   small(Preiss	   et	   al.,	   2007).	   This	   raises	   questions	  
regarding	  the	  timescale	  of	  changes	  in	  serum	  creatinine	  levels,	  because	  patients	  attending	  a	  
morning	  clinic	  may	  well	  have	  consumed	  a	  large	  cooked	  meat	  meal	  the	  previous	  evening.	  
The	   aim	   of	   the	   present	   study	   is	   to	   estimate	   the	   biological	   variation	   in	   creatinine	   levels	  
caused	  by	   a	   standardised	   cooked	  meat	  meal	   in	   subjects	  with	  Diabetes	  mellitus	  who	  have	  
various	  stages	  of	  chronic	  kidney	  disease,	  compared	  to	  healthy	  volunteers.	  
Hypotheses	  
1. A	  standardised	  cooked	  meat	  meal	  will	  cause	  a	  significant	  rise	  in	  serum	  creatinine	  in	  
diabetic	  patients	  with	  various	  stages	  of	  CKD	  compared	  to	  normal	  volunteers	  
2. Taking	  a	  blood	  sample	  after	  overnight	  fasting	  will	  eliminate	  the	  confounding	  effect	  of	  
a	  cooked	  meat	  meal	  in	  the	  evening,	  on	  creatinine	  levels	  in	  this	  population	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6.2	  RESEARCH	  DESIGN	  AND	  METHODS	  
This	   was	   a	   prospective,	   experimental,	   controlled	   study	   which	   involved	   a	   study	   group	  
consisting	   of	   patients	   with	   diabetes	   in	   different	   stages	   of	   CKD	   and	   a	   control	   group	   with	  
healthy	   volunteers.	   Each	   group	   consisted	   of	   16	   participants	   based	   on	   sample	   size	  
calculations	   described	   in	   the	   statistical	   section	   below.	   The	   study	   group	   consisted	   of	   4	  
subgroups:	  CKD	  stages	  1	  &	  2,	  stage	  3A,	  stage	  3B	  and	  stage	  4.	  We	  included	  CKD	  stages	  1	  &	  2	  
into	  one	  group,	  as	  the	  expected	  effect	  of	  cooked	  meat	  meal	  based	  on	  previous	  studies	  may	  
not	   be	   very	   clinically	   relevant.	   We	   did	   not	   include	   CKD	   stage	   5	   as	   they	   are	   under	   close	  
monitoring	  by	  the	  nephrologists	  and	  being	  prepared	  for	  renal	  replacement	  therapy.	  
	  
Figure	  6.2:	  Control	  and	  study	  groups	  
	  
• Healthy	  volunteers	  Control	  
• eGFR	  >60	  +	  Microalbuminuria	  CKD	  1&	  2	  
•  eGFR	  45	  -­‐59	  CKD	  3A	  
• eGFR	  30-­‐44	  CKD3B	  
• eGFR	  15-­‐29	  CKD4	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The	  study	  was	  reviewed	  and	  approved	  by	  the	  Liverpool	  Research	  Ethics	  Committee	  and	  all	  
study	  participants	  gave	  written	  informed	  consent.	  
	  
6.2.1	  Study	  subjects	  and	  Sampling	  
Study	   participants	   were	   recruited	   from	   the	   diabetic	   nephropathy	   and	   diabetes	   clinics	   at	  
Whiston	  and	  Aintree	  Hospitals.	  Healthy	  volunteers	  were	  drawn	  from	  staff	  and	  the	  general	  
public	  recruited	  via	  advertisements.	  As	  our	  sampling	  strategy,	  we	  employed	  quota	  sampling,	  
selecting	   consecutively	   to	   achieve	   equal	   numbers	   within	   the	   study	   groups	   to	   allow	  
progressional	  analyses	  through	  the	  stages.	  	  
	  
Inclusion	  criteria	  	  
• Type	  1	  or	  2	  Diabetes	  mellitus,	  	  
• CKD	  stages	  1	  to	  4	  and	  	  
• Age	  >18	  years	  
Exclusion	  criteria	  
• Patients	  known	  to	  have	  non-­‐diabetic	  renal	  disease	  	  
• Anyone	  who	  cannot	  eat	  meat	  and	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6.2.2	  Intervention	  
The	   intervention	  constituted	  of	  a	  standardised	  meal	  containing	  cooked	  meat	   in	  a	  quantity	  
considered	   a	   normal	   helping.	   Although	   there	   is	   no	   evidence	   in	   the	   literature	   for	   renal	  
damage	  from	  an	  acute	  protein	  load,	  we	  kept	  the	  protein	  load	  within	  the	  recommended	  daily	  
allowance	  for	  CKD	  patients.	  The	  effect	  of	  dietary	  protein	  restriction	  in	  patients	  with	  chronic	  
kidney	   disease	   remains	   controversial	   and	   research	   in	   this	   area	   has	   produced	   conflicting	  
results	  (Hartley,	  2001).	  A	  Cochrane	  review	  published	  in	  2007	  based	  on	  12	  studies	  with	  type1	  
and	   type2	   diabetes	   for	   at	   least	   4	   months,	   restricted	   protein	   intake	   appeared	   to	   slow	  
progression	   of	   diabetic	   kidney	   disease,	   but	   not	   by	   very	   much	   on	   average.	   The	   authors	  
concluded	   that	   although	   reducing	   protein	   intake	   appears	   to	   slightly	   slow	   progression	   to	  
renal	   failure	   but	   this	   was	   not	   statistically	   significant.	   The	   actual	   protein	   intake	   in	   the	  
intervention	  groups	   ranged	   from	  0.7	   to	  1.1	  g/kg/day	   (Robertson	   LM,	  2007)	  The	  European	  
Renal	   Care	   association	   (2002)	   recommend	   that	   the	   pre-­‐dialysis	   patient	   be	   advised	   to	  
achieve	  a	  protein	  intake	  of	  0.6-­‐1.0g/kg	  body	  IBW/day.	  We	  provided	  patients	  with	  one	  meat	  
and	   one	   non	   meat	   meal	   each	   providing	   approximately	   54g	   protein,	   which	   comprises	   no	  
more	  than	  75%	  of	  each	  patient’s	  daily	  protein	  allowance	  (1.0g	  protein/kg	  IBW	  per	  day).	  	  
On	   the	   first	   study	  visit	  participants	  attended	  after	  an	  overnight	   fasting	  and	  a	  pre-­‐prandial	  
and	  3	  post-­‐prandial	  blood	  samples	  1,	  2,	  and	  4	  hours	  after	  the	  meat	  meal	  were	  obtained.	  The	  
evening	  before	  the	  second	  visit	  they	  were	  advised	  to	  have	  the	  standardised	  meat	  meal	  and	  
attend	  following	  overnight	  fasting.	  A	  fasting	  and	  3	  post-­‐prandial	  blood	  samples	  1,	  2,	  and	  4	  
hours	  after	  the	  standard	  meat	  free	  meal	  were	  obtained.	  Participants	  also	  provided	  a	  fasting	  
and	  4	  hour	  post-­‐prandial	  urine	  sample	  on	  both	  study	  visits.	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The	   principle	   variable	   in	   the	   study	  was	   serum	   creatinine,	   which	  was	  measured	   using	   the	  
kinetic	  alkaline	  picrate	  assay	  on	  an	  Olympus	  AU640	  analyser.	  The	  modified	  MDRD	  equation	  
traceable	   to	   isotope	   dilution	   mass	   spectrometry	   (IDMS)-­‐creatinine	   and	   adjusted	   for	  
Olympus	  methodology	  (ml/min	  per	  1.73m2):	  	  	  
175	  x	  [((serum	  creatinine	  -­‐16.14)/0.955)	  x	  0.011312]-­‐1.154	  x	  	  	  	  	  [age]-­‐0.203	  x	  [0.742	  if	  	  	  
female]	  x	  [1.212	  if	  AfroCaribbean]	  was	  used	  to	  calculate	  eGFR	  (Reynolds	  and	  Twomey,	  
2007).	  	  
The	   other	  measures	   are	   urea,	   sodium,	   potassium,	   bicarbonate,	   phosphate,	   and	   urine	   for	  
albumin-­‐creatinine	  ratio.	  
• Consent	  
• History	  &	  Physical	  examinavon	  
• Fasvng	  blood	  sample	  
• Cooked	  meat	  brunch	  
• Blood	  samples	  1,2,	  &	  4hrs	  
postprandially	  
• parvcipant	  allowed	  home	  
Visit	  1	  
• Cooked	  meat	  meal	  the	  previous	  
evening	  
• Fasvng	  blood	  sample	  
• Cooked	  meat	  brunch	  
• Blood	  samples	  1,2,	  &	  4hrs	  
postprandially	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6.2.3	  Statistical	  considerations:	  
We	   regarded	   a	   clinically	   significant	   (effect	   size)	   change	   in	   creatinine	   as	   greater	   than	   10	  
µmol/L,	  as	  by	  Preiss	  et	  al.	  (David	  Preiss:	  personal	  communication).	  By	  this	  is	  interpreted	  that	  
a	  minimum	  clinically	  significant	  change	  in	  creatinine	  is	  a	  change	  of	  10	  micromoles/L.	  	  
Individual	   differences	   between	   baseline	   pre-­‐prandial	   and	   each	   of	   the	   1hour,	   2hour	   and	  
4hour	  post-­‐prandial	  measurements	  were	  computed.	  Differences	  for	  subjects	  with	  CKD	  were	  
compared	  to	  differences	  for	  healthy	  volunteers	  using	  un-­‐paired	  Mann-­‐Whitney	  tests	  as	  the	  
data	  are	  non-­‐normal.	  	  	  
The	   study	   by	   Preiss	   et	   al.	   listed	   as	   an	   appendix	   individual	   serum	   creatinine	   data	   for	   32	  
subjects	  before	  a	  cooked	  meat	  meal	  and	  then	  1-­‐2	  hours	  and	  3-­‐4	  hours	  afterwards.	  Using	  the	  
Kolmogorov-­‐Smirnov	   test	  each	  of	   these	  distributions	   could	  be	   regarded	  as	   coming	   from	  a	  
normal	  distribution	  with	  standard	  deviations	  of	  12.5	  (Jaffe)	  and	  14.2	  (IDSM)	  for	  differences	  
between	  baseline	  and	  1-­‐2	  hours	  and	  of	  10.4	  (Jaffe)	  and	  12.8	  (IDSM)	  for	  differences	  between	  
baseline	   and	   3-­‐4	   hours.	   These	  measures	   of	   scatter	   are	   about	   the	   same	   as	   the	  minimum	  
clinically	  significant	  difference.	  	  
To	  detect	  a	  mean	  shift	  of	  10	  micromoles/L	   (roughly	  equivalent	  to	  one	  standard	  deviation)	  
between	   post	   minus	   pre-­‐prandial	   values	   with	   a	   power	   of	   80%,	   p=0.05	   in	   a	   paired	   t-­‐test	  
requires	  10	  participants	  in	  each	  group	  and	  13	  participants	  for	  a	  power	  of	  90%.	  However,	  for	  
non-­‐normal	  distributions,	  to	  use	  Wilcoxon	  sign	  rank	  test	  number	  of	  participants	  required	  for	  
power	  of	  at	  least	  90%	  is	  15.	  Statistical	  analysis	  was	  carried	  out	  using	  SPSS	  (version	  17.0	  for	  
Windows:	   SPSS,	  Chicago,	   IL)	   and	  Graph	  pad	  prism	  5	   for	  Windows.	   The	   shifts	   in	   creatinine	  
and	  eGFR	  values	  in	  all	  groups	  were	  compared	  using	  Wilcoxon	  signed	  rank	  test	  as	  most	  data	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were	   non-­‐normally	   distributed.	   Results	   are	   presented	   as	  median	   and	   interquartile	   ranges	  
and	  p	  <	  0.05	  was	  taken	  to	  indicate	  statistical	  significance.	  
	  
6.3	  RESULTS	  
We	  obtained	  results	  from	  80	  participants	  following	  the	  standard	  cooked	  meat	  and	  non-­‐meat	  
meals.	  66	  of	  the	  participants	  were	  males	  and	  all	  were	  Caucasians.	  The	  mean	  age	  was	  62.2	  
±15.1.	  The	  mean	  HbA1c	  among	  the	  64	  participants	  with	  diabetic	  chronic	  kidney	  disease	  was	  
62.7±	  16.1	  mmol/mol.	  
Figures	  below	  demonstrate	  the	  fasting	  and	  post-­‐prandial	  creatinine	  and	  eGFR	  values	  in	  the	  
participants	  in	  all	  5	  groups.	  Post-­‐prandial	  values	  are	  1	  hour,	  2	  hours	  and	  4	  hours	  following	  
the	  meat	  and	  non-­‐meat	  meals.	  
Significant	   differences	   were	   found	   in	   serum	   creatinine	   and	   eGFR	   values	   following	   the	  
standard	  meat	  meal	  in	  healthy	  volunteers	  and	  the	  participants	  with	  chronic	  kidney	  disease,	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Figure	   6.9:	   demonstrates	   the	   shift	   in	   serum	   creatinine	   and	   eGFR	   following	   the	  meat	   and	  
non-­‐meat	  meals.	  In	  healthy	  volunteers	  and	  CKD	  stage	  1	  &	  2,	  the	  maximum	  rise	  in	  creatinine	  
was	  noted	  at	  2	  hrs,	  while	   in	  CKD	  3a	  and	  3b	   the	  maximum	  rise	  was	   seen	  at	  4	  hours	  post-­‐
prandially.	  In	  CKD	  4,	  the	  4	  hour	  creatinine	  was	  only	  0.5	  µmol/L	  lower	  than	  the	  2	  hour	  value	  
(table	  1).	  
	  
Panel	  A	  &	  B	  shows	  median	  and	  interquartile	  ranges	  of	  shift	  in	  serum	  creatinine	  2	  hours	  after	  a	  meat	  
and	   non-­‐meat	   respectively.	   Panel	   C	   &	   D	   shows	  median	   and	   interquartile	   ranges	   of	   shift	   in	   eGFR	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Effect	  of	  cooked	  meat	  meal	  on	  serum	  creatinine	  after	  overnight	  fasting:	  
The	  median	  difference	  between	   fasting	   creatinine	  12	  hours	   following	  meat	  and	  non-­‐meat	  
meal	  was	  not	  statistically	  significant	  as	  illustrated	  in	  figure	  6.10	  
Figure	  6.10:	  Effect	  of	  cooked	  meat	  meal	  on	  serum	  creatinine	  after	  overnight	  fasting	  
	  
	  
Median	  and	  inter	  quartile	  ranges	  of	  creatinine	  12	  hours	  following	  meat	  and	  non-­‐meat	  meals	  
in	   healthy	   volunteers	   and	   the	   4	   groups	   of	   participants	   with	   chronic	   kidney	   disease.	   No	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Table	  6.1:	  Changes	  in	  creatinine	  following	  meat	  and	  non-­‐meat	  meals	  
	   Creatinine	  
Fasting	  
Creatinine	  
1	  hr	  pp	  
Creatinine	  
2	  hrs	  pp	  
Creatinine	  









(68.2	  -­‐	  84.25)	  
	  
75	  








(69.5	  -­‐	  84.5)	  
P=0.047	  
CKD	  1	  &	  2	  
	  
98	  













(113	  –	  139)	  
135	  
(127	  –	  143)	  
P=0.001	  
146.5	  
(132	  –	  158)	  
P<0.001	  
150.5	  





(133	  –	  166)	  
158	  
(142	  –	  169)	  
P=0.014	  
165	  
(155	  –	  173)	  
P=0.001	  
165	  






















(66.5	  -­‐	  73.5)	  
71.5	  
(64.2	  -­‐	  79.2)	  
P=0.24	  
73.5	  
(65.7	  -­‐	  75.7)	  
P=0.39	  
72.5	  
(57.5	  -­‐	  81.5)	  
P=0.75	  
CKD	  1	  &	  2	  
	  
89	  
(76	  –	  106.5)	  
94.5	  
(80.2	  –	  104)	  
P=0.53	  
93	  
(83	  –	  100.2)	  
P=0.80	  
92	  





(128	  –	  150)	  
135.5	  
(129	  –	  143)	  
P=0.47	  
139	  
(126	  –	  145)	  
P=0.88	  
135	  







(131	  –	  178)	  
P=0.91	  
152	  
(129	  –	  180)	  
P=0.95	  
152	  





(202	  –	  322)	  
245	  






(196	  –	  331)	  
P=0.50	  
	  
Data	  are	  median	  and	  inter-­‐quartile	  ranges.	  Creatinine	  is	  expressed	  as	  micromoles/L	  and	  p	  
values	  compare	  fasting	  and	  post	  prandial	  results	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Table	  6.2:	  	  Changes	  in	  4-­‐variable	  MDRD	  eGFR	  following	  meat	  and	  non-­‐meat	  meals	  
	   eGFR	  
Fasting	  
eGFR	  











(85.3	  –	  130.4)	  
	  
93.5	  
(76.9	  –	  132.9)	  
P=0.125	  
95	  




(77.6	  –	  133.9)	  
P=0.116	  
CKD	  1	  &	  2	  
	  
80.4	  
(68.6	  –	  97.2)	  
71.8	  
(65.2	  –	  85.4)	  
P=0.003	  
71.6	  
(67.5	  –	  83.3)	  
P=0.002	  
72.5	  





(47.1	  –	  63.6)	  
49.8	  
(45.4	  –	  53.8)	  
P=0.001	  
45.2	  
(40.5	  –	  50.2)	  
P<0.001	  
42.8	  










(36.4	  –	  41.4)	  
P=0.001	  
37.7	  





(17.8	  –	  29.4	  
22.8	  
(15.8	  –	  29.8)	  
P=0.034	  
21.8	  




















(93.8	  –	  127)	  
P=0.6	  
102.6	  
(88.9	  –	  117)	  
P=0.51	  
CKD	  1	  &	  2	  
	  
83	  
(64	  –	  102.9)	  
78.2	  
(59.9	  –	  97.8)	  
P=0.85	  
81.6	  
(67.4	  –	  96.7)	  
P=0.92	  
83.5	  	  





(42.1	  –	  52.6)	  
47	  
(42.6	  –	  53.2)	  
0.73	  
46.7	  
(42.9	  –	  53.1)	  
P=0.97	  
47.5	  





(33.5	  –	  49.2)	  
40.1	  
(33	  –	  48.5)	  
P=0.83	  
40.5	  
(33.2	  –	  47)	  
P=0.97	  
40.9	  





(12	  –	  26.4)	  
21.6	  
(12.4	  –	  27)	  
P=0.03	  
21.3	  
(12	  –	  26.2)	  
P=0.14	  
21.7	  
(12	  –	  26.2)	  
P=0.75	  
Data	  are	  median	  and	  inter-­‐quartile	  ranges.	  eGFR	  as	  mls/min/1.73m2	  and	  p	  values	  compare	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6.4	  DISCUSSION	  
Our	   study	  demonstrates	   significant	   increase	   in	   serum	  creatinine	   levels	   following	  a	   cooked	  
meat	   meal	   in	   healthy	   volunteers	   and	   participants	   with	   diabetic	   chronic	   kidney	   disease	  
stages	  1	  to	  4.	  This	  is	  likely	  to	  be	  due	  the	  effect	  of	  absorbed	  creatinine	  present	  in	  the	  cooked	  
meat.	  This	  result	   in	  a	  drop	  in	  estimated	  GFR	  in	  all	  the	  groups	  studied.	  The	  relative	  drop	  in	  
eGFR	  secondary	  to	  rise	  in	  creatinine	  is	  proportionately	  less	  in	  patients	  with	  more	  advanced	  
CKD	   stages,	   but	   the	   percentage	   drop	   remains	   significant	   in	   all	   groups.	   A	   proportion	   of	  
patients	  with	  CKD	  could	  be	  misclassified	  to	  more	  severe	  stages	  depending	  on	  their	  baseline	  
eGFR.	  Six	  out	  of	   the	  sixteen	  patients	   in	  CKD	  3a	  were	  misclassified	   into	  CKD	  3b	  due	   to	   the	  
effect	  of	   cooked	  meat	   consumption.	   This	   could	  have	   significant	  effect	  on	  management	  of	  
these	   patients;	   particularly	   as	   the	   threshold	   for	   commencing	   and	   withdrawing	   certain	  
medications	  are	  defined	  by	  eGFR.	  
There	   is	   some	   literature	  suggesting	   that	  protein	   load	  and	   intravenous	  amino	  acid	   infusion	  
increases	  glomerular	  filtration	  rate. In	  a	  creatinine	  clearance	  study	  conducted	  in	  9	  healthy	  
vegetarians	  after	  an	  oral	  protein	  load	  of	  100	  grams	  of	  vegetarian	  protein	  5	  subjects	  showed	  
a	  significant	  increase	  of	  the	  creatinine	  clearance	  after	  the	  protein	  load of	  66.0%	  (mean).	  The	  
remaining	   4	   however	   did	   not	   increase	   their	   creatinine	   clearance	   following	   acute	   protein	  
challenge	  (Hirschberg	  et	  al.,	  1985).	  Bosch	  et	  al	  showed	  an	   increase	   in	  glomerular	   filtration	  
rate	  two	  and	  a	  half	  hours	  after	  protein	  load	  to	  a	  maximal	  glomerular	  filtration	  rate	  of	  171.0	  
+/-­‐	  7.7	  ml	  per	  minute	  in	  healthy	  volunteers.	  The	  authors	  conclude	  that	  the	  capacity	  of	  the	  
kidney	  to	  increase	  its	  level	  of	  function	  with	  protein	  intake	  suggests	  a	  renal	  function	  reserve	  
(Bosch	  et	  al.,	  1983).	  The	  mechanism	  by	  which	  renal	  plasma	  flow	  and	  GFR	  increases	  following	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protein	   load	   or	   amino	   acid	   infusion	   remains	   unclear.	   There	   are	   several	   proposed	  
mechanisms	   such	   as	   hormonal	   response	   to	   increase	   amino	   acids	   	   (insulin,	   glucagon,	   and	  
growth	  hormone	   levels)	  and	  amino	  acid	  metabolism	  by	   the	  kidney	  generating	  nitric	  oxide	  
and	   endothelium	  derived	   relaxing	   factor	  may	   increase	   renal	   plasma	   flow	   (Tolins	   and	  Raij,	  
1991).	   These	   studies	   suggest	   that	   there	   is	   a	   true	   increase	   in	   GFR	   following	   acute	   protein	  
load,	  however	  our	  study	  did	  not	  measure	  creatinine	  clearance	  or	  glomerular	  filtration	  rate	  
and	   was	   based	   on	   creatinine	   measurement	   and	   estimation	   of	   GFR	   using	   the	   MDRD	  
equation.	   Moreover	   patients	   with	   chronic	   kidney	   disease	   have	   lower	   renal	   reserve	   than	  
healthy	  volunteers	  and	  this	  increase	  in	  GFR	  may	  not	  be	  seen	  in	  our	  cohort.	  The	  blunting	  of	  
the	  effect	  of	  cooked	  meat	  protein	  due	   to	   transient	   rise	   in	  GFR	  may	   therefore	  not	  be	  very	  
prominent	  in	  CKD	  patients.	  
The	   published	   studies	   referenced	   in	   the	   introduction	   have	   shown	   significant	   effect	   of	  
cooked	  meat	  consumption	  on	  serum	  creatinine	  irrespective	  of	  the	  methodology.	  Preiss	  et	  al	  
2007,	   measured	   serum	   creatinine	   using	   the	   kinetic	   Jaffe	   method,	   enzymatic,	   isotope-­‐
dilution	   mass	   spectrometry	   [IDMS]).	   Jacobson	   et	   al	   used	   the	   Jaffe	   reaction	   as	   well.	  
Mayersohn	   et	   al	   used	   high-­‐pressure	   liquid	   chromatography	   to	  measure	   serum	   creatinine.	  
Sterner	  et	  al	  used	  a	  standard	  Jaffé	  method	  and	  also	  with	  a	  specific	  HPLC	  technique.	  All	  these	  
studies	  have	  shown	  significant	  increase	  in	  serum	  creatinine	  following	  a	  cooked	  meat	  meal.	  
We	   also	   demonstrate	   that	   the	   peak	   rise	   in	   creatinine	   following	   a	   cooked	   meat	   meal	   is	  
delayed	  in	  more	  advanced	  CKD	  stages	  of	  3a,	  3b	  and	  4,	  perhaps	  due	  to	  slower	  clearance	  from	  
the	   blood.	   After	   overnight	   fast,	   however	   the	   effect	   of	   cooked	  meat	   on	   serum	   creatinine	  
does	   not	   remain	   statistically	   or	   clinically	   significant.	   This	   argues	   for	   the	   opinion	   that	   GFR	  
should	   be	   estimated	   using	   fasting	   rather	   than	   random	   serum	   samples	   particularly	   for	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patient	  with	  CKD.	  Although	  this	  effect	  has	  been	  shown	  as	  early	  as	  1983,	  it	  was	  thought	  to	  be	  
caused	   only	   by	   excessive	   amount	   of	   cooked	  meat	   consumption	   and	   not	   very	   relevant	   in	  
clinical	  situations.	  Our	  study	  and	  the	  study	  by	  Preiss	  et	  al.	  (Preiss	  et	  al.,	  2007)	  demonstrate	  
that	  significant	  rise	  in	  serum	  creatinine	  can	  occur	  with	  what	  is	  considered	  a	  normal	  helping	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7.1	  INTRODUCTION	  
Urinary	  protein	  analyses	  have	  been	  known	  to	  help	  with	  diagnosing	  several	  renal	  disorders	  
(Butler	  and	  Flynn,	  1958).	  Urinary	   low	  molecular	  weight	  proteins	  such	  as	  β2-­‐microglobulin,	  
retinol	   binding	   protein	   and	   lysozyme	   are	   sensitive	   markers	   of	   impaired	   renal	   tubular	  
function	  while	   excretion	   of	   albumin	   and	   IgG	   are	   sensitive	  markers	   of	   glomerular	   damage	  
(Arai	  et	  al.,	  1991).	  
Urine	  dipstick	  commonly	  used	  to	  screen	  for	  proteinuria	  can	  only	  detect	  urinary	  protein	  from	  
150-­‐300	   mg/L,	   and	   hence	   is	   suitable	   only	   to	   detect	   gross	   proteinuria.	   Dipstick	   positive	  
proteinuria	   usually	   denotes	   urinary	   protein	   excretion	   >0.5	   grams/day	   (Abuelo,	   1983).	  
Approximately	  50%	  of	  urinary	  protein	   is	   constituted	  of	  Tamm-­‐Horsfall	  proteins,	  which	  are	  
shed	  by	  the	  terminal	  part	  of	  the	  renal	  tubules.	  In	  health,	  relatively	  small	  amounts	  of	  albumin	  
(<30	   mg/24	   h)	   are	   lost	   in	   the	   urine	   and	   also	   a	   large	   increase	   in	   albuminuria	   can	   occur	  
without	  raising	  the	  total	  protein	  significantly	  (Lamb	  et	  al.,	  2009).	  
Peterson	   et	   al	   studied	   the	   differential	   protein	   excretion	   in	   patients	   with	   glomerular	   and	  
tubular	   disorders;	   15	   patients	   with	   glomerular	   disorders	   such	   as	   glomerulonephritis,	  
nephrotic	   syndrome,	  and	  Alport	   syndrome	  and	  15	  patients	  with	   tubular	  disorders	   such	  as	  
renal	  tubular	  acidosis,	  chronic	  Cadmium	  poisoning	  and	  Wilson’s	  disease.	  They	  showed	  that	  
patients	  with	  glomerular	  disorders	  had	   increased	  urinary	  excretion	  of	  albumin	  and	  normal	  
or	   only	   somewhat	   increased	   excretion	   of	   β2-­‐microglobulin,	   but	   patients	   with	   tubular	  
disorders	  had	  increased	  excretion	  of	  β2-­‐microglobulin	  with	  normal	  or	  only	  slightly	  increased	  
albumin	  excretion	  (Peterson	  et	  al.,	  1969).	  Although	  albumin	  and	  IgG	  are	  known	  to	  be	  good	  
markers	   of	   glomerular	   damage,	   albumin	   is	  more	   consistently	   excreted	   during	   the	   natural	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course	  of	  diabetic	  kidney	  disease.	  The	  selectivity	  of	  proteinuria	  has	  been	  proposed	  to	  show	  
a	   triphasic	   change	   during	   the	   pathogenesis	   of	   diabetic	   nephropathy.	   In	   the	   first	   phase,	  
proteinuria	  is	  non-­‐selective	  with	  IgG	  clearance	  equal	  to	  or	  exceeding	  albumin	  clearance.	  As	  
microalbuminuria	   develops,	   there	   is	   preferential	   excretion	   of	   albumin	   compared	  with	   IgG	  
but	  in	  later	  stages	  of	  nephropathy,	  there	  is	  a	  return	  to	  non-­‐selective	  proteinuria	  (Jerums	  et	  
al.,	  1989).	  This	  selectivity	  at	  the	  microalbuminuria	  stage	  is	  due	  to	  a	  loss	  of	  anionic	  heparan	  
sulphate	  proteoglycan	  from	  basement	  membrane,	  which	  in	  turn	  leads	  to	  a	  loss	  of	  the	  fixed	  
negative	  charge	  of	  the	  glomerular	  basement	  membrane.	  In	  the	  later	  stages	  as	  the	  pore	  size	  
increases	  the	  charge	  selectivity	  becomes	  less	  important	  (Peter	  H.	  Winocour,	  1998).	  
Some	  authors	  evaluated	  the	  use	  of	  protein	  creatinine	  ratio	  instead	  of	  24-­‐hour	  urine	  protein	  
estimation.	  It	  was	  shown	  that	  in	  the	  presence	  of	  stable	  renal	  function,	  a	  protein/creatinine	  
ratio	  of	  more	  than	  3.5	  (mg/mmol)	  can	  be	  taken	  to	  represent	  "nephrotic-­‐range"	  proteinuria,	  
and	  a	  ratio	  of	  less	  than	  0.2	  is	  within	  normal	  limits	  (Ginsberg	  et	  al.,	  1983).	  
The	   first	   radioimmunoassay	   to	   detect	   albumin	   in	   low	   concentration	   in	   the	   urine	   was	  
proposed	   in	   1963	   by	   Keen	   and	   Chlouverakis	   and	   the	   term	   “microalbuminuria”	   was	   used	  
(Keen	   and	   Chlouverakis,	   1963).	   Urinary	   albumin	   excretion	   is	   used	   to	   define	   the	   extent	   of	  
glomerular	  damage	  in	  diabetes	  related	  chronic	  kidney	  disease.	  	  
The	   proteinuria	   normal	   ranges	   have	   been	   derived	   from	   studies	   that	   used	   24-­‐hour	   urine	  
collection	   or	   overnight	   urine	   collection;	   however	   this	   is	   burdensome	   for	   the	   patient	   on	   a	  
clinical	   basis.	   Most	   national	   and	   international	   guidelines	   now	   recommend	   the	   use	   of	  
protein:	  creatinine	  ratio	  (PCR)	  or	  albumin:	  creatinine	  ratio	  (ACR).	  This	  ratio	   is	  suggested	  to	  
reduce	   variability	   due	   to	   urine	   concentration	   at	   various	   timed	   during	   the	   day.	   Creatinine	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was	  considered	  the	  natural	  denominator	  as	  it	  is	  excreted	  at	  a	  constant	  rate	  in	  an	  individual	  
and	  it	  is	  easily	  measured.	  The	  ACR	  is	  a	  ratio	  of	  albumin	  in	  μg	  to	  creatinine	  in	  mg	  and	  is	  used	  
as	  an	   index	  of	  urinary	  albumin	  excretion	   (UAE).	  The	  ACR	   in	  μg/mg	  can	  be	  converted	   to	  SI	  
unit	  of	  mg/mmol	  by	  dividing	  by	  8.84	  (Warram	  et	  al.,	  1996).	  
Some	  authors	  have	  suggested	  that	  correction	  for	  albuminuria	  and	  proteinuria	  by	  creatinine	  
is	  flawed;	  particularly	  when	  we	  use	  age,	  gender,	  and	  race	  for	  correcting	  creatinine	  derived	  
GFR.	  Although	  creatinine	   is	  excreted	  at	  a	  constant	  rate	   in	  an	   individual	   it	   is	  dependent	  on	  
muscle	  mass.	  Muscle	  mass	  variation	  will	  have	  proportional	  effect	  on	  urinary	  creatinine	  as	  it	  
does	   on	   serum	   creatinine.	   It	   is	   therefore	   likely	   that	   the	   higher	   prevalence	   of	  
microalbuminuria	   reported	   in	   the	   elderly	   is	   due	   to	   lower	  muscle	  mass	   and	   consequently	  
lower	  urinary	  excretion	  of	  creatinine	  (Ellam,	  2011).	  	  
A	  first	  void	  morning	  urine	  sample	  has	  been	  shown	  to	  correlate	  better	  with	  24-­‐hour	  urinary	  
albumin	   excretion	   compared	   to	   random	   spot	   urine	   as	   shown	   in	   the	   figure	   below.	   In	   this	  
study	  241	  participants	  provided	  three	  24-­‐h	  urine	  collections,	  a	  first	  morning	  void,	  and	  spot	  
urine	  sample,	  and	  a	  regression	  analysis	  was	  performed	  to	  establish	  correlation	  (Witte	  et	  al.,	  
2009).	  Urinary	  excretion	  shows	  a	  circadian	  rhythm	  with	  lower	  excretion	  rates	  overnight	  and	  
also	   prolonged	   standing	   and	   exercise	   can	   increase	   albuminuria	   (Ellam,	   2011).	   The	  
mechanism	   of	   orthostatic	   proteinuria	   is	   unclear	   but	   venous	   pooling	   leading	   to	   decreased	  
renal	  plasma	  flow	  and	  activation	  of	  Angiotensin	  II	  has	  been	  proposed.	  This	  in	  turn	  increases	  
efferent	  arteriolar	  resistance	  and	  increased	  filtration	  of	  protein	  (Devarajan,	  1993).	  This	  could	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Figure	   7.1:	   The	   top	   panel	   shows	   correlation	   between	   24-­‐hour	  UAE	   versus	   first	  morning	  
void	   and	   spot	   urine	   sample	   UAC.	   The	   bottom	   panel	   shows	   24-­‐hour	   UAE	   versus	   first	  






Scatterplots showing the relationship between 24-h UAE and other albuminuria measures. 
Elsbeth C. Witte et al. JASN 2009;20:436-443 
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Microalbuminuria	   was	   shown	   to	   be	   a	   predictor	   of	   progression	   to	   diabetic	   nephropathy	  
(Mogensen,	   1987).	   It	   has	   been	   shown	   to	   be	   a	   strong	   predictor	   of	   all	   cause	   and	  
cardiovascular	   mortality	   and	   therefore	   proposed	   to	   be	   an	   ideal	   target	   for	   early	   primary	  
prevention	  using	  CV-­‐protective	  therapy	  regimens	  (de	  Zeeuw	  et	  al.,	  2006).	  	  
Studies	  comparing	  the	  intra-­‐individual	  variability	  of	  urinary	  protein	  estimation	  and	  albumin	  
creatinine	  ratio	  have	  not	  shown	  any	  significant	  difference,	  which	  suggested	  that	  spot	  UACR	  
can	  replace	  timed	  urine	  collection	  for	  albumin	  excretion	  rate	  (Cohen	  et	  al.,	  1987b,	  Claudi	  T,	  
2001).	   In	   a	   study	   by	   Hutchison	   et	   al,	   timed	   overnight	   urine	   collection	   from	   261	   patients	  
attending	  a	  diabetes	  clinic	  with	  albumin	  excretion	  rate	  >30	  μg	  /min	  was	  compared	  with	  spot	  
albumin	   to	   creatinine	   ratio	   and	   albumin	   concentration.	   They	   found	   a	   linear	   correlation	  
between	  the	  three.	  In	  the	  first	  morning	  specimen	  either	  an	  albumin	  concentration	  >17	  mg/L	  
or	  ACR	  >3	  mg/mmol	  predicted	  an	  overnight	  AER	  >30	  μg	  /min	  with	  a	  96.8%	  sensitivity	  and	  
90%specificity	  (Hutchison	  et	  al.,	  1988)	  
Urine	  ACR	  is	  also	  used	  to	  guide	  anti-­‐hypertensive	  and	  renin	  angiotensin	  aldosterone	  system	  
(RAAS)	   blockade	   therapies	   in	   patients	   with	   diabetes	   related	   chronic	   kidney	   disease.	  
Improvement	  in	  urine	  ACR	  is	  considered	  to	  be	  a	  surrogate	  measure	  of	  improvement	  in	  the	  
pathophysiology	  of	  diabetes	  related	  kidney	  disease.	  
Factors	   that	  have	  been	   shown	   to	   introduce	   variability	   in	   to	  urinary	   albumin	  excretion	  are	  
physical	  activity,	  dietary	  protein	   intake,	  glycaemic	   control,	   fever	  and	  UTI(Mogensen	  et	  al.,	  
1995).	  Reduced	  dietary	  protein	  has	  been	  shown	  to	  decrease	  albumin	  excretion	  in	  a	  3	  week	  
randomised	  crossover	  trial;	  when	  randomised	  to	  normal	  protein	  diet	  (median	  92	  (range	  55-­‐
117)	   g/day)	   and	   a	   low	   protein	   diet	   (47	   (38-­‐57)	   g/day),	   the	   median	   overnight	   albumin	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excretion	   rate	   fell	   from	  23.0	   (15.0-­‐170.1)	  micrograms/min	  during	   the	   normal	   diet	   to	   15.4	  
(4.1-­‐97.8)	   micrograms/min	   during	   the	   low	   protein	   diet	   (Cohen	   et	   al.,	   1987a).	   Long	   term	  
dietary	  protein	  restriction	  has	  also	  been	  shown	  to	  reduce	  albuminuria	  in	  patients	  with	  type	  
1	  diabetes	  and	  microalbuminuria	  in	  a	  2	  year	  randomised	  study	  (Dullaart	  RP,	  1993	  ).	  
A	  study	  involving	  10	  subjects	  with	  newly	  diagnosed	  type	  1	  diabetes	  looking	  at	  micro	  vascular	  
permeability	   showed	   significant	   increase	   in	   albumin	   excretion	   during	   poor	   metabolic	  
regulation,	   indicating	   a	   functional	  microangiopathy	   (Parving	   HH,	   1976).	   	   Exercise	   induced	  
albuminuria	  occurs	  at	  lower	  levels	  of	  exercise	  in	  patients	  with	  type	  1	  diabetes	  compared	  to	  
normal	   subjects	   and	   it	   improves	   significantly	   on	   insulin	   treatment	   (Vittinghus	   and	  
Mogensen,	  1982).	  Exercise	  has	  been	  proposed	  as	  a	  provocative	  test	  for	  albuminuria	  in	  early	  
renal	   disease	   in	   diabetes;	   exercise	   increases	   albuminuria	   in	   normal	   controls,	  
normoalbuminuric	   and	   albuminuric	   subjects	   with	   diabetes	   (Feldt-­‐Rasmussen	   B,	   1985).	  
Urinary	   tract	   infection	  has	  been	  shown	  to	  be	  associated	  with	  proteinuria	  and	  albuminuria	  
which	  can	  be	  ameliorated	  by	  antibiotic	  treatment	  (Carter	  et	  al.,	  2006).	  
The	  immediate	  effect	  of	  a	  cooked	  meat	  meal	  on	  UACR	  in	  diabetic	  patients	  with	  and	  without	  
microalbuminuria	  is	  unclear	  from	  the	  literature.	  Although	  it	  is	  advised	  that	  UACR	  be	  tested	  
on	  first	  voided	  morning	  urine	  sample,	  in	  clinical	  practice	  this	  is	  often	  overlooked.	  	  
The	  aim	  of	  our	  study	  was	  to	  determine	  the	  effect	  of	  a	  cooked	  meat	  meal	  on	  UACR	  in	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7.2	  RESEARCH	  DESIGN	  AND	  METHODS	  
This	   study	   was	   conducted	   using	   the	   data	   from	   a	   prospective,	   experimental,	   study	   that	  
involved	  16	  participants	  each	  with	  CKD	  stages	  1	  &	  2,	  3A,	  3B	  and	  4	  and	  16	  healthy	  volunteers	  
(total	  n=80).	  The	  research	  design	  and	  method	  is	  described	  in	  detail	  in	  the	  previous	  chapter	  
in	  this	  thesis.	  
The	   participants	   were	   provided	  meat	   and	   non-­‐meat	  meals	   each	   providing	   approximately	  
54g	  protein	  (The	  meat	  meal	  consisted	  of	  2	  Aberdeen	  Angus	  quarter	  pounder	  beef	  burgers,	  
and	  the	  non-­‐meat	  meal	  comprised	  of	  2	  vegetarian	  burgers).	  Each	  meal	  included	  250	  mls	  of	  
water	  to	  drink.	  
On	  the	  first	  study	  visit	  participants	  attended	  after	  an	  overnight	  fast	  and	  a	  pre-­‐prandial	  and	  
4-­‐hour	   post-­‐meat	  meal	   urine	   samples	  were	  obtained.	  On	   the	   second	   visit,	   a	   fasting	  urine	  
sample	  and	  a	  second	  sample	  4	  hours	  following	  the	  non-­‐meat	  meal	  were	  obtained.	   
The	  median	  changes	  in	  urine	  ACR	  from	  fasting	  to	  4-­‐hour	  post-­‐prandial	  urine	  samples	  were	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7.3	  RESULTS	  
Changes	  in	  ACR	  from	  baseline	  to	  4	  hours	  were	  -­‐0.08,	  -­‐0.31,	  -­‐3.0,	  -­‐12.1,	  and	  -­‐19.1	  in	  the	  
control,	  CKD	  1&2,	  CKD	  3a,	  CKD	  3b,	  and	  CKD	  4	  stages	  respectively.	  
The	  decrements	  in	  ACR	  levels	  were	  significant	  in	  CKD	  3b	  &	  4	  stages	  with	  p	  values	  of	  0.046	  
and	  0.028	  respectively.	  
	  























Figure	  7.3	  (a):	  UCmo	  &	  UCm4	  represent	  the	  urinary	  creatinine	  prior	  to	  and	  4	  hours	  after	  the	  meat	  
meal	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7.4	  DISCUSSIONS	  AND	  SUMMARY	  
	  
We	  demonstrate	  a	  fall	  in	  ACR	  after	  cooked	  meat	  meal	  in	  patients	  with	  diabetes	  associated	  
chronic	  kidney	  disease.	  A	  significant	  rise	  in	  serum	  creatinine	  following	  a	  meat	  protein	  meal	  
has	   been	   demonstrated	   previously	   (Mayersohn	   et	   al.,	   1983)	   (Preiss	   et	   al.,	   2007)	   (Nair	   et	   al.,	  
2014).	  In	  the	  study	  by	  Mayersohn	  et	  al	  cooked	  meat	  meal	  resulted	  in	  an	  average	  of	  180mg	  in	  
excess	   compared	   to	   that	   excreted	   on	   a	   control	   day.	   Our	   study	   showed	   a	   subsequent	  
increase	  in	  urinary	  creatinine	  following	  a	  meat	  protein	  meal	  as	  shown	  in	  Fig	  7.3	  (a).	  This	  rise	  
in	   urinary	   creatinine	   excretion	   following	   a	   meat	   meal	   can	   reduce	   the	   ACR	   as	   creatinine	  
forms	  the	  denominator	  in	  this	  ratio.	  	  
	  
Warram	  et	  al	  have	  previously	  demonstrated	  variability	  in	  ACR	  based	  on	  gender.	  In	  this	  study	  
with	  1613	  patients	  with	  type1	  diabetes	  and	  218	  healthy	  volunteers	  the	  range	  of	  ACR	  was	  25	  
to	   355	   μg/mg	   in	   females	   and	   17	   to	   250	   μg/mg	   for	   males.	   These	   gender	   specific	   ranges	  
correspond	  to	  AER	  of	  30	  to	  300	  μg/min.	  In	  the	  non-­‐diabetic	  healthy	  volunteers	  cohort	  ACRs	  
were	  below	  16	  μg/mg	  and	  the	  95th	  centile	   in	   females	  was	  25	  and	  17	  for	  men.	  The	  gender	  
difference	   is	   explained	   by	   higher	   muscle	   mass	   in	   males	   and	   higher	   serum	   and	   urinary	  
creatinine	  levels	  with	  consequent	  reduction	  in	  the	  ACR	  (Warram	  et	  al.,	  1996).	  
An	  infusion	  of	  amino	  acid	  or	  an	  acute	  protein	  load	  is	  known	  to	  increase	  creatinine	  clearance	  
(Bosch	   et	   al.,	   1983,	   Hirschberg	   et	   al.,	   1985).	   Our	   study	   demonstrates	   the	   effect	   of	   this	  
increased	  excretion	  of	  creatinine	  on	  albumin	  creatinine	  ratio.	  Most	  of	  these	  studies	  looking	  
at	   the	  acute	  effect	  of	  protein	   load	  show	  higher	  creatinine	  clearance	   in	  healthy	  volunteers	  
than	   patients	   with	   chronic	   kidney	   disease.	   This	   should	   mean	   that	   the	   rise	   in	   urinary	  
creatinine	  following	  cooked	  meat	  meal	  should	  be	  higher	  in	  healthy	  volunteers	  than	  patients	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with	   more	   severe	   CKD.	   However,	   our	   study	   shows	   that	   the	   fall	   in	   ACR	   increases	   with	  
worsening	  stages	  of	  chronic	  kidney	  disease.	  
Cooking	  converts	  creatine	  in	  meat	  into	  creatinine,	  which	  is	  absorbed	  from	  the	  gut.	  This	  has	  
been	  shown	  to	  increase	  serum	  creatinine	  by	  other	  authors	  and	  also	  in	  the	  previous	  study	  in	  
the	  thesis.	  This	  increased	  serum	  creatinine	  could	  raise	  urinary	  creatinine	  excretion,	  thereby	  
reducing	  the	  albumin-­‐creatinine	  ratio	  	  
Spot	  urine	  ACR	  makes	  clinical	  assessment	  for	  proteinuria	  immensely	  more	  easy	  compared	  to	  
timed/overnight	  urine	  collection.	  But	  clinicians	  should	  be	  aware	  of	  the	  variability	  of	  urinary	  
creatinine	  and	  the	  consequent	  effect	  on	  ACR.	  Cooked	  meat	  consumption	   is	  a	  major	  factor	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8.1	  Strengths	  and	  weaknesses	  of	  studies	  
The	  main	   strengths	   of	   these	   studies	   are	   that	   they	   attempt	   to	   answer	   important	   clinically	  
relevant	   issues;	   limitations	   of	   estimating	   GFR	   in	   the	   obese	   subjects	   and	   the	   reliability	   of	  
serum	  creatinine	  and	  eGFR	   following	  a	  meat	  meal.	   The	   studies	   involve	   real	  world	   routine	  
diabetes	  clinic	  patients.	  The	  main	   limitation	   is	   the	   relatively	   small	  number	  of	  participants,	  
which	  is	  primarily	  because	  of	  the	  intense	  nature	  of	  the	  interventions.	  
	  
Effect	   of	   obesity	   on	   eGFR	   in	   type	   2	   diabetes	   and	   derivation	   of	   obesity	   correction	  
equations:	  
This	  study	  had	  a	  well-­‐characterised	  study	  population	  of	  patients	  with	  diabetes	  and	  different	  
stages	   of	   chronic	   kidney	   disease	   with	   a	   wide	   range	   of	   eGFR	   from	   18.5	   to	   124.8	  
mls/min/1.73m2.	   The	   reference	   method	   for	   GFR	   measurement	   was	   51Cr-­‐EDTA	   method,	  
which	   has	   some	   limitations	   as	   mentioned	   in	   the	   introduction.	   The	   results	   may	   not	   be	  
directly	  comparable	   to	  many	  studies	  particularly	   from	  the	  United	  States	  as	   the	  commonly	  
used	  reference	  methods	  there	  are	  99	  Tc-­‐DTPA	  and	  125I	   Iothalamate.	  51Cr-­‐EDTA	  however	  has	  
definite	   advantages	   like	   stability	   and	   possibility	   of	   using	   stored	   samples	   and	   also	   is	   the	  
technique	   routinely	   used	   in	   our	   reference	   laboratory	   and	   across	   Europe	   in	   general.	   The	  
MDRD	  study	  used	  equation	  was	  derived	  using	   renal	   clearance	  of	   125I	   Iothalamate	  and	   this	  
could	  have	  contributed	  to	  some	  of	  the	  bias	  we	  observed.	  
Another	  limitation	  of	  our	  study	  is	  that	  in	  the	  calculation	  of	  GFR	  possible	  sex	  differences	  are	  
not	  addressed	  and	  also	  there	  is	  an	  imbalance	  between	  males	  and	  females	  in	  BMI	  <30.	  The	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MDRD	   equation	   includes	   a	   factor	   to	   correct	   for	   gender.	   	   Although	   the	   study	   was	   not	  
powered	  to	  investigate	  gender	  differences,	  we	  have	  analysed	  our	  data	  by	  gender	  categories;	  
in	  the	  obese	  subjects,	  there	  was	  no	  significant	  difference	  in	  bias	  across	  gender	  but	  overall,	  
females	  had	  higher	  bias.	  There	  is	  also	  an	  imbalance	  in	  the	  number	  of	  obese	  and	  non-­‐obese	  
subjects	  in	  this	  study.	  We	  employed	  a	  purposive	  or	  quota	  sampling	  from	  a	  hospital	  diabetes	  
clinic	  population	  to	  achieve	  the	  required	  numbers	  in	  the	  groups	  and	  as	  expected,	  the	  type2	  
diabetes	  clinic	  population	  was	  skewed	  towards	  obesity.	  
The	   suggested	   prediction	   equations	   needs	   patients	   BMI	   to	   be	   known	   which	   can	   make	  
automatic	   result	   generation	   challenging.	   However,	   we	   consider	   it	   possible	   that	   the	  
laboratory	  can	  apply	  such	  a	  correction	  if	  requested	  for	  an	  overweight	  or	  obese	  patient	  when	  
eGFR	  is	  an	  important	  determinant	  in	  the	  choice	  of	  antidiabetic	  medication.	  These	  correction	  
equations	   for	   the	   existing	   4-­‐variable	   MDRD	   equation	   need	   validation	   in	   larger	   external	  
datasets	   to	   attain	   better	   generalisability.	   One	   of	   the	   main	   challenges	   we	   faced	   is	   in	  
accessing	  data	  from	  studies	  that	  have	  used	  51Cr-­‐EDTA	  method	  for	  external	  validation.	  
	  
Effect	  of	  cooked	  meat	  protein	  on	  creatinine,	  eGFR	  and	  ACR	  
The	  main	  strengths	  of	  this	  study	  is	  that	  our	  study	  population	  had	  diabetes	  and	  well	  defined	  
CKD	   stages	   while	   previous	   studies	   were	   conducted	   in	   healthy	   volunteers	   or	   general	   day	  
units	   (Mayersohn	   et	   al.,	   1983,	   Preiss	   et	   al.,	   2007).	   This	   would	   make	   the	   study	   results	   more	  
relevant	   for	   patients	   with	   diabetic	   nephropathy.	   The	   intervention	   itself	   was	   more	  
standardised	   in	   that	   patients	   received	   same	   amount	   of	   protein	   load	   as	   they	   received	  
commercially	   packed	   and	   quantified	  meals.	   Like	   any	   other	   study	   of	   dietary	   interventions,	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there	  will	  be	  variability	   in	  absorption	  of	  cooked	  meal	  protein	   in	  various	   individuals,	  which	  
could	  affect	  the	  rise	  in	  serum	  creatinine.	  However	  our	  study	  draws	  comparison	  between	  rise	  
in	   serum	   creatinine	   in	   the	   same	   individual	   following	   meat	   and	   non-­‐meat	   meal.	   Some	  
previous	   studies	   have	   shown	   much	   more	   pronounced	   rise	   in	   serum	   creatinine	   of	   nearly	  
100%,	  but	  the	  amount	  of	  meat	  eaten	  by	  the	  healthy	  volunteers	  was	  much	  higher	  (Jacobsen	  
et	  al.,	  1979)	  while	  we	  administered	  a	  meat	  portion	  which	  would	  a	  normal	  helping.	  
There	  are	  some	  confounders	  that	  we	  were	  unable	  to	  control	  due	  to	  the	  nature	  of	  the	  study.	  
As	   the	  participants	  were	  only	  with	  us	   for	  a	  maximum	  of	  4	  hours	   in	  a	  day	   the	   food	   intake	  
during	  the	  rest	  of	   the	  day	  was	  not	  standardised	  although	  they	  were	  advised	  to	  have	  non-­‐
meat	  meals	  for	  the	  rest	  of	  the	  day.	  The	  amount	  of	  exercise	  and	  state	  of	  hydration	  are	  other	  
potential	  confounders	  in	  this	  study.	  Conducting	  these	  experiments	  in	  a	  residential	  manner,	  
which	   would	   significantly	   increase	   inconvenience	   to	   participants,	   could	   control	   these	  
confounders	  to	  a	  better	  extent	  but	  we	  feel	  it	  could	  have	  made	  recruitment	  of	  relatively	  high	  
numbers	  of	  participant	  more	  challenging.	  
	  
8.2	  Future	  directions	  
It	  is	  evident	  from	  our	  studies	  presented	  in	  this	  thesis	  and	  also	  other	  studies	  referenced	  here	  
that	   estimation	   of	   glomerular	   filtration	   has	   several	   variability	   and	   limitations.	   This	   is	  
particularly	  true	  when	  estimating	  GFR	  in	  the	  obese	  and	  morbidly	  obese	  subjects	  who	  form	  
an	   increasingly	   larger	  proportion	  of	  our	  patient	  population.	  This	  group	  of	  patients	  may	  be	  
seriously	   disadvantaged	   because	   of	   underestimation	   of	   GFR	   and	   being	   denied	   treatment	  
options	  for	  type2	  diabetes	  and	  potentially	  for	  other	  medical	  conditions.	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We	   need	   more	   studies	   with	   larger	   number	   of	   obese	   subjects	   to	   be	   able	   to	   derive	   new	  
equations	  to	  estimate	  their	  glomerular	  filtration	  rate.	  The	  current	  trend	  towards	  developing	  
well-­‐resourced	  obesity	   and	  bariatric	   assessment	   clinics	   in	   the	  NHS	   and	  world	  over	   should	  
help	  develop	  more	  robust	  datasets.	  	  
Indexing	  of	  GFR	  to	  BSA	  is	  clearly	  an	  area	  that	  needs	  more	  research,	  as	  it	  is	  a	  major	  factor	  in	  
the	   significant	   bias	   between	   measured	   and	   estimated	   GFR.	   This	   is	   particularly	   true	   for	  
patients	  with	  body	  sizes	  very	  different	  than	  average.	  It	  is	  possible	  to	  take	  away	  the	  effect	  of	  
indexing	  on	  eGFR	  by	  multiplying	  it	  by	  BSA	  and	  dividing	  by	  1.73;	  converting	  eGFR	  units	  from	  
mls/min/1.73m2	  to	  mls/min.	   	   A	   study	   looking	   at	   comparison	   between	  measured	  GFR	   (un-­‐
indexed)	   and	   eGFR	   in	   mls/min	   would	   be	   interesting	   to	   see	   if	   the	   bias	   can	   be	   avoided.	  
Another	  interesting	  study	  would	  be	  to	  compare	  GFR	  indexing	  with	  BSA	  calculated	  from	  ideal	  
body	  weight	  rather	  than	  the	  real	  body	  weight.	  	  
For	   the	  clinicians	   it	   is	   important	   to	   recognise	   the	  underestimation	  of	  GFR	   in	  obesity	  when	  
using	   the	  MDRD	   or	   CKD-­‐Epi	   equations.	   If	   a	   major	   clinical	   decision	   is	   based	   on	   the	   renal	  
function	   we	   should	   consider	   trends	   in	   serum	   creatinine	   or	   other	   indicators	   like	   24-­‐hour	  
urinary	  creatinine	  clearance	  or	  Cystatin	  C	  derived	  eGFR	  to	  have	  more	  information	  to	  make	  a	  
better	   judgement.	   Also	   meat	   protein	   meal	   induced	   rise	   in	   serum	   creatinine	   and	   drop	   in	  
urinary	   albumin	   creatinine	   ratio	   should	   be	   considered	   and	   a	   fasting	   sample	   requested	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